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Abstract  
Genome instability is a hallmark of human cancers. Patients with Bloom’s 
syndrome, a rare chromosome breakage syndrome caused by inactivation of the RecQ 
helicase BLM, result in phenotypes associated with accelerated aging and develop 
cancer at a very young age. Patients with Bloom’s syndrome exhibit hyper-
recombination, but the role of BLM and increased genomic instability is not fully 
characterized. Sgs1, the only member of the RecQ family of DNA helicases in 
Saccharomyces cerevisiae, is known to act both in early and late stages of homology-
dependent repair of DNA damage. Exo1, a 5′–3′ exonuclease, first discovered to play a 
role in mismatch repair has been shown to participate in parallel to Sgs1 in processing 
the ends of DNA double-strand breaks, an early step of homology-mediated repair. 
Here we have characterized the genetic interaction of SGS1 and EXO1 with other repair 
factors in homology-mediated repair as well as DNA damage checkpoints, and 
characterize the role of post-translational modifications, and protein-protein interactions 
in regulating their function in response to DNA damage. In S. cerevisiae cells lacking 
Sgs1, spontaneous translocations arise by homologous recombination in small regions 
of homology between three non-allelic, but related sequences in the genes CAN1, 
LYP1, and ALP1.  We have found that these translocation events are inhibited if cells 
lack Mec1/ATR kinase while Tel1/ATM acts as a suppressor, and that they are 
dependent on Rad59, a protein known to function as one of two sub-pathways of Rad52 
homology-directed repair.  
 xii 
Through a candidate screen of other DNA metabolic factors, we identified Exo1 
as a strong suppressor of chromosomal rearrangements in the sgs1∆ mutant. The Exo1 
enzymatic domain is located in the N-terminus while the C-terminus harbors mismatch 
repair protein binding sites as well as phosphorylation sites known to modulate its 
enzymatic function at uncapped telomeres. We have determined that the C-terminus is 
dispensable for Exo1’s roles in resistance to DNA-damaging agents and suppressing 
mutations and chromosomal rearrangements. Exo1 has been identified as a component 
of the error-free DNA damage tolerance pathway of template switching. Exo1 promotes 
template switching by extending the single strand gap behind stalled replication forks. 
Here, we show that the dysregulation of the phosphorylation of the C-terminus of Exo1 
is detrimental in cells under replication stress whereas loss of Exo1 suppresses under 
the same conditions, suggesting that Exo1 function is tightly regulated by both 
phosphorylation and dephosphorylation and is important in properly modulating the 
DNA damage response at stalled forks.  
 It has previously been shown that the strand exchange factor Rad51 binds to the C-
terminus of Sgs1 although the significance of this physical interaction has yet to be 
determined.  To elucidate the function of the physical interaction of Sgs1 and Rad51, we 
have generated a separation of function allele of SGS1 with a single amino acid change 
(sgs1-FD) that ablates the physical interaction with Rad51.  Alone, the loss of the 
interaction of Sgs1 and Rad51 in our sgs1-FD mutant did not cause any of the defects 
in response to DNA damaging agents or genome rearrangements that are observed in 
the sgs1∆ mutant. However, when we assessed the sgs1-FD mutant in combination 
with the loss of Sae2, Mre11, Exo1, Srs2, Rrm3, and Pol32 we observed genetic 
 xiii 
interactions that distinguish the sgs1-FD mutant from the sgs1∆ mutant. Negative and 
positive genetic interactions with SAE2, MRE11, EXO1, SRS2, RRM3, and POL32 
suggest the role of the physical interaction of Sgs1 and Rad51 is in promoting 
homology-mediated repair possibly by competing with single-strand binding protein RPA 
for single-stranded DNA to promote Rad51 filament formation.   
 Together, these studies characterize additional roles for domains of Sgs1 and 
Exo1 that are not entirely understood as well as their roles in combination with DNA 
damage checkpoints, and repair pathways that are necessary for maintaining genome 
stability. 
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Chapter One: 
Introduction 
 
Proper repair of DNA damage is essential for maintaining genome integrity and 
cellular function. Cells can encounter genomic insults via endogenous and exogenous 
damage caused by replication error, DNA damaging agents, reactive oxygen species, 
DNA base damage (such as deamination, alkylation), ionizing radiation, and ultraviolet 
rays [1]. Defects in genes that are involved in preventing genomic instability can lead to 
cancer, cell death, and premature aging; genomic instability is also a hallmark of 
cancer. A variety of enzymes contribute to the prevention of disease resulting from 
genes involved in the prevention of chromosome breakage (see Table 1). Defects in 
genes that prevent chromosome breakage results in severe phenotypes and an 
increased predisposition to cancer. In humans, defects in three helicases BLM, WRN, 
RECQ4  (listed in bold in Table 1) result in genetic disorders that lead to premature 
aging and early development of cancer. The helicases BLM, WRN, RECQL4, are three 
of the five helicases in humans that belong to the RecQ family of helicases so named 
after the first discovered in E. coli. The RecQ family of helicases has been implicated in 
DNA recombination and repair, highlighting their importance in maintaining genomic 
stability and prevention of disease. 
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Table 1.1 Chromosome breakage syndromes  
Syndrome/Disease Gene in Humans Cancer Predisposition/ 
Most common cancer 
Defect Reference 
Ataxia 
telangiectasia 
ATM Lymphomas, Leukemias  DNA damage 
checkpoint 
[2-4] 
Nijmegen breakage 
syndrome 
NBS1 Lymphomas Double strand 
break repair 
[5-7] 
Fanconi anemia FANC genes 
(A,B,C,D1,D2, 
E,F,G,J,L,M,N,O,P,Q) 
Leukemia, squamous cell 
carcinoma 
 
Genome 
Monitoring 
[8] 
Werner’s WRN Sarcomas Recombination [9-11] 
Bloom’s BLM Lymphomas, Leukemias 
Rothmund 
Thomson/ 
Rapadilino/ Baller-
Gerold 
RECQL4 Osteosarcoma/Lymphoma DNA 
replication 
Table adapted from a review by Duker (2002). 
Human Disease Linked to Defects in the RecQ helicases 
Bloom’s Syndrome 
Bloom’s syndrome (BS) is a rare autosomal recessive disorder as a result of the 
loss of function of BLM.  BS was initially described in 1954 by Dr. David Bloom in a case 
study of a two-year-old patient presenting telangiectatic erythema resembling lupus 
erythematosus from hypersensitivity to sun exposure, low birth weight, high-pitched 
voice, and short stature [12]. By 1965, nineteen individuals with the described syndrome 
were known. Of these patients, most were of Jewish ancestry, and some patients were 
siblings or had parents that shared common lineage; this led to the idea that this 
  3 
syndrome was inherited. It was also observed that chromosomes in Bloom's patients 
had increased genomic instability in the form of chromosome breakage, 
rearrangements, and an observed increase of sister-chromatid exchanges (SCE) 
something that is still used for diagnosis today [13-15]. Currently, the clinical features of 
BS are short stature, immune deficiency, insulin resistance, an increased risk for 
diabetes, low fertility, and an increased risk to develop cancer early in life [11, 16].   
 
Figure1.1 Clinical presentations of Bloom syndrome in individuals. Patient on the 
right has facial telangiectasias. The patients in the center are siblings with the person to 
the left positive for Bloom syndrome. Images are from the Bloom syndrome registry, 
Weill Cornell Medical College. 
[17] 
BS as a monogenic disorder and only requires the inactivation of the BLM protein 
as a result of a mutation.  The mutation that inactivates BLM in patients varies and is 
not as a result of a single unique mutation in BLM. Instead, some mutations have been 
found in BS patients that lead to a premature stop codon, truncated protein, or 
inactivation of the catalytic function of BLM [17]. BS has been found to be prevalent in 
the Ashkenazi Jewish population with the blmAsh (6-bp deletion and 7-bp insertion at 
nucleotide position 2281) mutation being the most common BS causing mutation [18, 
19].   
  4 
In C. elegans, the loss of function of the BLM ortholog, Him-6 has adverse effects 
on lifespan, increased germline apoptosis, mortal germ-line phenotype, IR sensitivity, 
and low brood size, all linked to genomic instability [20, 21].  In mouse, the BLM-/- 
mutation is embryonic lethal and has been shown to increase apoptosis during 
embryogenesis [22]. Mice containing a loss of function mutation in BLM that was not 
lethal were created and found to have an increased predisposition to cancer. In this 
study, the mice heterozygous for a loss-of-function mutation in BLM developed more 
metastatic T-cell lymphomas after injection with murine leukemia virus.  The BLM-/+ 
mice were crossed to mice that were heterozygous for the ApcMin/+ mutation, a mutation 
known to mediate intestinal tumorigenesis, and more intestinal tumors were observed in 
the BLM-/+ than the Blm+/+ mice. Moreover, the non-mutant allele of BLM allele was found 
to be functional in these tumors suggesting BLM haploinsufficiency [23]. Interestingly, 
BLM haploinsuffinciency in the formation of colorectal cancer has also been implicated 
in humans heterozygous for blmAsh  [24]. 
Functionally, BLM is a helicase with 3′-5′ polarity, and it is expressed highly in 
S/G2 phase of the cell cycle [25-27]. BLM is expressed in the thymus, testis, and spleen 
and localizes at promyelocytic leukemia (PML) bodies and telomeres [28-30]. BLM is 
known to function in resection of DNA double-strand breaks (DSB) and has a role in 
dissolving recombination intermediates and functions in a complex with Top3α, Rmi1, 
and Rmi2 to dissolve double Holliday junctions (dHJ), as well as the reversal of D-loops 
coated with Rad51 in vitro [31-34].  BLM is a target for the checkpoints ATM and ATR 
and is phosphorylated at residues T99 and T122 [35-38]. Cells treated with hydroxyurea 
(HU) have stalled replication. Cells that have a BLM mutant unable to be 
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phosphorylated fail to recover from HU treatment and stall at the G2/M checkpoint. It 
was also shown that this BLM mutant had no effect on sister chromatid exchange 
frequency, leading to the idea that BLM is necessary for replication to restart [35, 37]. 
Besides, it has been shown in vitro that BLM can catalyze replication fork reversal, a 
mechanism suggested to promote lesion bypass [39, 40].   
 
 Werner Syndrome 
Werner syndrome (WS) is a rare autosomal recessive disorder linked to defects 
of the RecQ helicase WRN. Werner syndrome is considered adult progeria disorder 
[41]. Otto Werner first described WS in his doctoral dissertation on the presentation of 
cataracts with scleroderma observed in four out of five siblings in a single family. The 
parents of the patients appeared normal, and one sibling (and her three children) did not 
display the characteristics of premature aging that the other siblings exhibited.  Otto 
Werner compared this case with those described previously by Rothmund in 1868. 
Between 1934 and 1941 Oppenheimer and Kugel, both internists had assigned Werner 
syndrome to the described disease, and in 1996 Epstein et al. distinguished WS from 
what was later designated Rothmund-Thompson Syndrome (RTS), another syndrome 
that results from the dysfunction of another RecQ helicase, RecQL4 [41-44].  
WS does not typically present symptoms until after the patient is ten years old 
and diagnosis must meet the criteria either of all cardinal symptoms or just three of the 
cardinal symptoms and genetic confirmation.  Suspected cases are those that present 
at least two of the cardinal symptoms and at least two additional symptoms that are not 
as common in all WS patients. 
  6 
Cardinal symptoms were categorized in a survey of WS patients as those that 
appear early and are likely found in >75% of WS patients.  Cardinal symptoms include 
progeroid changes of hair, cataracts, skin ulcers, soft tissue calcification, bird-like face, 
and abnormal voice (hoarse, high-pitched, squeaky). The list of symptoms that are not 
as prevalent across all WS patients but are used for diagnosis is abnormal glucose or 
lipid metabolism, bone deformation or abnormalities, cancer, parental consanguinity, 
premature atherosclerosis, hypogonadism, and short stature [41, 45]. Genetic testing is 
now included as part of diagnostic criteria to help distinguish WS from other syndromes 
caused by defects in other RecQ helicases due to the common symptoms they share. 
Genetic testing can help distinguish the syndromes based on the defects in BLM (BS), 
RECQL4 (RTS) [41, 45] as well Hutchinson-Gilford progeria syndrome, which is caused 
by the mutation of LMNA, a gene that codes for a component of the nuclear envelope, 
not a RecQ-helicase [46].  
 
Figure 1.2 Accelerated aging of an individual with Werner syndrome.   Individual 
with Werner syndrome at ages thirteen, twenty-one, forty-eight, and fifty-six (from left to 
right) exhibits signs of accelerated aging. Image from the University of Washington. 
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Similar to its RecQ family member, BLM, defects in WRN lead to an increased 
predisposition to cancer, in particular sarcomas, and increased cellular defects 
associated with genomic instability. WRN structurally shares all the domains in BLM 
except the strand exchange domain, and instead, the N-terminus contains a 3′-5′ 
exonuclease domain only found in its homolog in X. laevis, FFA-1 (Figure 1.4) [47]. 
Over seventy mutations in WRN have been identified in WS patients, a majority 
resulting in a premature stop codon, insertions/deletions, genomic rearrangements, 
missense mutations, or splicing defect resulting in a functionally null WRN protein [48].  
In mice, the knockout of WRN did not appear to age prematurely, although Lebel 
et al. reported that two male mice had extensive myocardial fibrosis at ten months and a 
female developed T cell lymphoma at 13.5 months not observed in the control mice [49-
51].  When WRN-/- mice were crossed to have a defect of the RNA in telomerase, age-
related defects were observed such as graying hair, alopecia, osteoporosis, type II 
diabetes, cataracts, and premature death [52, 53]. 
Functionally, WRN function has been implicated in different DNA repair 
pathways. WRN physically interacts with the tumor suppressor P53. It is believed in 
cells under replication stress, the physical interaction of WRN and P53 is vital in 
regulating WRN exonuclease activity and helicase activity at Holliday junctions [54-57]. 
WRN deficient cells are sensitive to DNA damaging agents camptothecin (CPT), 4-
nitroquinoline 1-oxide (4-NQO), and MMS [58, 59].  
 In yeast, while human BLM can complement the sgs1∆ defect of the slow growth 
in cells lacking Top3, WRN was not capable of complementation [60]. In other 
organisms, WRN homologs have many functional differences. In Xenopus egg extracts, 
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the WRN homolog FFA-1 accumulates on the chromatin following replication arrest and 
the induction DNA double-strand breaks while the BLM homolog, xBLM only slightly 
increased under these conditions [61]. WRN in Xenopus also plays a more dominant 
role than human WRN in DNA break end resection [62, 63]. In humans, WRN appears 
to play a role in resection with BLM.  In mouse, WRN is found only in the nucleoplasm 
and does not have the NLS found in human WRN that is necessary for nucleolar 
localization [64], and as WRN-/-  mice appear to develop normally, it is unsurprising that 
this would not show any defects. In mice, the localization does not seem to play a role in 
its function whereas in humans mutations that truncate the NLS in WRN are known to 
cause WS [64, 65]. Together this highlights an important role for WRN in humans and 
the differences in function in other organisms. 
 Rothmund-Thomson Syndrome 
 Rothmund-Thomson Syndrome (RTS) is a rare autosomal recessive genetic 
disorder caused by defects in the RecQ helicase RECQL4. Patients with RTS exhibit a 
characteristic face rash, Poikiloderma, as well as a combination of features including 
short stature, alopecia including eyelashes and eyebrows, juvenile cataracts, skeletal 
abnormalities, a predisposition to osteosarcoma and malignant tumor originating in 
bone, as well as premature aging (figure 1.3) [66-68]. RTS was first reported by in 1868 
by German ophthalmologist Rothmund. In 1936, the English dermatologist Thomson 
had three similar patients that displayed Poikiloderma, short stature and had skeletal 
defects, including bilateral thumb aplasia and hypoplastic radii and ulnae, and unlike the 
previously reported case, these patients did not have cataracts [66]. In 1957, the name 
‘Rothmund-Thomson syndrome' was adopted after three other patients with the 
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described clinical features were reported by Taylor [69]. RAPADILINO and Baller-
Gerald syndrome (BGS) are also associated with recessive mutations in the RECQL4 
gene.  Baller-Gerold syndrome is characterized by radial hypoplasia and 
craniosynostosis. RAPADILINO is mainly observed in Finland, and the name of the 
syndrome is derived from the clinical features of RAdial hypoplasia, Patella hypoplasia 
and cleft or Arched palate, DIarrhoea and dislocated joints, LIttle size and limb 
malformation, slender Nose and nOrmal intelligence [70-73]. 
The molecular basis of the defects in RECQL4 that lead to RTS is yet to be 
elucidated. Over 50 mutations of RECQL4 are known to be associated with the 
development of RTS, and four are either RTS and RAPADALINO, or RTS and BGS 
associated [74-77]. These changes result in missense mutations, resulting in premature 
stop codons, frameshift from insertion/deletion mutations, and mutations that cause mis-
splicing alterations.   
 Knockout mice that disrupted exons 5–8 were embryonic lethal between 3-6 
days. When knockout mice were generated by deleting exon 13, a coding exon of the 
helicase domain, the mice were viable, but only 5% survived two weeks. The survivors 
exhibited severe growth defects, abnormalities in several tissues including skin and 
bone defects, as well as impeded cell division [78]. The knock-out mice exhibit RTS 
phenotypes in seen humans, making them an excellent model to study the molecular 
defects. In another study, a viable Recql4 mutant mouse was created by replacing a 
1075 bp fragment spanning from within exon 9 through exon 13, a mutation located in 
the helicase domain, with a PGKHprt mini-gene. Fibroblast from this knockout mouse 
displayed an increase in genomic instability in the form of aneuploidy, premature 
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chromosome separation, and an increase of spontaneous micronuclei. It was also 
suggested that a cohesion defect contributes to the chromosomal instability [79].  These 
mouse studies indicate that function of RECQL4 resulting from specific defects in DNA 
repair mechanisms and can be explored in mice as they mimic the defects observed in 
humans. 
 
Figure 1.3 Clinical features of patients with Rothmund-Thomson Syndrome. The 
individual on the left shows the characteristic facial rash Poikiloderma. The individual in 
the center panel is 21 years old and has Poikiloderma with alopecia. The right panel 
illustrates the hand of an individual with RTS that has thumb aplasia. Images are from 
Larizza 2010 [66].  
 
RecQ family of helicases 
RecQ helicases unwind DNA from 3’-5’ and belong to the SF2 family of 
helicases.  In S. cerevisiae, S. pombe, only have a single known RecQ-like helicase 
Sgs1, and Rcq1, respectively. The number of RecQ-like helicases varies in single and 
multicellular organisms as is illustrated by the number of different homologs found in 
humans (BLM, WRN, Recql1, Recql4, Recql5) and C. elegans (HIM-6, WRN-1, RECQ1, 
and RECQ5) [80, 81].  RecQ helicases are defined by a conserved helicase domain 
consisting of seven helicase motifs [82, 83]. Outside of the helicase domain both the 
length and domains of the N and C-terminus vary between species. In the founding 
member RecQ in E. coli, there are two additional domains the RecQ-carboxy-terminal 
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(RQC), unique to RecQ family members, and the Helicase and RNase D C-terminal 
(HRDC).  The RQC and HRDC domains are not found in all members of the RecQ 
helicases in other organisms, and conversely, RecQ helicases have domains not found 
in the founding member, E. coli RecQ for example in humans, WRN also has an 
exonuclease domain and nuclear localization signal (see Figure 1.1). 
  
Figure 1.4 RecQ helicase conservation in unicellular and multicellular organisms. 
The helicase core is the most conserved domain containing motifs for ATP binding and 
hydrolysis. Many RecQ family members contain the RecQ C-terminal (RQC) domain, 
the conserved helicase and RNase D C-terminal (HRDC). WRN, BLM, and RECQL1 
contain a nuclear localization sequence. WRN has an exonuclease domain.  
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   Initially discovered in a search for mutants that resist thymine starvation, E. coli 
RecQ was found to be involved in the RecF pathway.  The recq mutant was described 
to be defective in recombination and sensitive to UV-induced damage [84]. The crystal 
structure of E. coli RecQ and human BLM and WRN have revealed the structure of the 
helicase, RQC, and HRDC domains.  This revealed two regions that form a cleft 
containing an ATP-binding site in the helicase core and opposite that, on the cleft, is a 
ssDNA binding site. After the seven helicase motifs is a zinc-binding domain that 
contains four conserved cysteine residues, and a winged-helix for DNA binding, helix-
hairpin-helix, β motif that forms the RQC domain that together is required for catalytic 
function [85]. All mutations in BS patients have been described to inactivate in the 
catalytic function of BLM or lead to premature protein-translation termination [17]. 
The HRDC domain is found in some members of the RecQ helicases.  It is not 
required for enzymatic function, and exact function of the HRDC has yet to be 
elucidated. In S. cerevisiae (Sgs1) and E. coli (RecQ), the HRDC domain was capable 
of binding ssDNA, but human BLM and WRN were not found to have this capability in 
vitro [86-90].  The function of the HRDC domain may be different in various organisms, 
as is implicated by the reduced conservation. In human BLM, the HRDC domain has 
been found to be required for dissolution of Holliday Junctions, recruitment of BLM and 
WRN to DSBs, and induced DNA damage by methyl methanesulfonate (MMS) and 
mitomycin C [91, 92]. 
Sgs1 in S. cerevisiae and BLM in humans have a domain in the unstructured N-
terminus that has been shown to interact with single strand DNA, has strand exchange 
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capability in vitro, and the function of which will be discussed with the role of complex 
formed by Sgs1 with Top3-Rmi1 [93].  
 
RecQ-like helicase Sgs1 in Saccharomyces cerevisiae. 
Yeast has been utilized as a model organism to study RecQ helicase function in 
its role to protect the genome [80].  Sgs1, the only RecQ helicase in S. cerevisiae, was 
discovered as a suppressor of the slow growth phenotype observed in top3∆ mutants 
and subsequently identified as a possible BLM homolog [94, 95].  Sgs1 function in 
maintaining genomic stability is diverse and has been shown to work in both 
recombinogenic and anti-recombinogenic capacity to promote repair and prevent 
illegitimate recombination as well.  Thus far, Sgs1 is known to play a role in both early 
and late recombination repair of DNA breaks, the start of stalled replication forks, 
telomere maintenance, and in meiotic recombination [96-99].  Cells lacking Sgs1 are 
sensitive to irradiation (IR) damage, DNA damaging agents, have increased 
accumulation of gross chromosomal rearrangements [100-104].   
 
Sgs1 substrates and physical interaction partners. 
Sgs1 preferentially binds specific DNA structures and physically interacts with 
many DNA repair proteins.  Sgs1 has been found to preferentially bind forked DNA, 
DNA with 3′ ssDNA overhangs, and G4-quadruplexes; it also binds blunt-ended duplex 
DNA with less affinity than the other DNA structures tested in vitro (Figure 1.2). Sgs1 
can unwind these structures as well as Holliday junctions and DNA structures that 
contain a bubble [97, 105-110]. Sgs1’s ability to unwind these structures in vitro 
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demonstrates its enzymatic capabilities in both its recombinogenic and anti-
recombinogenic functions. 
RecQ helicases in other organisms demonstrate varying capability to unwind 
different DNA structures (Table 1.2). In humans, BLM has also been found to bind and 
unwind the same structures as Sgs1 and additionally been found to unwind D-loops, 
and Rad51-coated strand invasion structures in vitro [106]. The differences in the ability 
of different RecQ helicases in different organisms may be due to the differences in 
domains. For example, in humans, WRN has an exonuclease domain that appears to 
be absent in C. elegans.  Wrn-1 in worms seems to have an additional function 
especially in the context of unwinding D-loops. Human WRN, in addition to unwinding, 
also recognizes the 3′ invading strand and the exonuclease domain can digest it 
independently of the helicase function. Much is left to be elucidated about the 
recombinogenic, and anti-recombinogenic functions in the RecQs across various 
organisms and additional analysis of their enzymatic activities on the same substrates 
would assist in the interpretation of phenotypes associated with genomic instability.  
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Figure 1.5 Sgs1 preferential DNA substrates. 
Representative figures of DNA substrates Sgs1 has been shown to unwind. It has been 
reported that Sgs1 can most efficiently unwind the Holliday junction, followed by the 
forked and ssDNA overhangs. Sgs1 can also unwind bubble and G4 quadruplex 
structures. This figure has been adapted from (Larsen and Hickson, 2013). 
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Table 1.2. RecQ -like Helicases Unwind a Variety of DNA Structures 
 
 
E.coli S. 
pombe 
S. 
cerevisiae 
D. 
melanogaster 
C. elegans H. sapiens 
Substrate RecQ Rqh1 Sgs1 DmBlm Him-6 Wrn-1 BLM WRN RECQL1 RECQL4 RECQL5β 
dsDNA + + + n.d. - + RPA - - - n.d. n.d. 
3′ 
overhang  
+ n.d. +++ + + + + + + + + n.d. 
3′ 
overhang 
DNA RNA 
hybrid 
n.d. n.d. + n.d n.d. n.d. + + - n.d n.d. 
 5′ 
overhang 
+ n.d. + ~/- - - n.d. n.d. ~/- - n.d. 
5′ flap n.d. n.d. n.d. n.d. n.d. + n.d. + n.d n.d n.d. 
Holliday 
Junction 
+ n.d. +++ n.d. n.d. + +++ ++ + - +RPA 
Y structure + n.d. +++ ++ ++ + +RPA + ++ + +RPA 
D-loop ++ n.d. +++ n.d. n.d. + + + n.d. - n.d. 
Telomeric 
D-loop 
n.d n.d. + n.d. n.d. n.d. + + + + - 
G4 
Quadraplex 
+ n.d. + n.d. n.d. n.d. +++ +++ - - n.d. 
Bubble n.d. n.d. + n.d. n.d. + + +++ + - n.d. 
Gray cells indicate an ability to bind the DNA structure with increased affinity from lightest to darkest gray. 
White cells are structures not tested for binding affinity to that DNA structure.   
n.d. – Ability to unwind was not determined. 
~/- indicates a partial ability to unwind the DNA structure. 
+RPA indicates unwinding was either only observed with the addition of RPA or is stimulated in the presence of RPA. 
Table was compiled from supporting data from these sources [25, 32, 33, 40, 97, 105-151]
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Sgs1 also interacts with many DNA metabolic factors involved in DNA repair.  
Mlh1, a factor involved in the repair of base mispairs generated during DNA replication 
has been found to physically interact with Sgs1, and this interaction is conserved in 
human BLM [152, 153]. The Mlh1 interaction was shown via yeast-two-hybrid with both 
human and yeast Mlh1.  
The N-terminus of Sgs1 is unstructured and is not required for the catalytic 
function [242]. The N-terminus of Sgs1 has been implicated in strand exchange and 
physically interacts with Top3 in a complex with Rmi1. The complex of Sgs1/Top3/Rmi1 
is conserved in humans as the BLM-TOP3α-RMI1/RMI2 [94, 154-157]. The 
Sgs1/Top3/Rmi1 complex is known to function late in homology-mediated repair to 
dissolve recombination intermediates to result in non-crossover products [97, 114, 158-
160].  Sgs1 was initially found to suppress the slow growth phenotype of a top3∆ mutant 
and as has also been shown Sgs1 to help produce the recombination substrate that 
requires Top3 [94].  
The single strand binding protein, RPA, has been shown to physically interact 
with Sgs1 in vivo and in vitro in the acidic region of the N-terminus [161].  RPA is known 
to stimulate BLM and WRN in humans [147] and Sgs1 in yeast in vitro [162] as well as 
preventing reannealing of ssDNA [163, 164].  
Via yeast-two-hybrid and co-immunoprecipitation, it was found that another DNA 
helicase physically interacts with the N-terminus of Sgs1, the anti-recombinase Srs2 
[165].  SGS1 and SRS2 also genetically interact as shown by the severe growth defect 
of cells lacking them both [166, 167], a defect that is dependent on recombination 
protein Rad51 [168]. It is thought that in the absence of Sgs1, recombination 
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intermediates accumulate and Srs2 dismantles the Rad51 filament that generates these 
recombination intermediates that if left unresolved are toxic [168-173]. Rad51 was also 
found to interact with the C-terminus of Sgs1 via yeast-two-hybrid, and in humans, this 
interaction also occurs between Rad51 and BLM at both the N- and C-terminus [174]. 
 
DNA double-strand break repair 
 Two pathways are known to repair dsDNA breaks, nonhomologous end-joining 
(NHEJ) and homologous recombination (HR).   Sgs1 is known to function in both early 
and late steps of HR repair, and its function determines the end repair product. NHEJ 
repairs a break by ligating the two ends of the break indiscriminate of homology and 
loss or gain of a few nucleotides in this process together makes this process to be 
regarded as error-prone [175].  Repair by NHEJ is the preferred method of repair in G1 
as there is no sister chromatid to use as a template for HR repair [176-179]; thus, HR 
repair is the preferred mechanism of repair during S/G2 phases.      
 
Common early steps of HR repair of DNA double-strand breaks 
In S. cerevisiae, once a DNA double-strand break occurs it is believed that there 
is competition between the non-homologous end joining pathway proteins (Ku70/80 
from here on called Ku complex) and the Mre11-Rad50- Xrs2 (MRX) to bind to the 
break ends [180, 181].  The prevention of repair by NHEJ is achieved by the small 
range resection of the break by the MRX complex in yeast with the additional help from 
Sae2 to remove the Ku complex from the DNA ends [182-184]. Phosphorylation of Sae2 
by cyclin-dependent kinase Cdc28 to promote MRX function in end resection has been 
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shown in vitro and in vivo although the exact mechanism of how Sae2 stimulates MRX 
function is yet to be elucidated [176, 177]. Resection by MRX/Sae2 leaves ~100-200 
nucleotide 3′ overhangs that are then coated by ssDNA binding protein RPA to promote 
HR repair [185-188].  Stimulation of MRX activity has been suggested to also be 
necessary for the removal of MRX as it has been shown in the absence of Sae2, Mre11 
is persistent at DNA ends and as a result regulation of the DNA damage checkpoint is 
defective [189, 190]. In humans, the MRX complex is MRN (Mre11-Rad50-Nbs1) and 
functions similarly to MRX, and defective Nbs1 is associated with the Nijmegen 
breakage syndrome [5-7].  
Following short-range resection by MRX, Sgs1/Dna2, and Exo1 are recruited to 
the RPA coated 3′ single-strand DNA and redundantly resect leaving 2000-6000 
nucleotide 3′ overhangs that will be used in the search for homology [162, 185, 191, 
192]. Sgs1 acts a helicase providing the substrate for Dna2 endonuclease activity to 
cleave the unwound DNA while Exo1, a 5′-3′ exonuclease, redundantly resects the DNA 
ends without the need of a helicase [185, 193-195]. Sgs1 and Dna2 have also been 
shown to physically interact in vitro. The Sgs1/Dna2 physical interaction has not been 
mapped to specific domains of the proteins but the function if the interaction has been 
determined to be preferential degradation of the 5′ strand by Dna2 [196]. Loss of Sgs1 
and Exo1 prevent any long-range resection, and the sgs1∆ exo1∆ mutant is 
hypersensitive to DNA damaging agents and has a high rate of gross chromosomal 
rearrangements as a result [192]. The long-range resection by Sgs1 and Exo1 produces 
the ssDNA substrate that allows for Rad51 filament strand invasion to continue 
homology-directed repair.  
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In the case of partial or incomplete long-range resection of HO-induced DNA 
breaks, recombination can still occur but can lead to aberrant repair by de novo 
telomere addition and break-induced replication [197, 198]. Recently, in the case of IR-
induced breaks during the G2 cell cycle phase, repair by recombination still occurs in 
the absence of Sgs1 and Exo1 resection and is not repaired by de novo telomere 
addition [199] 
 
Figure 1.6 Early steps of DNA double-strand break repair. Rad9 is bound to DNA in 
the absence of DNA damage but accumulates at DNA breaks. In the event of a DSB 
during G1, Ku complex binds the DNA end, committing repair to NHEJ and preventing 
HR repair.  During S/G2 both Ku and the MRX complex competitively bind the end of 
the DNA break. Sae2 is phosphorylated by Cdc28 (not shown) stimulating end 
processing by MRX, liberating both Ku and the MRX complex from the DNA ends.  This 
end processing leaves a small 3′ DNA substrate that is quickly coated with single-strand 
binding protein RPA and is further processed by Sgs1/Dna2 and Exo1 leaving longer 3′ 
overhangs to be used in the homology search in HR repair. Rad9 accumulates following 
the DNA break and creates a physical obstacle that regulates Sgs1 mediated end 
resection. 
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Regulation of Sgs1 and Exo1 resection is still not well understood, but a few 
mechanisms stimulate and inhibit their role in end resection. Ku complex bound DNA 
ends have been found to prevent Exo1 mediated end resection in vitro and loss of Ku 
has been found to suppress resection defects in cells lacking resection by MRX/Sae2 
[181, 183, 200]. It is also suggested that MRX and Sae2 recruit Exo1 to the break and in 
humans [201], BLM has been shown stimulates Exo1 activity [192, 202]. RPA is known 
to stimulate the resection activity of Sgs1 in vitro and is required for extensive end 
resection in vivo [196]. More recently in humans a novel protein, DNA helicase B 
(HELB), has been identified in control of resection during G1 through its physical 
interaction with RPA although the exact mechanism is yet to be determined [203]. The 
checkpoint adapter protein Rad9 is known to be bound to DNA even in the absence of 
DNA damage but in the event of a dsDNA breaks more Rad9 is recruited to the DNA 
ends and is suggested to create a physical barrier for Sgs1 function [204-206]. 
 
HR directed repair following Sgs1 and Exo1 resection of DNA ends 
Sgs1 plays a role later in HR in promoting noncrossover repair products (Figure 
1.4). Following resection, Rad51 displaces RPA on the 3′ single-strand DNA. Rad51 is 
recruited by Rad52 to form the presynaptic filament [207-209]. The Rad51 filament is 
then stabilized by Rad55/57 in preparation for strand invasion for the homology search 
[210, 211], which is assisted by Rad54 in stabilization in forming the D-loop [211, 212].  
Srs2 can reverse strand invasion at this point to prevent aberrant repair, and this 
coincides with the genetic interaction observed in sgs1∆ srs2∆ mutant since 
recombination intermediates that are formed are unable to be reversed or dissolved 
  22 
[166, 168, 213]. Following strand invasion, synthesis-dependent strand annealing can 
occur that requires Sgs1 to displace the new strand, a function dependent on its 
helicase function, to allow annealing and the removal of the flap [214]. If a second end 
is captured a double Holliday junction (dHJ) is formed and as the dHJs converge it 
forms a hemicatenane that is dissolved by the Sgs1/Top3/Rmi1 complex [114, 160] 
Dissolution of the HJ requires Top3, and top3Δ mutants are slow growing.  Slow growth 
of top3Δ is suppressed with the loss of Sgs1 as it is involved in the early steps that 
allow for HJs for form [94]. In C. elegans, the loss of Top-3α in him-6 worms rather than 
suppressing chromosomal aberrations resulted in more significant defects, including 
chromosomes in the gonad that appeared to be clumped together and first filial 
generation of worms were expectedly sterile.  It was found by the same group that 
Top3-α and Him-6 physically interact and either the N- or C-terminus of Him-6 is 
enough for this interaction to occur. These similarities and differences from yeast and 
worm indicated that while these are conserved interactions, there are differences in how 
they function [215].  In the absence of Sgs1 endonucleases such as Yen1 can resolve 
the dHJ and this results in a half of the repair products as non-crossovers and half as 
crossovers [216, 217].  
 
The role of Sgs1 at stalled replication forks 
In S. cerevisiae, the sgs1∆ mutant is highly sensitive to the DNA damaging 
agents HU and MMS that stall replication forks [60]. It has been shown that Sgs1 
physically interacts with Rad53 in vitro and in vivo [161, 218] in cells treated with 
hydroxyurea and this activates Rad53's kinase activity, an event independent of Sgs1 
  23 
helicase function. The activation of the checkpoint in MMS treatment appears to be 
regulated differently than what is observed in HU-treated cells, as Top3 and Rmi1 were 
not required for this activation in HU but are necessary for full activation of Rad53 in 
MMS treated cells [169, 219].  Sgs1 is also implicated in error-free damage bypass at 
stalled replication forks by template switching and regressed forks as the intermediates 
resemble those Sgs1 is known to dissolve in the homology-mediated repair of double-
strand breaks [220].  
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Figure 1.7 Role of Sgs1 in late steps of homology-mediated repair. 
(A) The Rad51 filament coating the 3′ single-strand DNA ends are stabilized by Rad55 
and Rad57 (B) which is then assisted by Rad54 to form the (C) D-loop for the search for 
homology and DNA synthesis can occur. The D-loop structure that can be reversed by 
Srs2 (D). (E) Synthesis-dependent strand annealing, Sgs1 can displace the invading 
strand which then can be annealed, the flap removed and ligated (F) to form a 
noncrossover repair product (G). If a second DNA end is captured, a double Holliday 
junction is formed (H). The two branches migrate toward each other (I) and can either 
be cut by an endonuclease such as Yen1 (J) resulting in half crossover and have 
noncrossover products or form a hemicatenane that is then dissolved by the Sgs1-
Top3-Rmi1 complex.  
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The role of Sgs1 in meiosis 
 Sgs1 has a role in meiosis. Diploids homozygous for the deletion of SGS1 can 
complete meiosis, but it takes a longer amount of time to complete meiosis than in 
wildtype cells and produces fewer viable tetrads, indicating a role for Sgs1 in meiosis 
[221, 222]. It was, also shown that there is an increase in nondisjunction in this mutant, 
as was observed in a red/white colony sectoring assay where the color of the colonies 
formed indicate chromosome loss and nondisjunction [222].  Truncation studies of the 
C-terminus have indicated that the helicase domain is dispensable for Sgs1 function in 
meiosis [103].  SGS1 and MLH1, a gene encoding a protein involved in mismatch 
repair, have a genetic interaction indicating a role in the resolution of joint molecules in 
meiosis. In a recent study, it was shown that in conjunction with Exo1, Mlh1 promotes 
joint molecule resolution to produce crossover products with Sgs1 while Sgs1 alone 
produces non-crossover products. Interestingly, Mlh1 physically interacts with the C-
terminus of Sgs1 in the region previously found to be dispensable for Sgs1's role in 
meiosis, indicating that the physical interaction of Sgs1 and Mlh1 is not required for its 
role in meiosis. Even with the loss of the nucleases known to act in joint molecule 
resolution into crossover and non-crossover products [152], Sgs1 could still carry out 
some of this function. In the absence of nucleases Yen1, Mus81-Mms4, Slx1-Slx4, 
crossover products still form but joint molecule resolution is dependent on Sgs1 in this 
context [223]. 
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DNA repair exonuclease, Exo1 
 Functions of Exo1 in mismatch repair  
Exo1 is a 5′→3′ exonuclease belonging to the Rad2p family of nucleases that are 
characterized by their N-terminal and Internal nuclease domains, sequence identity, and 
structure specificity.  The Rad2p family is divided into three classes categorized by the 
amino acid identity and positions of the blocks of homology; EXO1 is in the third class 
with the most amino acid similarity to the other family members contained in the N-
terminal and Internal catalytic domain [224, 225].   
Yeast Exo1 was initially discovered in Schizosaccharomyces pombe in a search 
for recombination proteins induced in cells undergoing meiosis and was subsequently 
found by the same group to be a protein involved in mismatch repair [225, 226].   
While investigating Exo1’s role in meiosis, Szankasi and colleagues observed a mutator 
phenotype in an exo1∆ mutant generated in an ade6- strain.  The ade6- strains, grown 
on adenine limiting media typically appear as red colonies and the exo1∆ mutant had 
the frequent appearance of white colonies despite being confirmed as ade6-.  The 
mutator phenotype seen in the exo1∆ mutant in the ade6- background implied mutations 
in genes upstream of ade6- in the adenine pathway, possibly due to a defect in mutation 
avoidance.  At the time, no eukaryotic exonucleases had been found to play a role in 
mismatch repair.  Following this discovery, the S. cerevisiae homolog of S. pombe, 
EXO1, was identified. Further identification of Exo1 in mismatch repair was found via 
Yeast-two-hybrid and co-immunoprecipitation as Exo1 physically interacts with Msh2 
and Mlh1. There was also an epistatic relationship of the exo1∆ msh2∆ mutant in the 
rate of spontaneous mutations observed in the msh2 mutant [152, 227]. Human EXO1 
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was identified, and the physical interaction of human Exo1 and Msh2 was observed and 
linked to mismatch repair [228, 229]. Following the discovery of EXO1’s role in 
mismatch repair, it was further characterized by Tran, Erdeniz, Dudley, and Liskay [194] 
by identifying phenotypes associated with the enzymatic function of Exo1. Th exo1∆ 
mutants were found to be sensitive to the DNA alkylating agent MMS, and a mutator 
phenotype was observed in the exo1∆ mutant as well as the nuclease deficient mutant 
that was dependent on Exo1’s enzymatic function. 
 
Regulation of Exo1 in response to DNA damage 
Uncapped telomeres appear as a one-sided break, and the MRX complex binds 
the telomere preventing Ku from binding. MRX in this instance, unlike its role at double-
strand breaks, instead of stimulating Exo1 activity it prevents Exo1 activity and recruits 
telomerase instead [230, 231].  It has been observed in yeast that Exo1 activity is 
negatively regulated by Mec1-dependent phosphorylation of four serine residues (372, 
567, 587, 692) found in the C-terminus [232]. The serine residue 372 was also found in 
a screen for phosphorylated sites in response to MMS treatment [233].  In humans, nine 
phosphorylation sites (S376, S422, T581, S598, S623, S639, S660, S674, S746) have 
been identified in the C-terminus of Exo1 in cells that are untreated, and three (S454, 
T621, S714) that are suggested to reduce Exo1 protein stability in response to stalled 
replication forks, IR and CPT-induced DSBs [234, 235]. Phosphorylation of the C-
terminus of Exo1 is also associated with regulation of Exo1 resection at stalled 
replication forks and sites of DNA damage by a physical interaction with 14-3-3 proteins 
in humans and yeast, and this inhibits the association of Exo1 at the site of damage 
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[236, 237].  In humans, it was found that PCNA physically interacts with the C-terminal 
end of Exo1 and this association contributes to the processivity of Exo1 resection at 
DNA double-strand breaks [238]. The stimulation of Exo1 mediated resection by RPA 
has also been proposed as a mechanism to promote repair [195, 199]; however, more 
recently it has been shown that other single-strand binding proteins regulate Exo1 
resection differently. Other groups have looked at regulation of Exo1 resection and 
found, in humans, the single-strand DNA binding complex SOSS1 helps recruit Exo1 to 
DNA and RPA removes Exo1 [239, 240]. While both groups used in vitro assays one 
group looked at the cycling of these proteins over time on DNA through single-molecule 
imaging and found that the removal of Exo1 by RPA occurs with both human RPA and 
yeast RPA, and the recruitment of Exo1 by SSOS1 was observed only for human Exo1 
[239].  
In yeast, the loss of replication fork stability in rad53∆ mutants when challenged 
with DNA damaging agent requires Exo1 function for sensitivity.  Exo1 resection could 
be responsible for additional damage from aberrant repair initiated by resection and 
excess single-strand DNA produced by Exo1 modulates the checkpoint response [241]. 
 
Hypothesis and Aims 
Understanding the underlying mechanisms of proteins involved in protecting 
genomic integrity is essential in understanding the ability to prevent disease.  As the 
genome is under constant stress from both endogenous and exogenous sources of 
DNA damage, the capacity to cope relies on DNA repair by many different enzymes that 
detect and repair the damage.  Homology-directed repair is one of two repair pathways 
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that repair dsDNA breaks and can complete repair through various homology-
dependent sub-pathways that share a common step, DNA break end resection.  Sgs1 
and Exo1 are essential for long-range resection of DNA DSBs and the loss of both 
leads to substantially increased genome instability.  Here we hypothesize that with the 
loss or dysregulation of Sgs1 or Exo1, additional defects in other repair pathways and 
interactions will increase genomic instability. 
 
Aim1- We seek to identify the DNA metabolic factors are required for the formation of 
translocations and characterize the domains of Exo1 in the suppression of GCRs. 
 
Aim2- We seek to identify pathways that promote or suppress genomic instability in 
cells lacking Sgs1 and Exo1 and identify the role of Exo1 in cells under replication 
stress. 
  
Aim3-We seek to determine the role of recombination factors in suppressing genomic 
instability through the physical interaction of Sgs1 and Rad51. 
 
Significance 
DNA double-strand breaks are one of the most toxic forms of DNA damage. If 
they are not repaired accurately this can lead to genome rearrangements, a hallmark of 
cancer. The exact mechanism of how large genome rearrangements occur and result in 
disease is not well understood. Determining defects in different repair pathways and the 
function of DNA metabolic factors in suppressing genomic instability will help 
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characterize the driving forces of cancer formation, allowing a better understanding of 
genetic risk factors leading to disease. 
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ABSTRACT 
Background: Genome instability is associated with human cancers and 
chromosome breakage syndromes, including Bloom’s syndrome, caused by inactivation 
of BLM helicase. Numerous mutations that lead to genome instability are known, yet 
how they interact genetically is poorly understood.  
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Results: We show that spontaneous translocations that arise by nonallelic 
homologous recombination in DNA- damage-checkpoint-defective yeast lacking the 
BLM-related Sgs1 helicase (sgs1Δ mec3Δ) are inhibited if cells lack Mec1/ATR kinase. 
Tel1/ATM, in contrast, acts as a suppressor independently of Mec3 and Sgs1. 
Translocations are also inhibited in cells lacking Dun1 kinase, but not in cells defective 
in a parallel checkpoint branch defined by Chk1 kinase. While we had previously shown 
that RAD51 deletion did not inhibit translocation formation, RAD59 deletion led to 
inhibition comparable to the rad52Δ mutation. A candidate screen of other DNA 
metabolic factors identified Exo1 as a strong suppressor of chromosomal 
rearrangements in the sgs1Δ mutant, becoming even more important for chromosomal 
stability upon MEC3 deletion. We determined that the C-terminal third of Exo1, 
harboring mismatch repair protein binding sites and phosphorylation sites, is 
dispensable for Exo1’s roles in chromosomal rearrangement suppression, mutation 
avoidance and resistance to DNA-damaging agents.  
Conclusions: Our findings suggest that translocations between related genes can 
form by Rad59-dependent, Rad51-independent homologous recombination, which is 
independently suppressed by Sgs1, Tel1, Mec3 and Exo1 but promoted by Dun1 and 
the telomerase-inhibitor Mec1. We propose a model for the functional interaction 
between mitotic recombination and the DNA-damage checkpoint in the suppression of 
chromosomal rearrangements in sgs1Δ cells.  
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INTRODUCTION 
Eukaryotic cells have mechanisms at their disposal for the detection and repair of 
spontaneous and induced DNA lesions, thus preventing them from giving rise to 
potentially abnormal daughter cells. However, if these mechanisms are defective or 
overwhelmed by damage, deleterious chromosomal rearrangements can arise. A 
multitude of genes and genetic pathways for the maintenance of genome stability has 
been identified mostly using genetic screens in simple model organisms such as the 
yeast Saccharomyces cerevisiae. They include DNA damage checkpoints, DNA repair 
factors and proteins for processing of recombination substrates and intermediates [1-
10]. The importance of the same mechanisms for maintaining genome stability in 
human cells is highlighted by the association of mutations in the human homologues of 
these yeast genes with chromosome breakage syndromes, which are characterized by 
signs of premature aging and/or cancer development. The syndromes include Nijmegen 
breakage syndrome associated with mutations in NBS1, the homologue of yeast XRS2 
[11-13]; Bloom’s syndrome and Werner syndrome associated with mutations in BLM 
and WRN, respectively, both related to yeast SGS1 [14,15]; and ataxia telangiectasia 
associated with mutations in ATM [16], which is related to yeast TEL1 [17].  
Yeast SGS1 encodes a 5’ to 3’ DNA helicase that preferentially unwinds three- 
and four-way junctions typical of replication and recombination intermediates and has 
recently been shown to collaborate with Exo1 in the long-range processing of double-
strand breaks (DBSs) [18-21]. Without Sgs1, cells accumulate gross-chromosomal 
rearrangements (GCRs), exhibit elevated levels of mitotic recombination, have a 
reduced replicative lifespan and are sensitive to chemicals that alkylate DNA or slow 
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replication forks [2,22-26]. Among DNA- damage checkpoint components, Mec1 kinase, 
also considered the homolog of mammalian ATR [27-29], has been identified as one of 
the strongest suppressors of GCRs in yeast [3,4]. Other cellular phenotypes of mec1Δ 
mutants include increased sensitivity to DNA damaging agents and deficient DNA-
damage checkpoint response [30], instability of stalled forks [31], accumulation of DNA 
breaks [32] and, in addition to these mitotic defects, deficiencies in meiotic checkpoint 
activation and recombination [33-35]. In contrast to Mec1, cells lacking the Tel1 
checkpoint kinase, which is related to mammalian ATM [17,36], are not sensitive to 
DNA damaging agents [17], do not accumulate GCRs above wildtype levels [3], but 
show telomere erosion [36]. Synergistic interactions between mec1Δ and tel1Δ 
mutations have been reported for many phenotypes, suggesting a functional 
relationship and redundancy between the two kinases [3,17,37,38]. Other checkpoint 
components, such as those involved in sensing DNA damage (Mec3, Rad24), appear to 
have only small to moderate roles in suppressing GCRs in yeast [3,4]. In cells lacking 
the Sgs1 helicase, however, Mec3 and Rad24 strongly suppress overall genome 
instability [3,4] as well as the formation of spontaneous, recurring translocations 
between short identical sequences in non-allelic, but related, DNA sequences [10]. 
Utilizing the high susceptibility of the sgs1Δ mec3Δ mutant to recurring translocation 
formation between CAN1, LYP1 and ALP1, we have in the current study conducted a 
candidate screen to identify two types of DNA metabolic factors those that are required 
for the formation of recurring translocations in the sgs1Δ mec3Δ mutant and those that 
act independently of Sgs1 and Mec3 to suppress translocations. For this purpose, 
mec1Δ, tel1Δ, dun1Δ, chk1Δ and rad59Δ mutations were introduced into the sgs1Δ 
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mec3Δ mutant and the accumulation of recurring translocations was assessed. We 
further determined how the lack of other DNA metabolic factors (yen1Δ, lig4Δ, exo1Δ, 
rad1Δ, pol32Δ) affects the accumulation of genome rearrangements, identifying a 
strong synergistic interaction between sgs1Δ and exo1Δ. We propose an integrated 
model for independent, functional interactions between Sgs1, HR subpathways and 
various DNA damage-checkpoint branches in the suppression of chromosomal 
rearrangements.  
 
 RESULTS AND DISCUSSION 
 
Functional interaction between Sgs1 and DNA-damage checkpoint 
components Mec3, Mec1, Tel1, Dun1 and Chk1 in the suppression of 
chromosomal translocations  
Chromosomal translocations between short stretches of homology in nonallelic 
sequences that are naturally present in the yeast genome, such as the highly similar, 
but diverged CAN1 (on chromosome V), ALP1 and LYP1 genes (on chromosome XIV, 
60-65% identity), are normally suppressed in yeast. However, they are recurrent in 
sgs1Δ mutants with certain additional DNA-metabolic defects, including mec3Δ, rad24Δ, 
cac1Δ, asf1Δ and rfc5- 1 [10]. One of the mutants most susceptible to recurring 
translocations between the CAN1, LYP1 and ALP1 loci is the sgs1Δ mec3Δ mutant, 
whereas translocations are not found in the sgs1Δ mec1Δ mutant [10]. Here, we wanted 
to test whether the lack of CAN1/LYP1/ALP1 translocations in the sgs1Δ mec1Δ mutant 
meant that Mec1 was not a suppressor of translocations and therefore its deletion had 
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no affect on translocation formation, or that Mec1 was actually required for the formation 
of viable chromosomal translocations. If the latter was true, we expected that 
introducing a mec1Δ mutation into the highly susceptible sgs1Δ mec3Δ strain should 
inhibit the accumulation CAN1/LYP1/ALP1 translocations. Indeed, we found that while 
deleting MEC1 led to a synergistic increase (~ 7-fold) in the rate of all GCR types 
compared to the sgs1Δ mec3Δ mutant (P < 0.0001), screening of GCR clones obtained 
from 431 individual sgs1Δ mec3Δ mec1Δ cultures failed to reveal a single 
CAN1/LYP1/ALP1 translocation, signifying a > 7-fold decrease in the translocation rate 
compared to the sgs1Δ mec3Δ mutant (Table 1). The synergistic GCR rate increase in 
the sgs1Δ mec3Δ mec1Δ mutant shows that Mec1 can activate its targets through 
Mec3-independent sensing of DNA damage. This may occur by Mec1-Ddc2 itself 
recognizing and binding to DNA lesions [39,40] or through DNA- damage sensors other 
than the Mec3 clamp signaling to Mec1. The synergistic GCR rate increase in the sgs1Δ 
mec3Δ mec1Δ mutant also indicates that the failure to form CAN1/LYP1/ALP1 
translocations when MEC1 is deleted is not due to an inability to form viable GCRs, but 
rather suggests that DNA lesions are channeled into GCR pathways other than 
homology-driven translocation. Most likely, Mec1 promotes chromosomal translocations 
by inhibiting de novo telomere synthesis at chromosome breaks [1], for example by 
phosphorylating the telomerase-inhibitor Pif1 [41] and by phosphorylating Cdc13 and 
thus preventing its accumulation at DNA breaks [42]. In a haploid wildtype cell, these 
chromosomal translocations are expected to be rare due to restraints placed on 
homologous recombination events by the need for relative long regions of sequence 
identity. However, when the restraints on homologous recombination are relaxed and 
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spontaneous DNA lesions are not properly detected by the DNA-damage checkpoint, as 
could be assumed for the sgs1Δ mec3Δ mutant, chromosomal translocations are 
promoted and occur between much shorter regions of sequence identity, such as the 5- 
41-bp segments present in CAN1, LYP1 and ALP1.  
Deleting TEL1, which encodes another DNA-damage checkpoint kinase that is 
considered at least partially functionally redundant with Mec1, had the same effect as 
deleting MEC1 on the accumulation of all types of GCR (Table 1), as evidenced by the 
44-fold increase in the overall GCR rate compared to the sgs1Δ mec3Δ mutant (5.7 × 
10-6 versus 1.3 × 10-7, P < 0.0001). However, deleting TEL1 had the opposite effect on 
CAN1/ LYP1/ALP1 translocation formation (Table 1). Instead of inhibiting 
CAN1/LYP1/ALP1 translocations like the mec1Δ mutation, the tel1Δ mutation led to an 
increase (~15-fold) in CAN1/LYP1/ALP1 translocations (Table 1). Unlike mec1Δ 
mutants, mutants lacking Tel1 are impaired in their ability to maintain telomeres [36] and 
may thus be unable to heal DNA breaks by de novo telomere addition. Thus, in the 
absence of Tel1, DNA breaks may be channeled into alternative pathways for repair, 
such as HR, and more frequently give rise to CAN1/LYP1/ALP1 rearrangements under 
conditions that favor aberrant HR such as those in the sgs1Δ mec3Δ mutant. That 
failure to activate either Tel1 or Mec3-checkpoint pathways contributes independently to 
recurrent CAN1/LYP1/ALP1 translocation formation suggests that both ssDNA 
overhangs or gaps, thought to be sensed in a Mec3-dependent manner, and DSBs, 
thought to be sensed in a Tel1-dependent manner, can lead to CAN1/LYP1/ALP1 
translocations and that they accumulate in unperturbed sgs1Δ cells spontaneously. The 
synergistic increase in overall genome instability in the sgs1Δ mec3Δ tel1Δ mutant 
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might also indicate that in the absence of lesion binding by the Mec3 clamp some 
lesions are further processed and eventually detected by the Tel1-dependent pathway. 
For example, a stalled replication fork might eventually be processed into double-
stranded ends in an attempt at fork restart by fork regression or template-switching.  
Thus, both Tel1 and Mec1 act independently of Mec3 and Sgs1 to strongly suppress 
overall genome instability, but they affect CAN1/LYP1/ALP1 translocation formation in 
opposite ways. The inhibition of CAN1/LYP1/ALP1 translocations upon MEC1 deletion 
as opposed to their increase upon TEL1 deletion can most likely be explained by their 
opposite effects on telomere synthesis, with Mec1 inhibiting it and Tel1 promoting it. 
This is also consistent with the previous report of different GCR spectra in the tel1Δ and 
mec1Δ single mutants [1]. Apart from regulating telomere maintenance factors, it is also 
conceivable that the DNA-damage checkpoint dependent phosphorylation of 
homologous recombination factors, such as Rad55, Slx4 and Mus81 [43-47] contributes 
to differential regulation of translocation formation in the sgs1Δ mec3Δ mutant.  
The opposing effects of Tel1 and Mec1 on CAN1/ LYP1/ALP1 translocation 
formation led us to investigate other DNA-damage checkpoint components in sgs1Δ 
and sgs1Δ mec3Δ mutants. We found that deletion of either CHK1 or DUN1 led to a 
synergistic increase in overall genome instability when combined with an sgs1Δ 
mutation (P < 0.0001), however only the dun1Δ mutation caused a further significant 
GCR rate increase in the sgs1Δ mec3Δ mutant (P < 0.0001, Table 1) whereas the 
chk1Δ mutation did not (P = 0.1615, Table 1). Analysis of the GCR types revealed 
accumulation of CAN1/ LYP1/ALP1 translocations in the Chk1-deficient sgs1Δ mec3Δ 
mutant at a similar rate as in the sgs1Δ mec3Δ mutant, but not in the Dun1-deficient 
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sgs1Δ mec3Δ mutant (Table 1), indicating that Dun1, like Mec1, promotes translocation 
events between CAN1, LYP1 and ALP1 whereas Chk1 does not. This is likely due to 
Mec1-mediated activation of Dun1 kinase, which in turn inactivates the transcription 
repressor Crt1, thus allowing transcription of several DNA-damage inducible genes 
[48,49]. Chk1 kinase is also activated through Mec1 in response to DNA damage and 
causes a transient G2/M arrest by blocking anaphase progression [50,51]. However, in 
contrast to Dun1, Chk1 is not thought to regulate DNA repair pathways, and its deletion 
did not inhibit translocation formation in the sgs1Δ mec3Δ mutant (Table 1). As 
expected, deletion of RAD17, which encodes another subunit of the Mec3/ Rad17/Ddc1 
checkpoint clamp, had a similar effect on CAN1/LYP1/ALP1 translocation formation in 
the sgs1Δ tel1Δ mutant as deletion of MEC3 (Table 1). The detection of a 
CAN1/LYP1/ALP1 translocation in two strains that expressed wildtype Sgs1 (mec3Δ 
tel1Δ (Table 1) and mec3Δ tel1Δ rad17Δ (not shown)) suggests that even in the 
presence of wildtype Sgs1 cells may accumulate CAN1/LYP1/ALP1 translocations as 
long as they are deficient in at least two independent suppressors of translocation 
formation, such as Tel1 and Mec3 identified here.  
 
Deletion of RAD59 inhibits spontaneous interchromosomal translocations 
between short repeats  
We previously showed that translocations between CAN1, LYP1 and ALP1 in the 
sgs1Δ mec3Δ mutant are Rad52-dependent, but translocations still formed when Rad51 
was absent [10]. To assess the role of other HR factors in translocation formation we 
deleted RAD59 in the highly susceptible sgs1Δ mec3Δ mutant and measured the rate of 
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accumulating all types of GCRs as well as CAN1/LYP1/ALP1 translocations. One 
CAN1/LYP1/ALP1 rearrangement was identified among GCR clones obtained from 158 
independent cultures of the sgs1Δ mec3Δ rad59Δ mutant (Table 2), indicating a 10-fold 
reduction in the CAN1/LYP1/ALP1 translocation rate compared to the sgs1Δ mec3Δ 
mutant. Thus, similar to Rad52, Rad59 is required for interchromosomal translocations 
between short identical sequences in related genes. If Rad59 was indeed required for 
translocation formation, we predicted that the formation of CAN1/ LYP1/ALP1 
translocations in the sgs1Δ mec3Δ rad51Δ mutant would also be inhibited by a rad59Δ 
mutation. Thus, we generated an sgs1Δ mec3Δ rad51Δ rad59Δ mutant and screened 
for CAN1/LYP1/ALP1 translocations. Among 168 independent GCR clones we identified 
one CAN1/LYP1/ALP1 translocation, indicative of a 28-fold reduction of the 
translocation rate compared to the sgs1Δ mec3Δ rad51Δ mutant (Table 2). Thus 
translocations between CAN1, LYP1 and/or ALP1 can form through Rad52/Rad59-
mediated HR that does not require Rad51. Rad59 has recently also been shown to 
contribute to GCRs mediated by certain Ty-elements and to translocations involving 
short DNA sequences of limited sequence identity [6,52].  
While Rad52 is required for all HR in yeast, some DNA breaks can be repaired 
by HR pathways that do not require Rad51, including single-strand annealing (SSA), 
break-induced replication (BIR) and recombination-mediated telomere-lengthening Type 
II [53-58]. SSA is a mechanism for the repair of a DSB between repeated DNA elements 
and requires Rad59, but not Rad51 [59]. In order for the interchromosomal CAN1/ 
LYP1/ALP1 rearrangements to arise by SSA, however, at least two DSBs would have to 
occur in the same cell one DSB within or downstream of CAN1 on chromosome V and 
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one DSB near ALP1 (or LYP1) on chromosome XIV. Resection would expose the short 
stretches of homology shared by CAN1 and ALP1 (or LYP1) [60], allowing them to 
anneal, followed by removal of the nonhomologous overhangs and ligation. Rad59-
dependent, Rad51-independent interchromosomal translocation between his3 
fragments was recently shown after induction of HO-breaks in the two recombining 
chromosomes [61]. Such an interchromosomal SSA event could also produce the types 
of rearrangements we have observed between CAN1, LYP1 and ALP1; however, the 
ends of chromosomes V and XIV not engaged in the SSA event would be left 
unrepaired and most likely would be lost after cell division unless the recombination 
event occurs in G2/M when sister-chromatids are present. Moreover, since we have 
shown that wildtype copies of LYP1 and ALP1 are still present in recombinants with 
CAN1/LYP1/ALP1 rearrangements, indicative of a nonreciprocal translocation event 
[60], and the parts of chromosome XIV that would be lost after SSA contain essential 
genes, SSA is unlikely to be the main recombination mechanism that gives rise to 
CAN1/ LYP1/ALP1 rearrangements.  
Besides SSA, BIR also matches the genetic requirements for CAN1/LYP1/ALP1 
translocation formation. BIR is initiated by invasion of a duplex by a single- stranded 
3’end of a one-sided DBS followed by replication to the chromosome end. Although 
Sgs1 has roles in recombination, specifically sister-chromatid exchange and resolution 
of recombination intermediates [2,9,62-64], it is not required for Rad51-independent BIR 
[57]. In contrast to SSA, the nonreciprocal nature of BIR events would maintain an intact 
copy of chromosome XIV in addition to the chromosome V/XIV translocation, 
suggesting that it is the more likely mechanism involved in CAN1/LYP1/ALP1 
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translocation. BIR has been implicated in the repair of one-sided DSBs, such as 
replication forks that collapsed at a single-strand break. BIR is also thought to allow 
telomerase-deficient cells (tlc1Δ), whose telomeres have shortened to a point where 
cells can no longer proliferate, to survive by extending what could be considered a one-
sided DSB. Survivors can arise either by adding subtelomeric Y’ elements in a Rad51-
dependent mechanism (Type I) or by adding telomeric (G1-3T)n repeats in a Rad51-
independent, but Rad59-dependent mechanism (Type II) [53-55]. The differential 
requirement for Rad51 and Rad59 in these two pathways is thought to result from the 
differences in length and sequence identity of the recombination substrates for Type I 
and Type II [53]. The long, nearly identical (~1% variation within the same strain) Y’ 
elements [65] are thought to be better substrates for Rad51-mediated strand invasion, 
whereas Rad59 is able to use the shorter stretches of homology likely to be found within 
the highly variable (G1-3T)n repeats [53]. Besides BIR, evidence of homology-length 
dependency is also seen in gene conversion, with Rad59 becoming increasingly 
important as the length of sequence homology decreases [59]. This length-dependency 
may also explain our observation that CAN1/ LYP1/ALP1 rearrangements, which show 
short regions of homology at the breakpoints [10,60], are inhibited by deletion of 
RAD59, but not by deletion of RAD51. Despite this differential effect on chromosome 
rearrangements between CAN1, LYP1 and ALP1, we observed no difference in the rate 
of overall genome instability between sgs1Δ mec3Δ rad51Δ and sgs1Δ mec3Δ rad59Δ 
mutants (P = 0.6892, Table 2), suggesting that the DNA lesions that give rise to viable 
GCRs are accessible to multiple repair pathways.  
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Candidate screen reveals EXO1 as a strong suppressor of GCR formation 
in cells lacking Sgs1   
To assess the possible role of other DNA metabolic factors in the suppression or 
formation of GCRs in cells lacking Sgs1, we introduced exo1Δ, pol32Δ, rad1Δ, lig4Δ 
and yen1Δ mutations into sgs1Δ and sgs1Δ mec3Δ mutants. Screening of the single, 
double and triple mutants revealed that RAD1, POL32, LIG4 and YEN1 are not strong 
suppressors of GCRs in wildtype cells, or in sgs1Δ or sgs1Δ mec3Δ mutants (Table 3). 
However, when we assessed the formation of CAN1/LYP1/ALP1 translocations in 
sgs1Δ mec3Δ mutants with pol32Δ or rad1Δ mutations we found that in both triple 
mutants CAN1/LYP1/ALP1 translocations were inhibited, revealing one CAN1/LYP1 
translocation among 98 independent GCR clones in the sgs1Δ mec3Δ pol32Δ mutant 
and none (0/55) in the sgs1Δ mec3Δ rad1Δ mutant. Pol32, a nonessential subunit of 
polymerase δ that promotes processivity of the polymerase, is not required for SSA, but 
for DNA repair processes that involve extensive DNA synthesis, such as BIR [66], 
consistent with BIR being a pathway for CAN1/LYP1/ALP1 translocation formation. 
Although Rad1, a subunit of the Rad1-Rad10 nuclease critical for the removal of non- 
homologous overhangs from annealed single strands in processes such as SSA 
[67,68], has not been shown to be required for BIR, it has been implicated in the 
removal of nonhomologous overhangs during GCR formation [69] and in recombination 
events that combine BIR and SSA processes [70,71].  
Deletion of EXO1, coding for a nuclease with 5’ to 3’ exonuclease and flap-
endonuclease activities, which has roles in mitotic and meiotic recombination as well as 
mutation avoidance and is thought to cooperate with Sgs1 in the processing of DSBs 
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[19,72], induced the largest synergistic GCR rate increase we have observed to date in 
the sgs1Δ mutant. While sgs1Δ and exo1Δ single mutants exhibited moderately 
increased GCR rates compared to wildtype, the GCR rate of the sgs1Δ exo1Δ mutant 
was several hundred-fold higher than the rates of the single mutants (P < 0.0001, Table 
3). This GCR rate increased another 26-fold upon deletion of MEC3 (P < 0.0001, Table 
3). Screening of GCRs obtained from 66 independent cultures of the sgs1Δ mec3Δ 
exo1Δ mutant identified two CAN1/LYP1/ALP1 translocations, indicating a ~ 200-fold 
increase in the CAN1/LYP1/ ALP1 translocation rate compared to the sgs1Δ mec3Δ 
mutant (3.5 × 10-6 versus 1.7 × 10-8).  
Exo1 contains conserved N-terminal N- and I-nuclease domains, apparently 
separated by a short disordered linker, and binding sites for the mismatch repair (MMR) 
proteins Mlh1 and Msh2 have been located within the C-terminal half of Exo1 [72-74], 
which is predicted to be intrinsically disordered (Figure 1A). Four phosphorylation sites 
(S372, S567, S587, S692) required for the regulation of the DNA-damage response 
have also been located in the disordered C-terminus [75]. To determine if the C-
terminus of Exo1 plays a role in the suppression of genome instability in the sgs1Δ 
mutant, we constructed a set of C-terminal deletions ranging from 100 to 400 residues 
(Figure 1A and 1B). We found that the C-terminal 260 residues of Exo1, making up 37% 
of the protein, play no major role in suppressing the accumulation of GCRs in the sgs1Δ 
mutant (Table 4). To test the possibility that the C-terminus with its binding sites for 
MMR proteins might be required for Exo1’s role in mutation avoidance, but not for its 
role in suppressing GCRs, we utilized a fluctuation assay to determine the rate of 
accumulating canavanine resistance (Canr) mutations in strains expressing the various 
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C-terminal Exo1 truncations (Table 5). As in the GCR assay, deletion of up to 260 
residues had no effect on the Canr mutation rate (P = 0.3524) whereas deletion of 280 
or more residues caused a null phenotype (P = 0.0001). Similarly, only deletion of 280 
or more residues caused sensitivity to methyl methanesulfonate (MMS) (Figure 1C). No 
sensitivity to 200 mM hydroxyurea was observed for any of the exo1 mutants (Figure 
1C). Thus, deletion of up to 260 residues caused a phenotype similar to wildtype in all 
assays tested here, whereas deletion of 280 or more residues caused a null (exo1Δ) 
phenotype. 
In addition to providing MMR protein interaction sites, the C-terminus of Exo1 
contains four phosphorylation sites (S372, S567, S587, S692), which were recently 
shown to be important for the regulation of the DNA damage checkpoint in response to 
uncapped telomeres in a cdc13-1 mutant [75]. Unlike in a cdc13-1 mutant, we did not 
detect Exo1 phosphorylation in the sgs1Δ mutant (data not shown), and deletion of the 
C-terminal third of Exo1 (exo1-ΔC260), which contains three of the four phosphorylation 
sites (S567, S587, S692), had no effect on Exo1 function in the assays used here (Canr 
mutation rate, GCR assay, MMS sensitivity). The fourth phosphorylation site (S372) is 
present in both the exo1-ΔC260 mutant and the exo1-ΔC280 mutant and, therefore, is 
not responsible for the different phenotypes associated with the two alleles. Thus, the 
known phosphorylation sites in Exo1 do not appear to be required for Exo1’s role in 
mutation avoidance, resistance to MMS or suppression of GCRs in a sgs1Δ mutant. 
Instead, it is likely that the ΔC280 deletion affects Exo1 nuclease activity directly by 
disrupting intramolecular interactions with the N-terminus. The loss of yet unknown 
post-translational modifications in this segment of Exo1 or an indirect effect caused by 
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the loss of interaction with other cellular factors could also lead to the deficiency of the 
exo1ΔC280 allele.  
Besides the overall increase in genome instability, CAN1/LYP1/ALP1 
rearrangements seen in the sgs1Δ mec3Δ mutant were also present in the sgs1Δ 
mec3Δ exo1Δ mutant. Normally, Exo1 and Sgs1 function in independent end resection 
pathways that cooperate in the processing of DSBs, especially the long-range resection 
of the 5’-strand [19,20], and Marrero and Symington [21] recently showed that this 
extensive resection inhibits BIR in a plasmid-based assay. Besides upregulation of BIR, 
which was also accompanied by chromosome rearrangements, the exo1Δ sgs1Δ 
mutant was also more proficient in de novo telomere synthesis at HO- endonuclease-
induced chromosome breaks [18,21]. The combination of increased BIR and more 
efficient de novo telomere addition, both of which have been identified as major 
mechanisms for the healing of chromosome V breaks in the GCR assay [76,77], likely 
also explains the remarkably strong accumulation of genome rearrangements 
originating from spontaneous DNA lesions in the exo1Δ sgs1Δ mutant studied here. Our 
study further adds that the exo1Δ sgs1Δ mutant has even greater potential for the 
accumulation of viable genome rearrangements, which is suppressed (~ 26-fold) in the 
sgs1Δ exo1Δ mutant by Mec3-dependent DNA- damage checkpoint functions (P < 
0.0001). Nonhomologous end-joining does not appear to be a significant source for 
these genome rearrangements, as indicated by the lack of any effect of LIG4 gene 
deletion in mutants with various combinations of sgs1Δ, exo1Δ and mec3Δ mutations 
(e.g., GCR rate of sgs1Δ mec3Δ exo1Δ compared to sgs1Δ mec3Δ exo1Δ lig4Δ, P = 
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0.3953, Table 3); however, it is also plausible that in the absence of one repair pathway 
DNA lesions simply become substrates for various other available repair pathways.  
 
 
CONCLUSION 
Our results indicate that spontaneous, interchromosomal translocations between 
short regions of sequence identity (5-41 bp), such as those present in the CAN1, LYP1 
and ALP1 genes used in our assay, are promoted by Mec1/Dun1/Rad59-dependent 
pathways whereas Tel1, Mec3 and Sgs1 act as independent suppressors (Figure 2). 
The requirement for Pol32 and Rad1 in the translocation process further suggests the 
need for extensive DNA synthesis, such as seen in BIR, and the removal of 
nonhomologous overhangs from annealed single-strands, critical for SSA and 
implicated in GCR formation. Exo1 nuclease is a suppressor of overall genome 
rearrangements as well as CAN1/LYP1/ALP1 translocations when cells lack Sgs1 or 
both Sgs1 and Mec3. That the disordered, C-terminal third is dispensable for Exo1 
function in our assays further indicates that physical interaction with MMR proteins in 
this region and regulation of Exo1 function in response to DNA-damage are not 
important for Exo1’s role in the suppression of spontaneous GCRs, mutation avoidance 
and resistance to MMS.  
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METHODS  
 
Yeast strains and media  
All strains used in this study are derived from KHSY802 (MATa, ura3-52, 
trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, hxt13::URA3) 
 or the isogenic strain of the opposite mating type. Desired gene deletions were 
introduced by HR-mediated integration of PCR products containing a selectable marker 
cassette flanked by 50-nt sequences complementary to the target locus [78]. C-terminal 
truncations of Exo1 were constructed by replacing the desired DNA sequence at the 
chromosomal EXO1 locus with a myc-epitope encoding sequence amplified from pFA-
13Myc. His3MX6 (a gift from Mark Longtine, Washington University, St. Louis). 
Expression of Exo1 truncation alleles was confirmed by Western blotting using 
monoclonal anti-c-myc antibody (Covance). All haploid strains with multiple gene 
deletions were obtained by sporulating diploids heterozygous for the desired mutations 
to minimize the risk of obtaining suppressors. This was especially important for 
combinations of mutations known to cause fitness defects, such as sgs1Δ and pol32Δ. 
Spore isolation was followed by genotyping of meiotic pro- ducts by spotting on 
selective media or by PCR. All strains used in this study are listed in Table 6. Media for 
propagating yeast strains have been previously described [76,77].  
 
Sensitivity to DNA damaging agents HU and MMS  
Cell cultures were grown in yeast extract/peptone/dextrose (YPD) media and 
adjusted to OD600 = 1. Tenfold dilutions were spotted on YPD, YPD supplemented with 
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0.05% methyl-methanesulfonate (MMS) and YPD supplemented with 200 mM 
hydroxyurea (HU). Colony growth was documented after incubation at 30°C for 3 days.  
 
Fluctuation Assays  
Rates of accumulating spontaneous gross-chromosomal rearrangements (GCRs) 
were determined by fluctuation analysis and the method of the median as previously 
described [77,79]. Cells with GCRs were detected by their resistance to canavanine and 
5-fluoro-orotic acid (Canr 5-FOAr) due to simultaneous inactivation of the CAN1 and 
URA3 genes, both located within a 12 kb nonessential region on the left arm of 
chromosome V. The median GCR rate is reported with 95% confidence intervals [80]. 
GCR clones were screened by PCR to identify clones with rearrangements between 
CAN1 on chromosome V and LYP1 and/or ALP1 (collectively referred to as 
CAN1/LYP1/ALP1 rearrangements in the text), located in opposite orientations on the 
same arm of chromosome XIV [10]. To determine the rate of accumulating spontaneous 
mutations that lead to inactivation of the CAN1 gene, 3-ml YPD cultures expressing 
wildtype Exo1 or C-terminal truncations of Exo1 were grown overnight and aliquots 
were plated on synthetic media lacking arginine (US Biological) supplemented with 240 
mg ml-1 canavanine (Sigma), and on YPD to obtain the viable cell count. Colonies were 
counted after two days of incubation at 30°C. At least twelve indepen-dent cultures from 
three isolates were analyzed per yeast strain. The median Canr mutation rate is 
reported with 95% confidence intervals [80]. Statistical significance of differences in 
GCR rates was evaluated by using the Mann-Whitney test and programs from Dr. R. 
Lowry at Vassar College http://faculty.vassar.edu/lowry/ VassarStats.html  
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Protein extraction and Western blot analysis  
Cells were grown in YPD until they reached OD600 = 0.5. Whole cell extract was 
prepared from 5 ml of culture using a standard trichloroacetic acid (TCA) extraction. 
Briefly, cells were pelleted, vortexed with glass beads for 10 minutes in 200 μl of 20% 
TCA, followed by centrifugation for 2 minutes. The pellet was resuspended in sample 
buffer and pH was neutralized with 2 M Tris buffer (pH 7.6). Proteins were separated by 
PAGE, transferred to a PVDF membrane and incubated with monoclonal anti-c-myc 
antibody (Covance) to detect myc-tagged proteins. Bands were visualized using ECL 
Plus Chemiluminescence kit (GE Healthcare).  
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FIGURES AND TABLES 
 
Figure 2.1 Expression of C-terminal truncations of Exo1 and sensitivity to DNA-
damaging agents.  
(A) Intrinsic disorder prediction of Exo1 using the IUPred algorithm in which values 
above 0.5 indicate residues predicted to be intrinsically disordered and values below 0.5 
to be ordered. The N-terminus, harboring conserved N- and I-nuclease domains, is 
predicted to be ordered, whereas the C-terminus, which appears devoid of enzymatic 
activity but contains phosphorylation sites and sites for interaction with mismatch repair 
proteins, is disordered. The sites at which the Exo1 truncations examined in this study 
terminate are indicted by vertical dotted lines. The location of conserved domains was 
adapted from reference [71]: nuclease domains (orange boxes, 16-96 aa, 123-257 aa), 
Mlh1 interaction domain (green box, 400-702 aa) and the Msh2 interaction domain (blue 
box, 368-702 aa). Phosphorylation sites at S372, S567, S587 and S692, implicated in 
checkpoint regulation [74], are indicated by red asterisks. (B) Western blot analysis of 
expression of myc-epitope tagged exo1 truncations and wildtype Exo1. Molecular 
weight markers (kD) are indicated on the left. (C) Cells expressing Exo1 truncations 
lacking 280 or more C-terminal residues are as sensitive to 0.05% MMS as the exo1Δ 
mutant whereas cells expressing exo1 truncations lacking 260 or fewer C-terminal 
residues show wildtype levels of resistance to MMS. No sensitivity to 200 mM 
hydroxyurea was observed for any of the tested yeast strains.  
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Figure 2.2 Factors affecting the suppression and promotion of chromosomal 
translocations between short segments of homology in CAN1 , LYP1 and ALP1 in 
cells lacking Sgs1. In the absence of Sgs1, translocations between CAN1, 
LYP1 and ALP1 (referred to as C/L/A) are independently suppressed by the checkpoint 
components Mec3 and Tel1 (shown in red font), as suggested by the synergistic 
increases in the GCR rate and the C/L/A translocation rate of the sgs1Δ mutant upon 
deletion of MEC3 (sgs1Δ mec3Δ) and subsequently TEL1 (sgs1Δ mec3Δ tel1Δ). If 
Mec3 is absent (sgs1Δ mec3Δ), C/L/A translocations form through a pathway that 
requires Mec1, Dun1 and homologous recombination (HR) factors (shown in green 
font), especially Rad52 and Rad59. Mec1 most likely promotes translocations by 
inhibiting de novo telomere additions by regulating Pif1 and Cdc13. In addition to 
mutagenic repair that leads to C/L/A translocations, other types of mutagenic repair 
(e.g., translocations between other genes, de novo telomere additions, deletions, 
insertions, inversions) and most likely also nonmutagenic repair products are formed. If, 
in addition to Mec3, Tel1 is also absent (e.g., sgs1Δ mec3Δ tel1Δ), an even greater 
number of DNA lesions are channeled through the Mec1-dependent, C/L/A-promoting 
pathway. In contrast to dun1Δ, the chk1Δ mutation does not lead to a significant GCR 
rate increase in the sgs1Δ mec3Δ mutant and does not inhibit C/L/A translocation 
formation. Possibly, the inability to regulate cell cycle progression in the absence of 
Chk1 leads to increased formation of inviable GCRs. Dotted lines indicate events that 
occur in the absence of the protein from which the arrow originates; full lines indicate 
events that occur in the presence of the protein. 
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Table 2.1 Functional interaction between Sgs1 and components of the DNA-
damage checkpoint in the suppression of GCRs and translocations between 
CAN1, LYP1 and ALP1 genes.  
 
Relevant 
Genotypedd  
All GCR typesa CAN1/LYP1/ALP1 
translocationsb 
Frequency of CAN1/LYP1/ALP1 
translocation typesc 
Rate 95% CI Rate Frequency 
CAN1-
ALP1 
CAN1-
LYP1 
CAN1-
LYP1-ALP1 
wildtype 1.1 <1-6.2 ND ND ND ND ND 
sgs1 220 144-276 <7.3 0/30 0/30 0/30 0/30 
rad17 57 26-74 ND ND ND ND ND 
mec3 46 18-75 <1.5 0/30 0/30 0/30 0/30 
mec3 rad17 49 32-64 ND ND ND ND ND 
sgs1 rad17 2515 903-4160 <101 0/25 0/25 0/25 0/25 
sgs1 mec3 1297 1120-2030 173 20/150 7/150 3/150 7/150 
sgs1 mec3 rad17 1690 1247-2230 75 2/45 1/45 1/45 0/45 
tel1 2 ND ND ND ND ND ND 
tel1 mec3 453 340-638 15 1/30 1/30 0/30 0/30 
tel1 rad17 129 72-246 <8.6 0/15 0/15 0/15 0/15 
sgs1 tel1 227 46-418 NDb ND ND ND ND 
sgs1 tel1 rad17 27600 22430-
39653 
4600 6/36 1/36 1/36 4/36 
sgs1 tel1 mec3 57370 47157-
76301 
2674 11/236 0/236 6/236 4/236 
sgs1 tel1 mec3 rad17 31960 23400-
51800 
ND ND ND ND ND 
mec1 471 209-859 ND ND ND ND ND 
sgs1 mec1 1930 960-2452 <10 0/190 0/190 0/190 0/190 
sgs1 mec1 mec3 9628 5870-
12100 
<22 0/431 0/431 0/431 0/431 
chk1 42 25-132 ND ND ND ND ND 
sgs1 chk1 446 337-528 <15 0/30 0/30 0/30 0/30 
sgs1 chk1 mec3 1099 725-1613 147 4/30 1/30 0/30 3/30 
dun1 252 86-472 ND ND ND ND ND 
sgs1 dun1 1145 698-1910 <23 0/50 0/50 0/50 0/50 
sgs1 dun1 mec3 2800 2270-3570 <21 0/135 0/135 0/135 0/135 
(a) GCR rate (Canr 5-FOAr × 10-10). 95% confidence intervals (CIs) for median GCR 
rates were calculated according to Nair [80], where non-overlapping confidence 
intervals indicate statistically significant differences between median GCR rates. GCR 
rates of wildtype [81], sgs1 [82], mec3, sgs1 mec3 [60], tel1 [3] were reported 
previously. 
  (b) Rate of accumulating translocations between CAN1, LYP1 and/or ALP1 genes (x 
10-10). GCR clones from sgs1, mec3, sgs1 mec3, sgs1 tel1 and sgs1 mec1 were 
previously screened for CAN1/LYP1/ALP1 translocations [10,60].  
(C) Types of CAN1/LYP1/ALP1 translocations were determined by sequencing. Of the 
20 CAN1/LYP1/ALP1 translocations identified among 150 GCR clones from the sgs1 
mec3 mutant, 17 were identified as being either C/A, C/L/A or C/L translocations and 3 
clones had a mixture of multiple translocations [60].    
(d) All mutants with a mec1 deletion also contain a sml1 deletion.  
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Table 2.2 Effect of homologous recombination mutations on the ability of the 
sgs1 mec3 mutant to accumulate GCRs and form rearrangements between the 
CAN1, LYP 1 and ALP1 genes.  
 
Relevant genotype  
All GCR typesa CAN1/LYP1/ALP1 
translocationsb 
Rate 95% CI Rate Frequency 
wildtype 1.1 <1-6.2 ND ND 
rad51a  <8 <7-15 ND ND 
rad52 138 16-267 ND ND 
rad59 24 13-50 ND ND 
sgs1a 220 144-276 <7.3 0/30 
mec3a 46 18-75 <1.5 0/30 
sgs1 rad59 126 107-300 ND ND 
sgs1 rad59 rad51 118 49-154 ND ND 
sgs1 mec3a 1297 1120-2030 173 20/150 
sgs1 mec3 rad51a 1491 NDc 198 4/30 
sgs1 mec3 rad52a 3168 NDc <23 0/136 
sgs1 mec3 rad59 2476 1595-3187 16 1/158 
sgs1 mec3 rad59 rad51 1124 734-1460 7 1/168 
(a) Median rate of cells resistant to canavanine and 5-FOA (Canr 5-FOAr × 10-10). 95% 
confidence intervals (CIs) for median GCR rates were calculated according to Nair [80], 
where non-overlapping confidence intervals indicate statistically significant differences 
between median GCR rates. GCR rates for wildtype [81], sgs1 [82], mec3, sgs1 mec3 
[60], rad51, sgs1 mec3 rad51 and sgs1 mec3 rad52 mutants [10] were reported 
previously and are included for comparison.  
(b) Rate of accumulating translocations between CAN1, LYP1 and/or ALP1 (Canr 5-
FOAr × 10-10). GCR clones from sgs1, mec3, sgs1 mec3, sgs1 mec3 rad51, sgs1 mec3 
rad52 were previously screened for CAN1/LYP1/ALP1 translocations [10,60]. ND, not 
determined.  
(c) To determine 95% CIs for sgs1 mec3 rad51 and sgs1 mec3 rad52 mutants, GCR 
rates were re-measured for the current study. The GCR rate for the sgs1 mec3 rad51 
mutant was 1933 × 10-10 (95% CIs: 601-2240 × 10-10) and the GCR rate for the sgs1 
mec3 rad52 mutant was 2220 × 10-10 (951-3470 × 10-10). The previously reported rates 
fall within the 95% CIs determined in the current study.  
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Table 2.3 Effect of lig4Δ, exo1Δ, rad1Δ, pol32 Δ and yen1Δ mutations on the 
accumulation of GCRs in checkpoint- proficient and checkpoint-deficient sgs1Δ 
mutants  
 
Relevant genotypea  GCR rateb  95% CIc  
wildtype 1.1 <1-6.2 
exo1 24 7-79 
sgs1 220 144-276 
sgs1 mec3 1297 1120-2030 
exo1 sgs1 43800 30400-186000 
exo1 mec3 30 12-39 
exo1 mec3 sgs1 1168498 549530-3251000 
sgs1 mec3 exo1 lig4 895988 701149-1236740 
lig4 16 ND 
sgs1 lig4 80 35-254 
sgs1 mec3 lig4 1335 948-2140 
yen1 <5 <4-6 
sgs1 yen1 81 57-265 
sgs1 mec3 yen1 1089 254-2540 
pol32 20 15-26 
sgs1 pol32 25 <24-105 
sgs1 mec3 pol32 2317 1800-3110 
rad1 10 <9-23 
sgs1 rad1 63 25-356 
sgs1 mec3 rad1 1173 1020-1540 
(a) Strains with multiple gene deletions were constructed by sporulation of the 
appropriate heterozygous diploids. GCR rates with 95% confidence intervals (CIs) for 
wildtype [81], sgs1 [82], sgs1 mec3 [60] and lig4 [1] were reported previously and are 
included for comparison. Spores with both sgs1Δ and pol32Δ mutations grew very 
slowly and exhibited a low viable cell count on YPD in the GCR assay.  
(b) The rate of accumulating gross-chromosomal rearrangements (GCRs) is calculated 
by selecting for cells resistant to canavanine (Canr) and 5-fluoro-orotic acid (5-FOAr) 
and is expressed as Canr 5-FOAr × 10-10 [77].   
(c) 95% confidence intervals (CI) for median GCR rates were calculated according to 
Nair [80].  
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Table 2.4 Effect of exo1 mutations on the accumulation of GCRs in wildtype cells 
or cells lacking Sgs1 helicase.  
 
Relevant genotype 
GCR rate    
(Canr 5-FOAr × 10-10) 
95% CIa   
(Canr 5-FOAr × 10-10) 
sgs1Δ  89 57-177 
exo1Δ 24 7-79 
exo1Δ sgs1Δ  40484 31076-49848 
EXO1.myc  5 4.4-5.3 
exo1-ΔC100.myc  5 4-6 
exo1-ΔC200.myc    < 4   < 3.8-4.8 
exo1-ΔC260.myc  < 11 < 8-79 
exo1-ΔC280.myc  < 11   < 8-29 
exo1-ΔC300.myc  < 18   < 5-70 
exo1-ΔC400.myc  13 5-41 
sgs1Δ EXO1.myc  78 29-118 
sgs1Δ exo1-ΔC100.myc  125 80-186 
sgs1Δ exo1-ΔC200.myc  158 94-215 
sgs1Δ exo1-ΔC260.myc  230 166-265 
sgs1Δ exo1-ΔC280.myc  26840 22925-34036 
sgs1Δ exo1-ΔC300.myc  31070 22871-33753 
sgs1Δ exo1-ΔC400.myc  48190 39133-54471 
(a) 95% confidence intervals (CI) for median GCR rates were calculated  
according to Nair [80].  
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Table 2.5 Effect of C-terminal deletions of Exo1 on the spontaneous mutation rate 
at the CAN1 locus. 
  
Relvant genotype CAN1 (Canr  × 10-7) 95% CIa  (Canr  × 10-7) Increase over 
wildtype 
wildtype 3.27 2.50-5.82 1 
exo1Δ 11.47 10.10-28.52 3.5 
exo1-ΔC100.myc  3.64 2.92-4.70 1.1 
exo1-ΔC200.myc  5.31 3.90-5.90 1.6 
exo1-ΔC260.myc  3.89 2.89-5.92 1.2 
exo1-ΔC280.myc  8.37 6.94-16.18 2.6 
exo1-ΔC300.myc  10.72 8.55-19.88 3.3 
exo1-ΔC400.myc  13.16 9.06-18.19 4.0 
(a) 95% confidence intervals (CI) for median Canr rates were calculated according to 
Nair [80].  
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Table 2.6 Saccharomyces cerevisiae strains used in this study  
 
Strain ID Genotype 
KHSY802  MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3,  
RDKY 3721a MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, rad17::HIS3  
RDKY 3739a  MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, dun1::HIS3  
RDKY 3745a  MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, chk1::HIS3  
RDKY 5209a  MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, tel1:G418  
KHSY 773  MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sml1::TRP1, mec1::HIS3  
KHSY 884 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, rad51::HIS3  
KHSY 906 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, mec3::HIS3  
KHSY 1330 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::HIS3, mec1::TRP1, sml1::G418  
KHSY 1498 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::HIS3, mec1::TRP1, sml1::G418, mec3::G418  
KHSY 1524 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1  
KHSY 2260 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, chk1::HIS3  
KHSY 2265 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, rad17::HIS3  
KHSY 2280 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, mec3::HIS3, rad59::G418  
KHSY 2283 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, dun1::HIS3  
KHSY 2317 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, tel1::G418, mec3::HIS3  
KHSY 2320 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, mec3::HIS3 
KHSY 2330 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, yen1::loxP-G418-loxP  
KHSY 2331 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, lig4::loxP-G418-loxP  
KHSY 2336 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, rad1::loxP-G418-loxP  
KHSY 2338 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1:loxp-G418-loxp  
KHSY 2388 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, rad59::G418  
KHSY 2402 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, exo1::loxP-G418-loxP  
KHSY 2408 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, exo1::loxP-G418-loxP, mec3::HIS3  
KHSY 2424 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, rad1::loxP-G418-loxP  
KHSY 2434 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, rad1::loxP-G418-loxP, mec3::HIS3  
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KHSY 2447 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, lig4::loxP-G418-loxP  
KHSY 2448 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, yen1::loxP-G418-loxP  
KHSY 2449 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, yen1::loxP-G418-loxP, mec3::HIS3  
KHSY 2559 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, mec3:: G418, rad17::HIS3  
KHSY 2565 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, mec3::G418, rad17::HIS3  
KHSY 2579 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1:: TRP1, lig4::G418, mec3::HIS3  
KHSY 2585 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, tel1::G418, rad17::HIS3  
KHSY 2588 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, tel1::G418, rad17::HIS3  
KHSY 2662 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, mec3::HIS3, chk1::HIS3  
KHSY 2665 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, mec3::HIS3, dun1::HIS3  
KHSY 2786 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, exo1::loxP-G418-loxP, lig4::loxP-G418-loxP, mec3::HIS3  
KHSY 3086 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, mec3::G418, rad17::HIS3, tel1::HIS3  
KHSY 3223 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sgs1::TRP1, mec3::HIS3, tel1::G418  
KHSY 3231 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, rad17::H1S3, mec3::HIS3, tel1::G418  
KHSY 3265 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1ΔC300.MYC.HIS  
KHSY 3271 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1ΔC400.MYC.HIS  
KHSY 3274 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1ΔC200.MYC.HIS, sgs1::TRP1  
KHSY 3278 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1ΔC100.MYC.HIS, sgs1::TRP1  
KHSY 3282 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1ΔC100.MYC.HIS  
KHSY 3287 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, EXO1.MYC.HIS, sgs1::TRP1  
KHSY 3395 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, EXO1.MYC.HIS  
KHSY 3396 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1Δ200.MYC.HIS  
KHSY 3402 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1Δ300.MYC.HIS, sgs1::TRP1  
KHSY 3635    MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1::loxP-G418-loxP, mec3::HIS3  
KHSY 3843    MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1Δ400.MYC.HIS, sgs1::TRP1 
KHSY 3849 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1Δ280.MYC.HIS 
KHSY 3857    MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1Δ280.MYC.HIS, sgs1::TRP1 
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KHSY 3860    MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1Δ260.MYC.HIS 
KHSY 3866 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1Δ240.MYC.HIS 
KHSY 3868 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1Δ260.MYC.HIS 
KHSY 3869 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1Δ260.MYC.HIS, sgs1::TRP1 
KHSY 3875 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, exo1Δ280.MYC.HIS, sgs1::TRP1  
(a) RDKY strains were a kind gift from Richard Kolodner (Ludwig Institute for Cancer 
Research, University of California - San Diego).  
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Abstract 
Exo1 belongs to the Rad2 family of structure-specific nucleases and possesses 
5′–3′ exonuclease activity on double-stranded DNA substrates. Exo1 interacts physically 
with the DNA mismatch repair (MMR) proteins Msh2 and Mlh1 and is involved in the 
excision of the mispaired nucleotide. Independent of its role in MMR, Exo1 contributes 
to long-range resection of DNA double-strand break (DSB) ends to facilitate their repair 
by homologous recombination (HR), and was recently identified as a component of 
error-free DNA damage tolerance pathways. Here, we show that Exo1 activity increases 
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the hydroxyurea sensitivity of cells lacking Pol32, a subunit of DNA polymerases δ and 
ζ. Both, phospho-mimicking and dephospho-mimicking exo1 mutants act as 
hypermorphs, as evidenced by an increase in HU sensitivity of pol32∆ cells, suggesting 
that they are trapped in an active form and that phosphorylation of Exo1 at residues 
S372, S567, S587, S692 is necessary, but insufficient, for the accurate regulation of 
Exo1 activity at stalled replication forks. In contrast, neither phosphorylation status is 
important for Exo1’s role in MMR or in the suppression of genome instability in cells 
lacking Sgs1 helicase. This ability of an EXO1 deletion to suppress the HU 
hypersensitivity of pol32∆ cells is in contrast to the negative genetic interaction between 
deletions of EXO1 and POL32 in MMS-treated cells as well as the role of EXO1 in DNA-
damage treated rad53 and mec1 mutants.  
 
Introduction 
Exo1 belongs to the Rad2-family of structure-specific nucleases and possesses  
5′–3′exonuclease activity on double-stranded DNA substrates as well as flap-
endonuclease activity [1,2]. Exo1 has a catalytic role during the excision step of DNA 
mismatch repair (MMR) and has been shown to physically interact with the MMR 
proteins Msh2 and Mlh1 in yeast and humans [1,3–8]. Although missense mutations in 
EXO1 from cancer patients have been shown to reduce binding to Msh2 in vitro, and 
disruption of EXO1 function has been associated with somatic hypermutation and 
development of cancer in older mice, a causative association between EXO1 mutations 
and hereditary nonpolyposis colorectal cancer (HNPCC), which is caused by MMR 
defects, remains unclear [9–15].  
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Independent of its role in MMR, EXO1 plays a role in the resection of DNA 
double-strand breaks (DSBs). Formation of long, single- stranded 3′ overhangs is 
necessary for Rad51 filament formation and non-mutagenic repair of DSBs by 
homologous recombination (HR) [16]. Resection appears to be a two-step reaction that 
commits repair of the DSB to the HR pathway. The Mre11/Rad50/Xrs2 complex binds 
first to the unprocessed DSB and, with help from Sae2 endonuclease, resects a short 
stretch. In the second step, long-range 5′–3′ resection is accomplished by Sgs1 and 
Dna2, which, respectively, contribute 3′–5′ helicase and endonuclease activities to the 
reaction [17,18]. In addition to Sgs1/Dna2, Exo1 can carry out long-range resection by 
removing nucleotides from the 5′-ended strand [17–19]. Yeast cells that lack both Sgs1 
and Exo1 exhibit severely retarded long-range resection and accumulate spontaneous 
chromosomal rearrangements at an extraordinarily high rate [20,21]. Analysis of 
rearranged chromosomes in sgs1∆ exo1∆ mutants where a DSB was induced by 
endonucleolytic cleavage revealed that incompletely processed DNA breaks become 
substrates for aberrant repair, predominantly de novo telomere addition and, to a lesser 
extent, break-induced replication [22,23].  
Recently, EXO1 was also identified in a genetic screen for components of the 
error-free DNA damage tolerance (DDT) pathway, which is engaged when the 
replisome encounters a blocking DNA lesion in the template strand [24]. As opposed to 
the error-prone pathway where a translesion DNA polymerase is recruited to 
monoubiquitinated proliferating cell nuclear antigen (PCNA) to replicate across a lesion, 
in the error-free pathway the replicative DNA polymerase is thought to switch from the 
damaged template to the undamaged sister chromatid in a HR-dependent reaction, also 
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referred to as template switching. Exo1 is thought to promote the HR-dependent steps 
in error-free DDT by extending the ssDNA gap behind the stalled replication fork [24]. 
Exo1-dependent ssDNA formation may also allow accumulation of enough replication 
protein A (RPA) at stalled forks to enhance the DNA-damage signal sufficiently for 9-1-
1/Mec1-dependent checkpoint activation [25,26]. In addition to bypassing replication 
blocking lesions in the template strand, error-free DDT can be specifically induced by 
deleting POL32, which encodes a noncatalytic subunit of DNA polymerase [27]. 
Through physical interaction with the polymerase clamp PCNA, Pol32 increases the 
processivity of DNA polymerase and the efficiency of DNA synthesis [28]. The DNA 
polymerase subunits Pol32 and Pol31 also function as subunits of DNA polymerase, 
whose catalytic core is made up of Rev3 and Rev7 [29–31]. DNA polymerase is 
conserved in eukaryotes and plays a critical role in translesion DNA synthesis and 
mutagenesis [32–34]. Although cells that lack Pol32 are viable, they experience 
replication stress that leads to phosphorylation of the checkpoint kinase Rad53, S 
phase delay, accumulation in G2/M, and hypersensitivity to DNA damaging agents 
[24,27,35].  
When replication forks stall due to exposure to the DNA damaging agents 
hydroxyurea (HU) or methyl methanesulfonate (MMS), which deplete the dNTP pool 
and generate base adducts in the template strand, respectively, activation of the 
replication checkpoint helps to maintain the activity of the replisome, possibly through 
phosphorylation, that permits fork restart after withdrawal of the genotoxin [36–38]. 
Although Exo1 has been found at these stalled forks the presence of the intact 
replisome is thought to prevent it from acting on the nascent strands [26]. In cells that 
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lack a functional replication checkpoint, components of the replisome, most notably 
DNA polymerase and the replicative helicase Mcm2-7, have been found to dissociate 
from stalled forks, which might make the ends of the nascent strands vulnerable to 
degradation by nucleases, including Exo1 [39–41]. Nascent strand degradation may 
contribute to the destabilization of stalled replication forks in checkpoint mutants and, 
possibly, provide sufficiently long ssDNA regions for recombination [26,42,43]. A recent 
comparison of the composition of replisomes in checkpoint-deficient cells and wildtype 
cells also raised the possibility that the inability to restart stalled forks in checkpoint-
deficient cells may be due to a lack of phosphorylation of replisome components and 
accessory factors rather than their loss from the replication fork [44,45]. Exo1 has been 
found to be phosphorylated in a Mec1-dependent manner upon treatment of cells with 
HU or MMS [38,46]. In cells with uncapped telomeres (cdc13-1), four phosphorylated 
serine residues were identified in the C-terminal half of Exo1 [47,48]. Although the effect 
of mutating these serine residues on the viability of the cdc13-1 mutant was small, it 
hinted that DNA-damage induced phosphorylation inhibits Exo1 activity.  
To better understand Exo1 function in the DNA-damage response and the 
regulation of these functions by phosphorylation, we have determined the effect of 
defects in DNA repair and the replication stress response on DNA-damage sensitivity 
and accumulation of mutations in the exo1∆ mutant and cells harboring alleles that 
encode phospho-mimicking and dephospho-mimicking mutants of Exo1.  
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Materials and Methods 
 
Yeast strains and media  
Yeast strains used in DNA-damage sensitivity and mutation assays were all 
derived from KHSY802 (MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, 
ade2∆1, ade8, hxt13::URA3). Gene deletions were carried out as described [49] using 
HR- mediated integration of a selectable cassette. Mutants containing more than one 
gene deletion or mutation were obtained by random spore isolation from diploids 
heterozygous for the desired mutations [50]. Residues S372, S567, S587, and S692 of 
Exo1 were changed to alanine (exo1-SA) or aspartic acid (exo1-SD) and residues E150 
and D173 to aspartic acid and alanine, respectively (exo1-ND, exo1-ND-SA, exo1-ND-
SD) by site-directed mutagenesis of the EXO1 ORF in plasmid pKHS610. pKHS610 
was generated by inserting EXO1 into pXP320 [51] by gap-repair using yeast strain 
KHSY2331 (lig4::kanMX6) to promote HR-mediated insertion. The resulting plasmids 
with mutant exo1 alleles were pKHS611 (exo1- SD), pKHS612 (exo1-SA), pKHS613 
(exo1-ND-SA), and pKHS614 (exo1-ND-SD). The exo1 alleles, including a HIS3MX6 
cassette were amplified from the appropriate plasmids and integrated at the 
chromosomal EXO1 locus in KHSY2338 (exo1::KANMX6) using the lithium acetate 
method [49]. Yeast strains used in this study are listed in Supplemental Table S1.  
Yeast was grown at 30◦C in yeast extract (10g/l), peptone (20 g/l), dextrose (20 g/l), 
media (YPD) with or without Bacto agar, or in synthetic complete (SC) media (yeast 
nitrogen base 6.7 g/l, dextrose 20g/l) supplemented with the appropriate amino acid 
mix.  
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Gross-chromosomal rearrangement (GCR) assay  
GCR rates were determined by fluctuation analysis by taking the median rate of 
at least 15 cultures from at least two isolates [52,53] and are shown with 95% 
confidence intervals [54]. Cells with GCRs were identified by their resistance to 
canavanine and 5-fluoro-orotic acid (Canr 5-FOAr), which is indicative of simultaneous 
inactivation of CAN1 and URA3 on chromosome V. Selective media for the GCR assay 
was prepared as previously described [55].  
 
Fluctuation assays and CAN1 mutation spectrum analysis  
Forward mutation rates were determined by fluctuation analysis by method of the 
median as previously described [53,56] and are shown with 95% confidence intervals 
[54]. Five cultures from at least two different isolates were grown overnight in 3–5 ml of 
YPD media. Dilutions were plated on YPD agar plates to determine the viable cell 
count, and either 500 l or 1000 l were plated on synthetic media supplemented with 60 
g/ml canavanine, but lacking arginine (SC-ARG/canavanine) to select for can1 mutants. 
To select for Thr+ (hom3-10) revertants, 250–4000 l were plated on synthetic media 
lacking threonine. Semi-quantitative assessment of accumulation of CAN1 mutations 
was performed by a patch assay. Briefly, three independent colonies of each mutant 
were spread over approximately 1-inch squares on YPD agar or YPD agar containing 
10mM HU. Patches were allowed to grow for five days at 30 ◦ C and replica plated onto 
SC-ARG/canavanine. Formation of papillae was documented each day for four days of 
incubation at 30 ◦ C. To determine the CAN1 mutation spectrum, the CAN1 open 
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reading frame (ORF) and 50 bp upstream as well as 43bp downstream of the ORF were 
amplified by PCR from canavanine-resistant colonies and sequenced.  
 
Hydroxyurea (HU) and methylmethanesulfonate (MMS) sensitivity assays  
Cultures of single colonies grown overnight at 30°C in YPD liquid media were 
adjusted to OD600 =0.2 and grown at 30°C to OD600 = 0.5. Ten-fold serial dilutions were 
spotted on YPD, and YPD supplemented with the indicated concentrations of MMS and 
HU. Colony formation was documented each day for 5 days of incubation at 30°C  
 
Results  
 
Functional interactions between Exo1, DNA repair and DNA-damage 
response 
Exo1 and Sgs1/Dna2 act in parallel in long-range 5′ end resection during DSB 
repair by HR [18]. When both pathways are disrupted (sgs1∆ exo1∆) the accumulation 
of gross-chromosomal rearrangements (GCRs) increases synergistically to 450-fold 
over the rate of the sgs1∆ single mutant [20,21]. Here we report that this rapid 
accumulation of GCRs in the sgs1∆ exo1∆ mutant can be further accelerated by 
increasing replication stress either by impairing DNA polymerase δ (pol32∆) or by failure 
to complete repair (apn1∆, rad1∆) or bypass (rev3∆, pol32∆) of spontaneous DNA 
lesions (Table 1). Disruption of these activities in the exo1∆ single mutant (Table 2), but 
not in the sgs1∆ single mutant (Table S2), also caused significant increases in genome 
instability, with the strongest synergistic increases caused by the rev3∆ and pol32∆ 
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mutations. Deletion of TEL1 also caused a significant increase in GCR accumulation in 
the sgs1∆ exo1∆ mutant, but to a lesser extent than the 28-fold increase observed upon 
deletion of MEC3 [20], suggesting that the Mec3-Ddc1-Rad17-mediated replication 
stress response plays a significantly greater role in the suppression of genome 
instability in the sgs1∆ exo1∆ mutant than the Tel1-mediated checkpoint response to 
DNA breaks.  
The small, but significant, increases in genome instability in the sgs1∆ exo1∆ 
mutant upon deletion of either TEL1, REV3 or APN1 were accompanied by increases in 
sensitivity to hydroxyurea (HU), which impedes replisome progression by depleting the 
dNTP pool, whereas no such increase was observed upon deletion of RAD1 (Fig. 1A–
D). Combining sgs1∆ and pol32∆ mutations caused a clear fitness defect on rich media, 
which was not further exacerbated by deletion of EXO1 (Fig. 1E). However, deletion of 
EXO1 appeared to slightly suppress the HU hypersensitivity of the sgs1∆ pol32∆ 
mutant, but not its hypersensitivity to methyl methanesulfonate (MMS), which impairs 
replisome progression by generating DNA lesions (e.g., base adducts) in the template 
strand (Fig. 1E). Since insensitivity to HU (200 mM) and sensitivity to MMS (0.05%) are 
characteristic of an exo1∆ mutant [20], we next evaluated the HU sensitivity of sgs1∆ 
and pol32∆ single mutants in the presence and the absence of EXO1. We increased the 
HU concentration from 10 to 55 mM – a level at which sgs1∆ and pol32∆ mutants 
display significantly higher HU sensitivity than the wildtype strain. We found that the 
exo1∆ mutation suppressed the HU hypersensitivity of the pol32∆ mutant to a level 
comparable to the wildtype strain, but had no effect on the sgs1∆ mutant (Fig. 1F). 
Disrupting the nuclease activity of Exo1 (exo1-ND) achieved the same level of 
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suppression of HU hypersensitivity in the pol32∆ mutant as deletion of EXO1 (Fig. 2A). 
Disruption of Exo1, however, had no effect on the viability of pol32∆ cells treated with 
high concentrations of HU (200 mM) (Fig. 2 B). These findings suggest that under low 
replication stress Exo1-dependent events, most likely ssDNA formation at stalled 
replication forks, are the major contributor to the inviability of pol32∆ cells, whereas 
under conditions when DNA synthesis is grossly impeded by high concentrations of HU 
Exo1-independent lesions, such as DNA breaks, are the major cause of pol32∆ 
inviability.  
In contrast to HU, Exo1 was not found to be toxic to MMS-treated pol32∆ cells at 
the tested concentrations. In fact, when the pol32∆ mutant was exposed to MMS we 
observed the opposite response: while exo1, exo1-ND and pol32∆ single mutants grew 
almost like wildtype cells on 0.01% MMS, combining the pol32∆ mutation with exo1∆ or 
exo1-ND mutations increased MMS sensitivity synergistically (Fig. 2A). This is 
consistent with the recent finding that EXO1 is required for the bypass of MMS-induced 
DNA lesions by error-free DNA-damage tolerance pathways [24].  
 
Phosphorylation-site mutants of Exo1 are hypermorphic in HU-treated 
pol32∆ cells  
In yeast cells with a defective telomere capping complex (cdc13-1), the C-
terminal half of Exo1 has been found to be phosphorylated in a Mec1-dependent 
manner at four dispersed sites (S372, S567, S587, S692) [47]. To determine how 
phosphorylation contributes to the adverse effect of Exo1 on HU-treated pol32∆ cells we 
crossed pol32∆ cells with exo1 mutants that either mimicked constitutive Exo1 
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phosphorylation (exo1-SD) or were refractory to phosphorylation at these four sites 
(exo1-SA). Although we expected that mutating the phosphorylation sites would affect 
Exo1 activity and therefore affect the viability of pol32∆ cells on HU we were surprised 
to find that both alleles, exo1-SA and exo1-SD, led to increases in HU hypersensitivity 
that clearly exceeded that of the pol32 mutant with an EXO1 wildtype allele (Fig. 2A). 
Since the nuclease activity of Exo1 appears to sensitize pol32∆ cells to HU, the strong 
synergistic increases in HU sensitivity in the pol32∆ exo1-SA and pol32∆ exo1-SD 
mutants could indicate that the exo1-SA and exo1-SD alleles code for hyperactive 
nucleases. To test this, we inactivated the nuclease activity of the exo1-SA and exo1-
SD mutants by introducing E150D and D173A mutations. Consistent with our 
hypothesis we observed suppression of HU hypersensitivity for both alleles (Fig. 2C). 
To determine if the exo1-SA and the exo1-SD alleles were equally toxic to HU-treated 
pol32∆ cells we lowered the HU concentration to a level at which the pol32∆ mutant was 
no more sensitive than wildtype (20 mM) and compared the growth of exo1-SA pol32∆ 
and exo1-SD pol32∆ cells. We observed that the dephospho-mimicking exo1-SA allele 
was slightly more damaging than the phospho-mimicking exo1-SD allele (Fig. 2D). This 
difference disappeared at higher HU concentrations (≥40 mM).  
In contrast to the exo1∆ mutation, expression of the exo1-SA and exo1-SD 
alleles had no effect on the viability of pol32∆ cells exposed to MMS (Fig. 2A). As 
expected from the phenotype of exo1-ND pol32∆ cells, mutation of the nuclease domain 
of exo1-SA or exo1-SD alleles in pol32∆ cells caused a synergistic increase in MMS-
hypersensitivity (Fig. 2C).  
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Since Pol32 not only plays a major role as the processivity factor for DNA 
polymerase δ, but also functions as a subunit of the translesion DNA polymerase ζ , we 
wanted to determine if the effect of the pol32∆ mutation on HU and MMS sensitivity 
could be due to disruption of Pol ζ activity. We found that deletion of REV3, which 
encodes the catalytic subunit of Pol ζ, did not cause an increase in sensitivity to 55 mM 
HU, a concentration to which the pol32∆ mutant is hypersensitive (Fig. 2E), or 100 mM 
HU (Supplemental Figure S1). Opposite to the effect in the pol32∆ mutant, deletion of 
EXO1 had no effect on the HU sensitivity of the rev3∆ mutant at 55 mM HU and 
increased its sensitivity when exposed to 100 mM HU (Fig. 2E, Supplemental Figure 
S1). Also in contrast to the pol32∆ mutant, the exo1-SA and exo1-SD alleles had no 
effect on the HU sensitivity of the rev3∆ mutant, even at 100 mM HU (Supplemental 
Figure S1). These differences between rev3∆ and pol32∆ mutations suggest that the 
genetic interactions between pol32∆ and exo1 mutations on HU are largely caused by 
the role of Pol32 as a subunit of Pol δ. On 0.01% MMS, deletion of REV3 did not 
increase the sensitivity of the exo1∆ or pol32∆ mutant, but led to a further increase in 
the sensitivity of the pol32∆ exo1∆ double mutant, suggesting that Pol32, Exo1 and 
Rev3 play at least partially redundant roles in the response to MMS (Fig. 2A and E).  
Similar to the rev3∆ mutant, we observed no difference in the HU sensitivity between 
sgs1∆ or tel1∆ mutants expressing the exo1-SA or the exo1-SD allele or the EXO1 
wildtype allele (Supplemental Figure S1). Using the gross-chromosomal rearrangement 
(GCR) assay [55,57], which measures the rate of accumulating viable outcomes of 
chromosome break repair, we found that the loss of Exo1 activity in untreated pol32∆ 
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cells caused a significant (8-fold) increase in chromosomal instability whereas 
expression of the exo1-SA or exo1-SD allele had no effect (Table 3). These results 
mirror the role of EXO1 in MMS-treated pol32∆ cells. Although, EXO1 is the strongest 
known suppressor of spontaneous chromosome rearrangements in sgs1∆ cells [20,21], 
the four phospho-sites are also dispensable for this suppressor function (Table 3).  
 
Mismatch repair activity partially contributes to Exo1 toxicity in pol32∆ 
cells  
In addition to its role in DSB processing, Exo1 performs a late step in MMR, most 
likely degradation of the mismatch-containing nascent strand, and binds to the MMR 
factors Msh2 and Mlh1 through its C-terminus [1,58]. Thus, one way in which Exo1 
could localize to replicating DNA is through interaction with the MMR machinery, whose 
subunits Msh6 and Msh3 interact with the replication machinery by binding to PCNA 
[59,60]. Once there, Exo1 is thought to be able to degrade nascent DNA strands by 
acting on the 5′ ends of Okazaki fragments [61,62]. In addition to these pre-existing 5′ 
ends, the MMR factor MutLα is thought to make incisions in the nascent strand [63]. 
Disruption of the MMR pathway by deletion of MSH2 would disrupt one avenue for 
recruitment of Exo1 to replicating DNA and prevent the formation of MutLα-dependent 
strand nicks for Exo1 entry and increased ssDNA formation. To test the possibility that 
MMR factors contribute to Exo1 toxicity in HU-treated pol32∆ cells, we assessed the HU 
sensitivity of pol32∆ msh2∆ cells expressing either exo1∆, EXO1, exo1-SA or exo1-SD 
alleles. We observed that a msh2∆ mutation had no effect on the HU sensitivity of the 
pol32∆ and pol32∆ exo1-SA mutants, but suppressed the HU sensitivity of the pol32∆ 
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exo1-SD mutant (Fig. 3A). These results show that MMR activity contributes 
significantly to the hypertoxicity of the phospho-mimicking exo1-SD allele in pol32∆ 
cells. It also suggests that MMR-independent functions of Exo1 are mostly responsible 
for the toxicity of the dephospho-mimicking exo1-SA allele in HU-treated pol32∆ cells. 
That the impact of Exo1 activity in the pol32∆ mutant exceeds its role in MMR is also 
suggested by the different responses of the exo1∆ pol32∆ and msh2∆ pol32∆ mutants 
to MMS; whereas the exo1∆ pol32∆ mutant shows an increase in MMS sensitivity 
compared to the single mutants, sensitivity of the msh2∆ pol32∆ mutant is 
indistinguishable from that of the pol32∆ single mutant (Fig. 3B). Additionally, exo1∆, 
but not msh2∆, caused a statistically significant increase in the accumulation of GCRs in 
the pol32∆ mutant (Table 2).  
Since the four phosphorylation sites are located in the C-terminal half of Exo1 
where Mlh1 and Msh2 have been reported to bind we tested if the exo1-SA and exo1-
SD alleles were associated with a mutator phenotype. Three single colonies of wildtype, 
pol32∆, or sgs1∆ cells with either EXO1, exo1∆, exo1-SA or exo1-SD alleles were 
grown into thick, 1-inch squares on nonselective rich media (YPD) and replica-plated 
onto synthetic media containing canavanine to select for clones that had spontaneously 
acquired inactivating mutations in the CAN1 gene. In contrast to exo1∆, neither the 
exo1-SA nor the exo1-SD mutation affected the CAN1 mutation rate in wildtype, sgs1∆ 
or pol32∆ cells (Fig. 4A, Supplemental Figure S2), mirroring the lack of effect of these 
exo1 alleles on GCR accumulation (Table 3). A more accurate determination of the 
CAN1 mutation rate using a fluctuation assay confirmed the previously reported weak 
mutator phenotype of the exo1∆ cells [1], but did not reveal statistically significant 
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differences between the exo1∆ pol32∆ mutant and the single mutants, or the exo1-SA 
pol32∆ or exo1-SD pol32∆ mutants and the single mutants (Fig. 4C). These findings 
indicate that the phosphorylation site mutations do not affect the function of Exo1 in 
mutation avoidance at the CAN1 locus. However, when we determined the mutation 
rate of the hom3-10 allele (Thr−), which detects mutations that revert a +1T insertion in 
a mononucleotide (T10) run, we observed a synergistic (24-fold) increase in Thr+ 
reversion events in the pol32∆ exo1∆ mutant (Fig. 4C), consistent with a previously 
reported synergistic mutation rate increase in the lys2-10A assay, which detects 
mutations that revert +1A insertions [64]. In the hom3-10 assay, we also detected a 
small (2.8-fold), but significant increase of Thr+ revertants in the exo1-SD mutant; but no 
synergistic interaction when the exo1-SD and pol32∆ mutations were combined (Fig. 
4C). Finally, growing the cells in the presence of 10mM HU before replica-plating onto 
canavanine media did not lead to noticeable changes in mutation rates, except in the 
exo1-SA pol32∆ mutant, which exhibited a markedly reduced number of papillae 
compared to the single mutants (Fig. 4B). The slow growth of pol32∆ exo1-SA cells 
even in the presence of a very low concentration of HU (Fig. 2C) is the most likely 
cause of the lower number of Canr papillae in this mutant.  
When we analyzed the CAN1 mutation spectrum in Canr clones (Supplemental 
Table S3) we found that the majority (89.5%) of mutations in the exo1∆ mutant were 
base substitutions and small (≤3 bp) insertions/deletions, whereas larger 
insertions/deletions ranging from 18 to 72bp dominated (52.6%) in pol32∆ mutant. Upon 
deletion of EXO1 in the pol32∆ mutant these large deletions decreased to 20% whereas 
small insertions/deletions increased (40%), with a similar fraction of base substitutions 
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(30%) as in the pol32∆ mutant (36.8%). We also identified rare complex 
rearrangements that consist of large deletions (8–233 bp) that contain small insertions 
(2–36 bp). 
 
Discussion 
In wildtype cells, the nuclease activity of Exo1 is important for 5′ end resection of 
DSB ends during HR, for the excision step of MMR and for HR-mediated template 
switching during error-free bypass of DNA lesions. Exo1 has also been shown to 
counteract fork reversal in checkpoint-deficient cells and is thought to promote template 
switching by contributing to the extension of ssDNA behind stalled replication forks [25–
27,65–67]. We have shown here that Exo1 nuclease activity is toxic to HU-treated 
pol32∆ cells and that this toxicity can be further increased by mutating four serine 
residues in the C-terminal tail of Exo1 that have previously been shown to be 
phosphorylated in response to telomere uncapping [47]. That the viability of HU-treated 
pol32∆ cells could be rescued by disruption of the nuclease activity of Exo1 suggests 
that phosphorylated Exo1, which forms in response to HU [46], is still a potent nuclease, 
but at a level that is compatible with normal growth of HU-treated wildtype cells. Only 
when replication fork stalling due to HU treatment is combined with another event that 
independently impairs DNA synthesis (pol32∆), do Exo1 nuclease-dependent events, 
most likely ssDNA formation, reach toxic levels. This could suggest that there is a 
balance between the speed of ssDNA formation at replication forks and the speed of 
DNA synthesis, which does not allow ssDNA to accumulate at deleterious levels. If the 
speed of DNA synthesis is reduced (HU treatment), this balance may be restored by 
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reducing Exo1 activity through Mec1-dependent phosphorylation of Exo1. However, this 
reduced level of Exo1 activity might be damaging if DNA synthesis is inhibited further 
(e.g., HU-treatment of the pol32∆ mutant) and DNA resection exceeds DNA synthesis. 
That Exo1 phosphorylation also occurs in MMS-treated cells [38], which depend on 
Exo1 activity for viability, also supports a model in which phosphorylation reduces, 
rather than deactivates, Exo1 nuclease function. This model is also consistent with the 
finding that the C-terminal tail of Exo1, where the phosphorylation sites are located, is 
dispensable for normal function of Exo1 in MMS-treated cells [20] and the finding in this 
study that expression of exo1-SA and exo1-SD alleles has no effect on the viability of 
MMS-treated wildtype or pol32∆ cells, leading us to suggest that downregulation of 
Exo1 activity by phosphorylation is tolerated in MMS-treated cells, but not necessary.  
As in HU-treated pol32∆ cells, endogenous Exo1 activity was previously shown to inhibit 
proliferation of the cdc13-1 mutant [47]. In these cells, which accumulate uncapped 
telomeres, a phospho-mimicking exo1 allele led to a minor increase in cell viability 
whereas a dephospho-mimicking allele had no effect. Although the effect was subtle, it 
suggested that phosphorylation inhibits Exo1 activity. Unlike in the cdc13-1 mutant, 
however, we did not observe a rescue of cell viability upon expression of the phospho-
mimicking exo1-SD allele in HU-treated pol32∆ cells. Instead, exo1-SD and exo1-SA 
inhibited proliferation more strongly than wildtype EXO1. For both alleles this negative 
effect was dependent on the nuclease activity, suggesting that exo1-SA and exo1-SD 
encode functional exonucleases that are trapped in an active state. The hyperactivity of 
both alleles further suggests that both, phosphorylated and the non-phosphorylated 
forms of Exo1, and possibly the ability to convert one form into the other, are necessary 
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for the proper response of pol32∆ cells to HU. Although Pol32 functions as a subunit of 
Pol δ and Pol ζ, the different effects of pol32∆ and rev3∆ mutations, the latter of which 
disrupts the catalytic activity of Pol ζ, suggest that the observed genetic interactions 
between pol32∆ and exo1∆ mutations on hydroxyurea are dominated by the role of 
Pol32 as a processivity factor of Pol δ.  
The inability to phosphorylate serine residues 372, 567, 587 and 692 could 
explain the unrestrained activity of the exo1-SA mutant, which appears to exceed that of 
the exo1-SD mutant slightly. Whereas hypertoxicity of exo1-SA suggests that 
phosphorylation of the four serine residues is necessary for the proper regulation of 
Exo1 activity, hypertoxicity of the exo1-SD mutant could suggest that it is insufficient. 
That the aspartic acid substitutions in the exo1-SD mutant, which mimic the negative 
charge of phosphorylated serine residues, do not inactivate, even partially, Exo1, 
argues that irreversible negative charges at residues 372, 567, 587, and 692 may 
interfere with additional events that are required for the downregulation of Exo1 activity 
at stalled replication forks, such as additional phosphorylation events or conformational 
changes. In addition to phosphorylation, the activity of Exo1 could be affected by 
binding to proteins that modulate its activity through conformational changes, 
recruitment to DNA substrates, subcellular relocalization, or sequestration. The proteins 
that are currently known to bind to yeast Exo1 are the MMR factors Msh2 and Mlh1 [1], 
the 14-3-3 proteins Bmh1 and Bmh2 [46], and Mec3, a subunit of the Ddc1/Rad17/Mec3 
(9-1-1) checkpoint clamp [24]. All could affect Exo1 activity. First, we show here that 
deletion of MSH2 significantly suppresses the detrimental effects of the hyperactive 
exo1-SD allele, suggesting that constitutive phosphorylation of the Exo1 C-terminus 
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might lead to a dysregulation of its physical interaction with Msh2. MMR factors, which 
travel with the replisome via interaction with PCNA [59,60], could be involved in 
recruiting Exo1 to replication forks and provide additional 5′ ends for Exo1 to resect, 
thereby contributing to increased Exo1-dependent ssDNA formation at stalled 
replication forks. Recent evidence in yeast indeed suggests a role for MMR activity and 
Exo1 in checkpoint activation through promoting ssDNA formation at stalled replication 
forks and DNA repair-induced gaps [68,69]. Second, 14-3-3 proteins can modulate 
protein activity through affecting access to substrates by changing a protein’s 
subcellular localization, by inducing conformational changes that either increase or 
decrease activity, or by bridging interaction with another protein [70]. Although the vast 
majority of 14-3-3 proteins interact with phosphorylated targets, the question whether 
Bmh1/2 interacts with a phosphorylated or a unphosphorylated form of Exo1 is currently 
unresolved, as is the molecular mechanism by which Bmh1/2 affects Exo1 activity [46]. 
Third, as Exo1 phosphorylation occurs in a Mec1-dependent manner in response to HU 
and MMS [38,46], it is plausible that phosphorylation-dependent binding of Exo1 to the 
Mec3/Ddc1/Rad17 checkpoint clamp, which loads onto the ds/ssDNA junctions at 
ssDNA gaps, could control Exo1 activity during the DNA-damage response. Whereas 
Rad27 activity is strongly stimulated through physical interaction with PCNA [71–73], it 
is not known if Exo1 activity at replication forks is regulated by another protein. The 
interaction of Exo1 with the Mec3 checkpoint clamp, however, could provide such 
regulation during the DNA damage response – analogous to the interaction between 
Rad27 and PCNA during DNA replication.  
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The ability of an EXO1 deletion to rescue pol32∆ cells treated with a low dose of HU (55 
mM), but not those exposed to a high dose of HU (200mM) might be due to a difference 
in the types of DNA lesions and their quantity induced by low and high doses of HU. For 
instance, deletion of EXO1 may have a positive effect on viability by preventing 
excessive ssDNA formation at slowed or stalled forks, which are likely to dominate in 
pol32∆ cells exposed to low HU concentrations. In contrast, deletion of EXO1 is unlikely 
to prevent the formation DNA breaks, which may be more typical in cells exposed to 
high HU concentrations. Similarly, the different extent by which the dephospho-
mimicking and phospho-mimicking exo1 alleles affect the viability of the cdc13-1 mutant 
[47] and HU-treated pol32∆ cells could indicate that the DNA-damage response is 
differently regulated for different regions of the genome. Specifically, differences in the 
sets of proteins and DNA structures found at telomeres versus those found at 
replicating DNA could cause differences in the regulation of Exo1 activity and the extent 
of DNA resection at those sites. In an cdc13-1 mutant, for instance, Exo1 is responsible 
for the majority of new ssDNA formation at the unprotected telomeres and for the 
initiation of Mec1-dependent checkpoint activation [74,75] reviewed in [76], whereas 
Exo1 appears to be redundant with other nuclease functions during 5′ end resection 
elsewhere in the genome, most notably in the processing of DSB ends during HR [18] 
and degradation of the mismatch-containing strand in MMR [1]. Finally, the differences 
between the effect of the exo1 phosphorylation mutants in pol32∆ and cdc13-1 mutants 
could also suggest that phosphorylation is more important for regulating Exo1 activity at 
slowed and stalled replication forks than at uncapped telomeres.  
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Although in the absence of Exo1 excessive ssDNA formation and loss of cell 
viability could be prevented during increased fork stalling, other aberrant structures may 
still form due to lack of resection by Exo1, leading to genome instability. This is 
supported by the synergistic increase in the GCR rate in the exo1∆ pol32∆ mutant. Lack 
of resection in the absence of Exo1 could also provide an explanation for the rare 
complex mutations we observed at the CAN1 locus, which appear to be a combination 
of deletion and insertion events. They could, for example, arise if ends of the nascent 
strands dissociate from their templates, misanneal in a chickenfoot structure and then 
dissociate after limited DNA synthesis to reanneal with their template strands.  
Our findings are consistent with the report in cells with uncapped telomeres that 
phosphorylation inhibits Exo1 activity, but they do, on their own, not exclude the 
possibility that phosphorylation upregulates Exo1 activity at stalled replication forks. 
Upregulation of Exo1 activity by phosphorylation is consistent with our finding that 
disruption of the nuclease activity of Exo1 rescues the viability of HU-treated pol32∆ 
cells. It would also provide an explanation for the hypertoxicity of the phospho-
mimicking exo1-SD mutant in HU-treated pol32∆ cells and the normal function of the 
allele in MMS-treated pol32∆ cells, whose viability depends on functional Exo1. The 
hypertoxicity of the exo1-SA mutant, which is refractory to phosphorylation at the 
previously identified four serine residues, could be explained if activating 
phosphorylation events shift to other residues. Since the C-terminal half of Exo1 is 
predicted to be unstructured [20], other serine residues in this 331-residue region 
should be easily accessible to phosphorylation. Indeed, Western blot analysis has 
shown that the exo1-SA mutant can still be phosphorylated in the presence of DNA 
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damage [47]. Additional analyses of Exo1 post-translational modifications will therefore 
be needed to determine if Exo1 activity is regulated differently in response to varying 
DNA damage-inducing agents, genetic mutations, or types of DNA lesions, and how 
these modifications affect the binding of Exo1 to proteins that might modulate its 
activity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 118 
Figures and Tables 
 
Figure 3.1. Effect of DNA repair and checkpoint mutations on DNA-damage 
sensitivity of sgs1∆, exo1∆ and sgs1∆ exo1∆ cells. (A–D) At 10 mM HU, the tel1∆, 
rad1∆, rev3∆ and apn1∆ mutations do not affect the viability of sgs1∆ and exo1∆ 
mutants, but inhibit growth of the sgs1∆ exo1∆ mutant. (E) The exo1∆ mutation 
suppresses the hypersensitivity of the pol32∆ sgs1∆ mutant to HU, but not to MMS. (F) 
Hypersensitivity of the pol32∆ mutant to higher concentrations of HU (55 mM) is 
suppressed by exo1∆.  
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Figure 3.2. Sensitivity of pol32∆ cells to HU and MMS is differently affected by 
nuclease-dead and phosphorylation site mutants of EXO1. (A) Toxicity of Exo1 in 
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HU-treated pol32∆ cells is due to the nuclease activity of Exo1. exo1 mutants with four 
serine residues substituted with either alanine (exo1-SA, dephospho-mimic) or aspartic 
acid (exo1-SD, phospho-mimic) are more toxic to HU-treated pol32∆ cells than wildtype 
Exo1. In MMS-treated pol32 cells, deletion of Exo1 activity causes a decrease of 
viability whereas the phospho-site mutants of Exo1 have no effect. (B) Deletion of EXO1 
does not improve viability of pol32∆ cells exposed to a high concentration of HU. (C) 
The hypertoxicity of exo1-SA and exo1-SD in HU-treated pol32∆ cells depends on the 
nuclease activity of Exo1. (D) The dephospho-mimicking exo1-SA allele is more toxic to 
HU-treated pol32∆ cells than the phospho-mimicking exo1-SD allele. (E) The rev3∆ 
mutation does not affect the sensitivity of the exo1∆ pol32∆ mutant to 55 mM HU, but 
increases its sensitivity to 0.01% MMS. Unlike the exo1∆ mutation, the rev3∆ mutation 
is not a major suppressor of the hypersensitivity of the pol32∆ mutant to 55 mM HU.  
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Figure 3.3. Effect of DNA mismatch repair on DNA damage sensitivity of pol32∆ 
and exo1∆ mutants. (A) Deletion of MSH2 does not affect the HU hypersensitivity of 
the pol32∆ mutant or the pol32∆ exo1-SA mutant, but suppresses the hypertoxicity of 
the phospho-mimic exo1-SD allele in HU-treated pol32∆ cells. (B) In contrast to 
inactivation of EXO1 (exo1∆, exo1-ND), deletion of MSH2 does not increase the 
sensitivity of the pol32∆ mutant to 0.01% MMS.  
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Figure 4.4. Effect of phosphorylation site mutations on the function of Exo1 in 
mutation avoidance. Patches were grown from individual colonies of the indicated 
mutants to allow accumulation of mutations at the CAN1 locus. Patches were then 
replica-plated onto media supplemented with canavanine to select Canr mutants. The 
exo1-SA and exo1-SD alleles do not exhibit a mutator phenotype when grown in the 
absence of HU (A) or presence of 10 mM HU (B) prior to replica-plating onto 
canavanine media (see Supplemental Figure S4.2. for the exo1-SD allele). (C) 
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Compared to the single mutants, the exo1∆ pol32∆ mutant exhibits a synergistic (24-
fold) increase in Thr+ reversion events (hom3-10 allele), but no increase in the 
accumulation of Canr mutants (CAN1 locus). Whereas the exo1-SA allele exhibits a 
wildtype mutation rate, the exo1-SD allele causes a small (2.8-fold), but significant, 
increase in the accumulation of Thr+ revertants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 124 
 
Fig. S3.1. Effects of exo1Δ and exo1 phosphorylation site mutants exo1-SA and 
exo1-SD on HU sensitivity of sgs1Δ, rev3Δ, and tel1Δ mutants. 
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Figure S4.2. Effect of the phospho-mimicking exo1-SD allele on the spontaneous 
mutation rate at the CAN1 locus in the pol32Δ and the sgs1Δ mutant. The 
mismatch-repair-defective msh2Δ mutant is included as a positive control. 
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Table 3.1 Gross-chromosomal rearrangements  (GCRs) in the sgs1∆ exo1∆ 
mutant. 
Relevant genotype GCR rate (Canr 5-
FOAr × 10-10) 
95% CIa  
(Canr 5-FOAr × 10-10) 
Fold increase 
over sgs1∆ 
exo1∆ 
Wildtype 1.1 <1-6.2 _ 
exo1∆ 14 7-28 _ 
sgs1∆ 89 57-177 _ 
exo1∆ sgs1∆ 40,500 31,000-49,800 _ 
exo1∆ sgs1∆ rev3∆ 176,000 148,000-210,000 4.4 
exo1∆ sgs1∆ pol32∆ 141,000 107,000-166,000 3.5 
exo1∆ sgs1∆ tel1∆ 140,000 126,000-174,000 3.4 
exo1∆ sgs1∆ rad1∆ 96,600 74,500-180,000 2.4 
exo1∆ sgs1∆ apn1∆ 78,500 57,000-131,000 1.9 
(a) 95% confidence intervals (CI) were calculated according to Ref. [54].  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Table 3.2 EXO1- dependent suppression of gross-chromosomal rearrangements 
(GCRs) in DNA repair and DNA-damage checkpoints mutants. 
Relevant genotype GCR ratea  
(Canr 5-FOAr × 10-10) 
95% CIb  
(Canr 5-FOAr × 10-10) 
Increase over 
single 
mutantc 
Wildtype 1.1 <1-6.2 
 exo1∆ 14 7-28 
 rad1∆ 10 <9-23 
 exo1∆ rad1∆ 45 30-66 3.2 
apn1∆ 19 14-41 
 exo1∆ apn1∆ 64 42-224 3.3 
tel1∆ 2 1.8-2.2 
 exo1∆ tel1∆ 95 46-180 6.7 
pol32∆ 20 15-26 
 exo1∆ pol32∆ 173 94-273 8.6 
rev3∆ 13 8-20 
 exo1∆ rev3∆ 205 127-304 14.6 
msh2∆ 40 n.d. 
 msh2∆ pol32∆ 41 25-102 1 
(a) GCR rates for msh2∆ and tel1∆ are from Refs. [77,78].  
(b) 95% confidence intervals (CI) were calculated according to Ref. [54]. n.d., not 
determined.  
(c) The increase in the GCR rate of the double mutant was calculated by dividing the 
GCR rate of the double mutant by the higher GCR rate of the two single mutants.  
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Table 3.3. Effect of nuclease-dead and phosphosite mutaitons in EXO1 on the 
accumulation of gross-chromosomal rearrangements. 
Relevant genotype GCR rate (Canr 5-FOAr × 10-10) 95% CIa (Canr 5-FOAr × 10-10) 
Wildtype 1.1 <1-6.2 
exo1Δ 14 7â€“28 
exo1-ND 58 12-100 
exo1-ND sgs1Δ 69,000 45,000-79,000 
exo1Δ sgs1Δ 40,500 31,000-50,000 
pol32Δ 20 15-26 
exo1-ND pol32Δ 270 110-650 
exo1Δ pol32Δ 170 94-270 
exo1-SA 23 16-85 
exo1-SA sgs1Δ 33 <12-119 
exo1-SD sgs1Δ 43 <22-140 
exo1-SA pol32Δ <20 <17-33 
exo1-SD pol32Δ <8 <7-19 
(a) 95% confidence intervals (CI) were calculated according to Ref. [54].  
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TABLE S3.1. Saccharomyces cerevisiae strains used in this study 
Strain ID Genotype 
KSHY 802 MATa, ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2Bgl, hom3-10, ade2Δ1, 
ade8, hxt13::URA3 
KHSY 1338 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, sgs1::TRP1 
KHSY 1954 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, rev3::TRP1 
KHSY 1957 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, apn1::TRP1 
KHSY 2311 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, sgs1::TRP1, tel1::G418 
KHSY 2316 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, tel1::G418 
KHSY 2333 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, pol32::loxP-G418-loxP 
KHSY 2338 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1::loxP-G418-loxP 
KHSY 2402 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1::loxP-G418-loxP, sgs1::TRP1 
KHSY 2425 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, rad1::loxP-G418-loxP, sgs1::TRP1 
KHSY 2430 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, rad1::loxP-G418-loxP 
KHSY 2437 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, pol32::loxP-G418-loxP, sgs1::TRP1 
KHSY 3782 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, msh2::TRP1 
KHSY 4394 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, apn1::TRP1, exo1::loxP-G418-loxP 
KHSY 4398 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1::loxP-G418-loxP, rad1::loxP-G418-loxP, 
sgs1::TRP1 
KHSY 4402 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1::loxP-G418-loxP, rev3::TRP1 
KHSY 4417 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, apn1::TRP1, exo1::loxP-G418-loxP 
KHSY 4421 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1::loxP-G418-loxP, rev3::TRP1 sgs1::TRP1 
KHSY 4430 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1::loxP-G418-loxP, sgs1::TRP1, tel1::G418 
KHSY 4438 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-E150D-D173A.HIS3, sgs1::TRP1 
KHSY 4454 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1,  
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 ade8, hxt13::URA3, exo1::loxP-G418-loxP, tel1::G418 
KHSY 4458 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1::loxP-G418-loxP, pol32::loxP-G418-loxP 
KHSY 4460 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-E150D-D173A.HIS3 
KHSY 4701 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-S392A, S567A, S587A, S692A.HIS3 
KHSY 4710 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3 exo1-S392A, S567A, S587A, S692A.HIS3, 
pol32::loxP-G418-loxP 
KHSY 4803 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1::loxP-G418-loxP, pol32::loxP-G418-loxP, 
sgs1::TRP1 
KHSY 4836 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-S392A, S567A, S587A, S692A.HIS3, 
sgs1::TRP1 
KHSY 4839 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, apn1::TRP1, exo1::loxP-G418-loxP, sgs1::TRP1 
KHSY 4844 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1::loxP-G418-loxP, rad1::loxP-G418-loxP 
KHSY 4847 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-E150D-D173A.HIS3,  pol32::loxP-G418-loxP 
KHSY 4852 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, rev3::TRP1, sgs1::HIS3 
KHSY 4888 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, msh2::TRP1, pol32::loxP-G418-loxP 
KHSY 4892 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-S392A, S567A, S587A, S692A.HIS3, 
sgs1::TRP1 
KHSY 4896 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-S392A, S567A, S587A, S692A.HIS3 
KHSY 4897 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3 exo1-S392A, S567A, S587A, S692A.HIS3, 
pol32::loxP-G418-loxP 
KHSY 4963 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-S392A, S567A, S587A, S692A.HIS3, 
sgs1::TRP1, tel1::G418 
KHSY 4968 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-S392A, S567A, S587A, S692A.HIS3,  
sgs1::TRP1, tel1::G418 
KHSY 4969 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-E150D-D173A-S392D-S567D-S587D- 
S692D.HIS3 
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KHSY 4986 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-S392A, S567A, S587A, S692A.HIS3, 
rev3::TRP1, sgs1::HIS3 
KHSY 4987 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-S392A, S567A, S587A, S692A.HIS3, 
rev3::TRP1, sgs1::HIS3 
KHSY 4989 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-E150D-D173A-S392D-S567D-S587D- 
S692D.HIS3 
KHSY 4993 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-E150D-D173A-S392D-S567D-S587D- 
S692D.HIS3, HIS3, pol32::loxP-G418-loxP 
KHSY 5004 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-S392D-S567D-S587D- S692D.HIS3, 
msh2::TRP1, pol32::loxP-G418-loxP 
KHSY 5008 MATalpha, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, 
ade2∆1, ade8, hxt13::URA3, exo1-S392A, S567A, S587A, S692A.HIS3, 
msh2::TRP1, pol32::loxP-G418-loxP 
KHSY 5014 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1-E150D-D173A-S392D-S567D-S587D- 
S692D.HIS3, pol32::loxP-G418-loxP 
KHSY 5037 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1::loxP-G418-loxP, msh2::TRP1, pol32::loxP-
G418-loxP 
KHSY 5043 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, exo1::loxP-G418-loxP, pol32::loxP-G418-loxP, 
rev3::TRP1 
KHSY 5044 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, 
ade8, hxt13::URA3, pol32::loxP-G418-loxP, rev3::TRP1 
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TABLE S3.2. SGS1-dependent suppression of gross-chromosomal 
rearrangements. 
Relevant Genotype GCR Ratei 
(Canr 5-FOAr x 10-10) 
95% CIII 
(Canr 5-FOAr x 10-10) 
wildtype 1.1 < 1 – 6.2 
sgs1Δ 89 57-177 
tel1∆ 2 1.8–2.2  
sgs1Δ tel1∆ 227 46-418 
rev3Δ 13 8-20 
sgs1Δ rev3∆ 195 75-279 
pol32Δ 20 15-26 
sgs1∆ pol32∆ 25 <24-105 
rad1Δ 10 < 9-23 
sgs1∆ rad1∆ 63 25-356 
apn1Δ  19 14-41 
sgs1∆ apn1∆ 141 72-362 
(i) GCR rate for tel1∆ is from reference [75]. 
(ii) 95% confidence intervals (CI) were calculated according to reference [51]. 
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Table S3.3. Spontaneous CAN1 mutations identified in exo1∆, pol32∆ and exo1∆ 
pol32∆ mutants. 
Genotype Mutation typea Mutation Frequency (%) 
wildtype base substitution C→T 17/20 (85) 
A→T 
G→T 
T→C 
G→A 
C→G 
T→G 
A→C 
G→C 
C→A 
≤ 3 bp insertion/deletion T3 → T2 1/20 (5) 
> 3 bp insertion/deletion 148 bp deletion 1/20 (5) 
complex 24 bp del/ 2 bp ins 1/20 (5) 
exo1∆ base substitution A → T 14/19 (73.7) 
G → C 
C → A 
T → G 
T→C 
G→T 
C→A 
G→C 
A→T 
C→G 
C→T 
≤ 3 bp insertion/deletion GCT → GT 3/19 (15.8) 
T2 → T3 
> 3 bp insertion/deletion 53 bp deletion 1/19 (5.3) 
complex 233 bp del/36 bp ins 1/19 (5.3) 
pol32∆ Base substitution G→C 7/19 (36.8) 
C→G 
G→A 
G→T 
T→A 
A→C 
≤ 3 bp insertion/deletion ATG →AG  2/19 (5.3) 
T4→T2 
> 3 bp insertion/deletion 8 bp deletion 10/19 (52.6) 
 
 
 
 
 
 
 
 
 
18 bp deletion 
22 bp deletion 
24 bp deletion 
31 bp deletion 
36 bp deletion 
38 bp deletion 
41 bp deletion 
72 bp deletion 
32 bp insertion 
complex  0/19 (0) 
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Table S3.3. Spontaneous CAN1 mutations identified in exo1∆, pol32∆ and exo1∆ 
pol32∆ mutants (continued). 
Genotype Mutation type Mutation Frequency (%) 
exo1∆ pol32∆ base substitution G → A 6/20 (30) 
T → C 
T → G 
C→A 
≤ 3 bp insertion/deletion 
 
A6 → A5 8/20 (40) 
T3 → T2 
T4 → T3 
T6 → T5 
G4 → G3 
T6 → T7 
2 bp insertion (TC) 
> 3 bp insertion/deletion 8 bp deletion 4/20 (20) 
26 bp deletion 
94 bp deletion 
586 bp deletion 
complex 8 bp del/5 bp ins 2/20 (10) 
27 bp del/3 bp ins 
 
(a) The CAN1 open reading frame was amplified by PCR from independent canavanine-
resistant colonies and sequenced. The identified mutations were divided into four 
groups: base substitutions, insertions/deletions  ≤ 3 bp), insertions/deletions (> 3 bp), 
and complex mutations. Complex mutations were deletions (8-233 bp) that contained a 
small insertion (2-36 bp). 
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ABSTRACT 
Accurate repair of DNA breaks is essential for maintaining genome integrity and 
cellular fitness. Sgs1, the sole member of the RecQ family of DNA helicases in 
Saccharomyces cerevisiae, plays important roles in both early and late stages of 
homology-dependent repair of DNA lesions. Its large number of physical and genetic 
interactions with cellular factors that play roles in DNA recombination, repair and 
replication have established Sgs1 as a key player in the maintenance of genome 
integrity. To determine the significance of Sgs1 binding to the strand exchange factor 
Rad51 we have identified a single amino acid change in an unstructured linker C-
terminal of the helicase core of Sgs1 that disrupts Rad51 binding. In contrast to an 
SGS1 deletion or a helicase-defective sgs1 allele, this new separation-of-function allele, 
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sgs1-FD, does not cause DNA damage hypersensitivity or genome instability but 
exhibits negative and positive genetic interactions with sae2∆, mre11∆, exo1∆, srs2∆, 
rrm3∆, and pol32∆ that are distinct from those of known sgs1 mutants. Our findings 
suggest a role for the Sgs1-Rad51 interaction in stimulating homologous recombination 
(HR). However, unlike sgs1 mutations that impair the resection of DNA double-strand 
ends, negative genetic interactions of the sgs1-FD allele are not suppressed by YKU70 
deletion. We, therefore, propose that the Sgs1-Rad51 interaction stimulates HR by 
facilitating the formation of the presynaptic Rad51filament, possibly by Sgs1 competing 
with replication protein A for single-strand DNA binding during resection.   
 
INTRODUCTION  
DNA double-strand breaks (DSBs) can be induced exogenously by DNA 
damaging agents or form endogenously if the replisome collapses at a break in the 
template strand or encounters a physical barrier that blocks progression of the 
replisome, such as a bound protein, DNA adduct, interstrand crosslink, or unusual DNA 
structure. Cells can repair such DSBs by homologous recombination (HR) or non-
homologous end-joining (NHEJ). In the event of a DSB, the NHEJ proteins Ku70/Ku80 
(Ku) and HR proteins Mre11-Rad50-Xrs2 (MRX) initiate the repair process by binding to 
the DSB ends [1]. NHEJ is preferred in G1 as there is no sister chromatid whereas HR 
is preferred during S phase and G2 [2-4]. In S phase, Ku and MRX bind to the DSB first 
and recruitment of Sae2 activates short range resection, removing Ku and MRX and 
leaving a small 3’ single-stranded DNA (ssDNA) overhang [1, 5-9]. These trimmed DNA 
ends are then more extensively resected by the 5’- 3’ exonuclease Exo1 or by Dna2 
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nuclease, which works with the 3’- 5’ helicase Sgs1 [9-11]. Rad52, an essential HR 
factor in budding yeast, then allows a recombinogenic Rad51 filament to assemble on 
the replication protein A (RPA) coated 3’-overhang [12, 13]. Regulation of HR at this 
stage relies on the antirecombinase Srs2, which can disassemble Rad51 filaments [14-
16]. If Rad51-mediated homology search is successful, the 3' end of the invading strand 
is used as a priming site for DNA synthesis and thus extended. In classic DSB repair 
(DSBR) the second end of the DNA break is also captured to form a double-Holliday 
Junction (dHJ), which can either be resolved by endonucleases Mus81/Mms4 or Yen1 
to produce both crossovers and noncrossovers, or the HJs are converged and 
decatenated by the Sgs1/Top3/Rmi1 complex, resulting in only noncrossovers [17-19].  
Homology-directed repair of DSBs in mitotic cells often occurs in ways other than by 
DSBR, such as synthesis-dependent strand annealing (SDSA), single-strand annealing 
(SSA) and break-induced replication (BIR) [20-22]. In SDSA the invading strand is 
extended by DNA synthesis, but then displaced before capture and annealed to 
complementary sequences on the other side of the DSB; since this process does not 
lead to the formation of HJs, it always results in noncrossover products [23]. In contrast 
to DSBR and SDSA, SSA and BIR are error-prone. SSA occurs when regions of 
sequence homology are recognized during resection, annealed and then ligated, 
resulting in the loss of the DNA sequence between the repeats [24, 25]. BIR is used for 
homology-directed repair of one-ended DSBs, such as those that arise when a 
replication fork collapses at a nick in the template strand or when a stalled replication 
fork is cut [26-30].  
  149 
Resection of the DSB ends is essential for all HR. After initial trimming by 
MRX/Sae2, long-range resection by Sgs1/Dna2 and Exo1 is redundant, with loss of 
both activities resulting in a severe resection defect and mutagenic repair [9, 10, 31]. 
Exo1 and Dna2 differ in that Exo1 can degrade the 5’ strand in double-strand DNA 
(dsDNA) whereas Dna2 requires the Sgs1 helicase to unwind the dsDNA to provide 
ssDNA on which Dna2 can act [11, 32]. In a yeast-two-hybrid assay, Sgs1 was found to 
interact with Mre11, and it has been proposed that this helps to recruit Sgs1/Dna2 to the 
DSB after initial resection [33, 34]. Sgs1 is a member of the highly conserved family of 
RecQ-like DNA helicases, which interact with a large number of proteins with functions 
in genome maintenance. Sgs1 not only interacts with Dna2, Mre11, Top3/Rmi1 but also 
contains acidic regions in its long unstructured N-terminal tail that are required for 
binding the ssDNA binding protein RPA [35-39]. Rad53 kinase, Top2 topoisomerase 
and the nucleotide excision repair factor Rad16 have also been shown to physically 
interact with the N-terminal tail of Sgs1, whereas Rad51 and Mlh1 binding has been 
narrowed down to the region C-terminal of the helicase core [38, 40-44].  
Lack of Sgs1 results in increased sensitivity to DNA damaging agents, shortened 
lifespan, missegregated chromosomes, and moderate accumulation of gross-
chromosomal rearrangements (GCRs), including characteristic recurrent translocations 
between short homologous, but non-allelic, sequences [29, 45-48]. Cells lacking Sgs1 
exhibit growth defects or die in the absence of structure-specific endonucleases 
Mus81/Mms4 and Slx1/4 that resolve recombination intermediates and stalled 
replication forks, the HR factors MRX or Sae2, the antirecombinase Srs2, or the Rrm3 
helicase, which regulates replisome progression [45, 49-54].   
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 This multitude of physical and genetic interactions has established Sgs1 as a key 
player in the maintenance of genome integrity. The molecular basis and functional 
significance of some of the physical interactions for HR are increasingly well 
understood, especially the interaction of Sgs1 with Top3/Rmi1 in dHJ dissolution, with 
Dna2 in DSB resection, and with mismatch repair factors in the suppression of mitotic 
and meiotic homeologous recombination [11, 39, 46, 55-57]. Here, to understand the 
role of the physical interaction of Sgs1 with Rad51 in homology-dependent DNA repair, 
we set out to identify a separation-of-function allele of SGS1 that disrupts Sgs1-Rad51 
binding and to characterize the genetic interactions of this sgs1 allele in cells with 
replication-dependent DNA lesions.  
 
Materials and Methods  
Yeast Strains and Media  
Yeast strains were derived from S288C strain KHSY802 (MATa, ura3-52, 
trp1Δ63, his3Δ200, leu2Δ1, lys2Bgl, hom3-10, ade2Δ1, ade8, hxt13:: URA3).  SGS1 
mutant alleles for amino acid changes K706A (sgs1-HD, pKHS787) and F1192D (sgs1-
FD, pKHS786) were generated by site-directed mutagenesis (QuikChange, Stratagene) 
of wildtype SGS1 in pKHS360 (pRS405-SGS1.TRP1) and integrated into the 
chromosome under control of the endogenous SGS1 promoter by LiAc-mediated 
transformation as described [58]. Haploid strains with multiple mutant alleles were 
obtained by sporulating diploids heterozygous for the desired mutations and genotyping 
spores on selective media or PCR. All yeast strains used in this study are listed in 
Supplementary Table S1. Yeast were grown at 30° in yeast extract, peptone, and 
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dextrose (YPD) or synthetic complete (SC) media as previously described [59]. Solid 
media was supplemented with 20 g/l agar (US Biological).  
 
DNA-damage sensitivity assays 
  Sensitivity of yeast cells in exponential growth phase to HU and MMS was tested 
by spot assays as previously described [60]. Briefly, cell cultures were grown in liquid 
YPD medium OD600=0.5 and ten-fold serial dilutions were spotted on YPD containing 
the indicated concentration of HU (US Biological) or MMS (Sigma-Aldrich). Images of 
colony growth were acquired every 24 hours for five days of incubation at 30° with a 
GelCam 315 CCD camera mounted on a Gel-Doc IT Imaging system (UVP) and 
VisionWorks software.   
 
Gross-Chromosomal Rearrangement (GCR) Assay  
Cells with GCRs were identified by simultaneous inactivation of CAN1 and URA3 
on chromosome V indicated by resistance to canavanine and 5-fluoro-orotic acid (Canr 
5-FOAr). Cultures were grown for two days in at least 10 ml of YPD media. Viable cell 
counts were determined by plating dilutions on YPD agar plates, and cells with GCRs 
were identified by plating 0.25 ml-15 ml on synthetic media lacking arginine and uracil 
and supplemented with 60 mg/l canavanine (Sigma) and 1 g/l 5-fluoro-orotic acid (US 
Biological). The rate of accumulating GCRs was calculated as previously described [61].   
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Mutator Assays and Mutation Spectrum Analysis  
Rates of accumulating mutations at the CAN1 locus or reversion mutations in the 
hom3-10 or lys2-Bgl alleles were determined by fluctuation analysis by the method of 
the median [62] in at least fourteen cultures from at least two different isolates as 
previously described [63]. Cultures were grown overnight in 3 - 6 ml of YPD media. 
Viable cell counts were determined by plating dilutions on YPD agar plates and 250 μl - 
6 ml were plated on synthetic media lacking arginine and supplemented with 60 μg/ml 
canavanine for selection of inactivation of CAN1, or on SC media lacking threonine or 
lysine to select for threonine (hom3-10) or lysine (lys2-Bgl) revertants, respectively. 
Median rates are reported with 95% confidence intervals [64]. The spectrum of 
inactivating mutation at the CAN1 locus was determined by sequence analysis of CAN1 
from canavanine-resistant colonies using primer pairs that anneal 50 bp upstream and 
43 bp downstream of the CAN1 ORF.    
 
Tetrad analysis  
Diploid strains for tetrad dissection were derived from S288C strains provided by 
Richard Kolodner (UC San Diego) and are listed in Supplementary Table S1. To 
generate the diploid heterozygous for sgs1∆, rad52∆, and exo1∆ mutations 
(KHSY4810) RDKY5290 was crossed to KHSY4805, a spore obtained from a cross 
between RDKY2614 and RDKY2710. RAD59 and RAD51 deletions were obtained by 
HR-mediated integration of a selectable marker at these loci in RDKY2666 using the 
LiAc method [58] and diploids heterozygous for sgs1∆, exo1∆, and rad51∆ or rad59∆ 
were obtained by crossing as described above. For tetrad dissections, diploids were 
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grown overnight in YPD at 30° and starved of nitrogen in 0.1% potassium acetate. Asci 
were briefly incubated with zymolase and dissected on YPD agar plates using a 
micromanipulator mounted on an Axioscop 40 (Zeiss). YPD plates were incubated for 4 
days at 30° and spore germination and colony growth were documented at 24 hour 
intervals with a CCD camera mounted on a GelDoc-IT Imager (UVP).  
 
Pull-Down Assay and Western Blotting  
Plasmid pKHS657, expressing GST-Sgs1647-1447, was created by inserting the 
last 2400 bp of SGS1 into pGEX-6p-2 (GE Healthcare) using BamHI and XhoI 
restriction sites. Stop codons and F1192A and F1192D mutations were introduced at 
the indicated positions by site-directed mutagenesis (Quikchange, Agilent Genomics). 
Sgs1 fragments were expressed in E. coli BL21 (DE) in LB media (10 g/l tryptone, 5 g/l 
NaCl, 5 g/l Yeast extract) supplemented with 1.5 μg/ml ampicillin for 3 hours in the 
presence of 1 mM IPTG. Cells were resuspended in 100 µl GST buffer (125mM Tris, 
150mM NaCl, pH 8.0) plus HALT protease inhibitor cocktail (Pierce), lysed using glass 
beads with a BeadBeater (Biospec Products, Inc.) at 4° and lysate cleared by 
centrifugation at 14000 rpm for 10 min at 4°. Lysate was treated with benzonase 
(Sigma) and 1mg of lysate was added to glutathione magnetic beads (Pierce) and 
incubated for 1 h at 4°C before beads were washed three times with GST buffer. 
Similarly, yeast cells expressing endogenous levels of VSV-tagged Rad51 (Open 
Biosystems) were resuspended in Rad51 buffer (50 mM Tris, pH 7.5, 0.01% NP-40, 5 
mM β-glycerol phosphate, 2 mM magnesium acetate, 120 mM NaCl) with HALT 
protease inhibitor cocktail (Pierce), lysed with glass beads in a BeadBeater and cleared 
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by centrifugation at 14000 rpm for 20 min at 4°. Lysate was treated with benzonase 
(Sigma) and 10 mg of lysate were incubated with Sgs1-bound magnetic beads for 120 
min at room temperature while rotating. Beads were washed five times with Rad51 
buffer plus HALT protease inhibitor cocktail (Pierce) and then boiled in Laemmli buffer 
(BioRad) for 10 min. The eluate was separated by 10% SDS-polyacrylamide gel 
electrophoresis. Sgs1 fragments and Rad51 were detected by Western blotting using 
monoclonal antibodies against GST (Covance) and VSV (Sigma) epitopes. 
 
Data and reagent availability: Yeast strains are available upon request. Table S1 
contains a list of yeast strains used in this study and detailed genotype descriptions.  
 
RESULTS 
Rad51 binds to the loop that connects the helicase core of Sgs1 to the 
HRDC domain  
SGS1 and RAD51 are epistatic and the gene products interact physically [40, 
51]. Using a yeast-two-hybrid assay, the physical interaction with Rad51 was mapped to 
the last 469-residues of Sgs1 (residues 978-1447). This region flanks the ATPase 
domain and contains the conserved RQC domain, which is essential for the helicase 
activity of Sgs1, as well as other conserved sites, including the HRDC domain and a 
Mlh1 binding site [40, 65]. Thus, disrupting Rad51 binding by deleting this 469-residue 
region disrupts multiple other Sgs1 functions. Therefore, to enable elucidation of the 
biological importance of the interaction between Sgs1 and Rad51 for HR, we sought to 
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identify a separation-of-function mutation in Sgs1 that specifically disrupts Rad51 
binding but leaves other functional sites intact. 
To narrow down the Rad51 binding region we purified fragments of Sgs1 as 
GST-fusions from E. coli and tested their ability to pull-down endogenous VSV-epitope 
tagged Rad51 from yeast whole cell extract. We determined that deleting up to 240 C-
terminal residues of Sgs1 did not impair its ability to bind Rad51, whereas a deletion of 
260 residues abolished it (Figure 1A and 1B). This critical 20-residue region maps to 
residues 1187 to 1207 immediately C-terminal of the WH-domain and contains a 
phenylalanine at position 1192. Mutating this hydrophobic residue to aspartic acid 
(F1192D) disrupted Rad51 binding, whereas mutating it to alanine did not have a major 
effect (F1192A) (Figure 1B).   
Unlike loss of Sgs1 helicase activity, loss of Sgs1-Rad51 binding does not 
cause DNA damage sensitivity and genome instability in haploid cells 
 To determine how the loss of Rad51 binding affects Sgs1 function in vivo we 
integrated the sgs1-F1192D allele (hereafter sgs1-FD) at the chromosomal locus under 
control of the SGS1 promoter. Unlike an SGS1 deletion, the sgs1-FD mutation did not 
lead to an increase in genome instability (Table 1) or an increase in sensitivity to 
hydroxyurea (HU), which induces replication stress by inhibiting ribonucleotide 
reductase, or methyl methanesulfonate (MMS), an alkylating agent that directly 
damages bases (Figure 1C). Since the sgs1-FD mutation is disrupting a link between 
Sgs1 and HR, we also tested its effect on DNA-damage sensitivity in diploids, which 
depend more strongly on HR for repair of DNA breaks than haploids [66, 67]. Diploids 
were indeed more sensitive to 0.025% MMS if they were homozygous for the sgs1-FD 
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mutation than if they were heterozygous for sgs1-FD or homozygous for the wildtype 
allele (Figure 1D), indicating a mild DNA repair defect in the sgs1-FD mutant.  
 
Rad51 binding to Sgs1 is required for normal growth, DNA damage tolerance, 
and genome stability in the absence of Sae2, but not Mre11: To identify Sgs1 functions 
that are impacted by its binding to Rad51, we first investigated genetic interactions 
between sgs1-FD and HR genes. In HR, Sgs1 acts in addition to Exo1 in the resection 
of DSBs after their initial nucleolytic processing by Sae2 and the MRX complex [9]. In 
cells lacking SGS1, deletion of EXO1 causes a fitness defect and one of the largest 
known synergistic increases in genomic instability (>500-fold) [31, 68, 69] whereas a 
deletion of SAE2 or MRE11 is synthetically lethal with sgs1∆ [53, 70]. These reported 
phenotypic similarities between Sae2 and Mre11 deficiency, however, did not apply to 
the sgs1-FD mutant. The sgs1-FD mutation caused a significant fitness defect in the 
sae2∆ mutant but had no detrimental effect on the growth of the mre11∆ mutant (Figure 
2A). The sgs1-FD allele also increased hypersensitivity of the sae2∆ mutant to HU and 
MMS but exhibited a wildtype phenotype in the mre11∆ mutant (Figure 2B-C). 
Moreover, the sgs1-FD allele led to a synergistic (25-fold) increase in the GCR rate in 
the sae2∆ mutant but did not affect the accumulation of genome rearrangements in the 
mre11∆ mutant (Figure 2E).  
In the current model of DSB end processing, MRX and Sae2 bind to the 
unprocessed ends, trimming off a few nucleotides and causing their own release from 
the DNA [9, 10]. These trimmed ends are poor substrates for Ku binding, but good 
substrates for extensive nucleolytic processing by Exo1 and Sgs1/Dna2 to produce the 
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long 3’ terminated overhangs for Rad51-mediated homology search [9, 10]. When initial 
trimming and long-range resection are impaired due to absence of Sae2 and Sgs1 cells 
die [71, 72]. However, these cells are rescued by deleting YKU70, suggesting that 
preventing Ku from binding to the DSB ends makes them accessible to the alternative, 
Exo1-mediated pathway for long-range resection, thus bypassing the requirement of 
Sae2 for removal of Ku and that of Sgs1 for long-range resection [1]. Based on this 
finding, any sgs1 mutation that causes a resection defect and a synthetic growth defect 
with sae2∆ should be suppressed by deletion of YKU70. Indeed, the defects of the 
sgs1-D664∆ mutant, which include a severe fitness defect with sae2∆ and a resection 
defect, are bypassed in cells lacking Ku [73, 74]. However, we observed that neither the 
severe fitness defect the sgs1-FD sae2∆ mutant nor its DNA damage sensitivity was 
suppressed by deleting YKU70 (Figure 2C), suggesting that the sgs1-FD mutation does 
not cause a resection defect.           
To test the possibility that the requirement of Sae2 in the sgs1-FD mutant was 
related to a MRX-related function of Sae2, we next deleted MRE11 in the sae2∆ sgs1-
FD mutant. We observed that the mre11∆ mutation suppressed the growth defect and 
the associated HU/MMS sensitivity of the sgs1-FD sae2∆ mutant to levels observed in 
the mre11∆ sae2∆ mutant (Figure 2A and 2C), indicating that unlike in the sgs1∆ mutant 
MRX is not required in the sgs1-FD mutant and that, in fact, the inability to remove MRX 
from the DSB ends is toxic in the sgs1-FD mutant.   
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sgs1-FD increases genome instability and DNA damage hypersensitivity in 
cells lacking Exo1 
The need in the sgs1-FD mutant for SAE2 prompted us to further investigate the 
requirement of EXO1, which cooperates with Sgs1/Dna2 during more extensive 
resection of DSB after Sae2. The exo1∆ mutant is mildly sensitive to high 
concentrations of MMS, but not HU [69]. The sgs1-FD allele increased the sensitivity of 
the exo1∆ mutant to MMS and caused sensitivity to 200 mM HU, but remained far 
below the effect of an SGS1 deletion (Figure 3A and 3B). The sgs1-FD allele also 
caused a significant (6-fold) increase in the accumulation of genome rearrangements in 
the exo1∆ mutant albeit this, too, was much milder than the 500-fold increase in GCR 
accumulation previously reported for the SGS1 deletion [31, 68].  
 
Suppression of the severe growth defect of the top3∆ mutant by the sgs1-
FD mutation 
In addition to interacting with Dna2 and RPA during DSB resection, Sgs1 forms a 
complex with Top3/Rmi1 to dissolve dHJ [35, 37, 75]. In vitro, Top3 also stimulates 
Sgs1 activity in DSB resection and resolves protein-bound D-loops [76, 77]. Both, 
deletion of SGS1 or loss of Sgs1 helicase activity, suppress the severe growth defect of 
the top3∆ mutant, which has been interpreted to mean that Sgs1 produces HR 
intermediates that then require Top3 for dissolution [37]. We found that the sgs1-FD 
allele, too, suppressed the severe slow growth phenotype of the top3∆ mutant to a 
similar extent as the sgs1∆ or sgs1-HD alleles and improved growth during exposure to 
HU or MMS (Figures 2D and 2E), suggesting that the interaction between Sgs1 and 
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Rad51 drives the formation of recombination intermediates and thereby significantly 
contributes to the severe growth defect of the top3∆ mutant.  
 
Opposite effects of the sgs1-FD mutation on the DNA-damage sensitivity of 
srs2∆ and rrm3∆ mutants: Srs2 acts as an inhibitor of HR through its ability to disrupt 
the Rad51 presynaptic filament [14, 15]. In the absence of Srs2, cells become hyper-
recombinogenic, hypersensitive to exogenous DNA damage and replication stress, as 
well as dependent on Sgs1 for viability [14, 15, 54]. The negative genetic interactions of 
the sgs1-FD allele with sae2∆ and exo1∆ mutations, and the positive interaction with 
top3∆ suggest that sgs1-FD is a hypo-recombination allele of SGS1. To further explore 
this possibility, we introduced sgs1-FD into the srs2∆ mutant, which we expected to 
benefit from a reduction in HR. Indeed, in stark contrast to a deletion of SGS1 or loss of 
Sgs1 helicase activity, which are both lethal to srs2∆ cells, the sgs1-FD allele had no 
detrimental effect on the growth of srs2∆ cells and in fact suppressed the 
hypersensitivity of srs2∆ cells to HU and MMS by more than 10-fold (Figure 3B), 
consistent with sgs1-FD being a hypo-recombination allele.  
We also investigated the importance of the Sgs1-Rad51 interaction in the rrm3∆ 
mutant. Replisomes pause frequently at many sites throughout the genome when the 
Rrm3 helicase is absent, generating DNA lesions that are substrates for Sgs1 and 
Rad51-dependent repair [50, 51, 78]. Like a deletion of SRS2, deletion of RRM3 causes 
a severe growth defect in sgs1∆ cells that can be suppressed by deleting RAD51 [50, 
51]. The sgs1-FD mutation did not cause a growth defect in rrm3∆ cells; however, cells 
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became highly sensitive to both HU and MMS (Figure 3B). Despite the increased DNA 
damage sensitivity, the rrm3∆ sgs1-FD mutant did not accumulate genome 
rearrangements (Figure 3D, Table 1) in contrast to the rrm3∆ sgs1∆ mutant [30]. This 
genetic interaction between rrm3∆ and a hypomorphic allele of SGS1 further 
underscores the strong dependence of the repair of the replication-associated DNA 
lesions in rrm3∆ cells on homology-directed replication fork restart and rescue [52].   
 
Sgs1-Rad51 interaction promotes large deletions and contributes to DNA 
damage hypersensitivity of cells lacking Pol32: In the absence of POL32, which codes 
for the structural subunit of polymerase δ that attaches the polymerase to the 
processivity factor PCNA, DNA replication is inefficient and prone to pausing and 
mutations [79-81]. Since an SGS1 deletion causes a fitness defect and increased HU 
and MMS sensitivity in the pol32∆ mutant, we decided to assess the effect of the sgs1-
FD allele in this mutant. Surprisingly, we found that the sgs1-FD mutation had the 
opposite effect of the SGS1 deletion and the helicase-defective sgs1-HD allele, 
suppressing the HU hypersensitivity of the pol32∆ mutant (Figure 4A, and 4C). Since 
the HU hypersensitivity of the pol32∆ mutant is also suppressed by deletion of EXO1 
[69], we next tested the combined effect of exo1∆ and sgs1-FD mutations on HU 
sensitivity of the pol32∆ mutant (Figure 4D). Instead of suppression, however, we 
observed an increase in HU and MMS sensitivity even at low drug concentrations, 
suggesting that Exo1 and the Sgs1-Rad51 interaction cooperate in a pathway that is 
required in the absence of Pol32. Since both Sgs1 and Exo1 act in DSB end processing 
to initiate HR, we investigated the effect of a RAD51 deletion on the HU/MMS sensitivity 
  161 
of the pol32∆ mutant and observed a strong increase in sensitivity (Figure 4E). This 
suggests that pol32∆ cells depend on a Rad51-dependent HR pathway for the survival 
of replication stress and that Exo1 and the Sgs1-Rad51 interaction independently 
promote this pathway. 
The accumulation of large deletions between short repeats in CAN1 or other 
genomic loci is characteristic of pol32∆ cells and has been explained by an increased 
propensity of the nascent strands to dissociate from their templates as a result of 
frequent pausing, followed by error-prone reannealing [80]. When we combined the 
pol32∆ mutation with the sgs1-FD mutation, there was no significant change in the 
mutation rate at CAN1 (Supplemental Table S2), but the rate of large deletions was 
reduced 4-fold similar to the 6-fold reduction when SGS1 was deleted, suggesting that 
the interaction of Sgs1 with Rad51 contributes to the formation of large deletions in the 
absence of Pol32 (Figure 4B). In contrast, when we deleted EXO1 in the pol32∆ mutant, 
the rate of large deletions increased 4-fold (Figure 4B). These observations indicate 
that, in contrast to their cooperative roles in DSB end resection, Exo1 and Sgs1 have 
opposite effects at impaired replication forks. For example, Exo1 could prevent 
deletions by degrading the mutagenic substrate, whereas Sgs1 and the Sgs1-Rad51 
interaction might help generate deletions by facilitating DNA slippage by misannealing 
at nearby repeats.  
Rad52/Rad59-mediated DNA repair, but not Rad51, is essential for cells with 
compromised DNA resection due to lack of Sgs1 and Exo1: Cells lacking Sgs1 and 
Exo1 show minimal resection of DSBs and accumulate GCRs at an extreme level [9, 
31, 68]. Because of the failure to sufficiently resect DSB ends we expected that DSBs 
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would not be suitable for repair by HR. Surprisingly, however, we found that deleting 
RAD52 was lethal in the sgs1∆ exo1∆ mutant, and deletion of RAD59 caused an 
extreme growth defect (Figure 5A). In contrast, deleting RAD51 caused only a mild 
fitness defect (Figure 5A), consistent with the ability of other groups to readily obtain 
and characterize the sgs1∆ exo1∆ rad51∆ mutant [9, 73, 82].  
When we analyzed the effect of HR mutations on chromosome rearrangements 
in the sgs1∆ exo1∆ mutant, we found that deleting RAD51 significantly suppressed (3.1-
fold) their accumulation (Figure 5C, Table 2). We also analyzed GCR formation in the 
sgs1∆ exo1∆ rad59∆ mutant. Because of the severe growth defect of this mutant and 
the associated risk of obtaining suppressors with prolonged propagation, we set up all 
cell cultures from colonies immediately after they formed from meiotic products of the 
heterozygous diploid. In contrast to the decrease upon RAD51 deletion, RAD59 deletion 
doubled (2.4-fold) the GCR rate of sgs1∆ exo1∆ cells (Figure 5C, Table 2).  
The dramatic decrease in viability of the sgs1∆ exo1∆ mutant upon RAD59 and RAD52 
deletion suggests that a Rad59-dependent HR pathway repairs DNA lesions in this 
mutant. The decrease in GCR formation upon RAD51 deletion and the opposite effect 
of a RAD59 deletion further suggest that Rad51 and Rad59 compete for repair of these 
incompletely processed DNA lesions in the sgs1∆ exo1∆ mutant and that repair by 
Rad51, but not Rad59, is mutagenic.     
Interestingly, we observed that the effect of RAD51 and RAD59 deletions on the 
accumulation of GCRs is the same in sgs1∆ cells with EXO1 intact as in cells with 
EXO1 deleted; that is, a RAD51 deletion led to a significant (5.1-fold) decrease in the 
GCR rate of sgs1∆ cells (versus 3.1-fold decrease in sgs1∆ exo1∆) and RAD59 deletion 
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to a significant (1.8-fold) increase (versus a 2.3-fold increase in sgs1∆ exo1∆) (Figure 
5B and 5C, Table 2). Essentially, deleting EXO1 increased all GCR rates by ~ 700-fold, 
but had no effect on the genetic interactions between sgs1∆, rad51∆, and rad59∆ 
(compare the last three columns in Figures 5B with 5C).  
 
 
   
DISCUSSION 
We have identified a novel separation-of-function mutant of Sgs1 (sgs1-FD) that 
fails to bind Rad51 but does not cause the severe sensitivity to DNA-damaging agents 
seen in cells lacking Sgs1 or expressing helicase-defective Sgs1. Novel positive and 
negative genetic interactions between this sgs1-FD allele and mutations in genes with 
roles in HR (mre11∆, sae2∆, srs2, exo1∆, top3∆) or replisome progression (pol32∆, 
rrm3∆) suggest that the physical interaction between Sgs1 and Rad51 stimulates 
homology-dependent DNA repair.  
We observed the strongest genetic interaction of the sgs1-FD allele with a SAE2 
deletion (Figure 2). Sae2 removes MRX from DSB ends and prevents yKu binding, 
making the DSB accessible to extensive resection by Sgs1/Dna2 and Exo1 [1]. YKU70 
deletion suppresses resection defects in cells that lack Sae2 and Sgs1 activities by 
allowing the alternative Exo1 pathway access to the DSB ends for resection [1, 73, 74, 
83]. In addition to suppressing the DNA-damage sensitivity and fitness defect of the 
sgs1∆ sae2∆ mutant, the resection-defective sgs1-D664∆ mutant was found to benefit 
from deleting YKU70 [73, 74]. In contrast, deleting YKU70 had no effect on the sgs1-FD 
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sae2∆ mutant identified here, indicating that the sgs1-FD mutant does not benefit from 
increased Exo1 activity at DSBs and, thus, that sgs1-FD is proficient for resection.  
Surprisingly, even though Sae2 acts with MRX in the initial processing step and sgs1∆ 
is synthetically lethal with both sae2∆ and mre11∆, disruption of the Sgs1-Rad51 
interaction was not detrimental to mre11∆ cells. In fact, the MRE11 deletion suppressed 
the detrimental effects of the sgs1-FD mutation in sae2∆ cells, suggesting that the Sae2 
function that is critical in sgs1-FD cells is the removal of MRX from DSB ends. If MRX 
stays bound, the DNA-damage checkpoint is activated and oligomers of the Rad9 
checkpoint adaptor accumulate nearby [84-87]. Disrupting the DNA damage checkpoint 
alleviates the requirement for Sae2 at DSBs [88]. Although this suggests that Sgs1 can 
compensate for the lack of initial resection by Sae2, more extensive resection and 
Rad51 filament formation are still impaired by MRX stuck on the DSB ends [88, 89]. 
Recent findings have indicated that Sgs1 can eventually remove MRX and analysis of 
the sgs1-D664∆ mutant linked this ability to long-range resection by Sgs1 [73, 88]. 
Because of the resection defect of the sgs1-D664∆ mutant, defects of the sgs1-D664∆ 
sae2∆ mutant could be suppressed by deleting YKU70. That the YKU70 deletion had no 
effect on the sgs1-FD sae2∆ mutant indicates that the suppression by MRE11 deletion 
is not related to a resection defect in the sgs1-FD mutant. We propose, therefore, that 
the disruption of Sgs1-Rad51 interaction by the sgs1-FD mutation reduces the efficiency 
of Rad51 filament formation, and thus repair by HR. Removing MRE11 from the DSB 
ends and, consequently, preventing Rad9 accumulation around the DSB ends could 
compensate for this deficiency in the sae2∆ sgs1-FD mutant by increasing the efficiency 
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of long-range resection due to increased access of sgs1-FD/Dna2 to the DSB ends. 
Thus, when DNA end processing is impaired because of the lack of Sae2, and 
persistent MRX binding and resulting checkpoint activation inhibit Sgs1/Dna2 function in 
resection, HR increasingly depends on the stimulation of Rad51 filament formation by 
Sgs1.  
All other genetic interactions of the sgs1-FD allele investigated here are also in 
agreement with a role of the Sgs1-Rad51 interaction in stimulating HR, such as the 
positive interactions of the sgs1-FD mutation with top3∆, pol32∆ and srs2∆ and the 
negative interaction with rrm3∆. Especially the suppression of the DNA damage 
sensitivity of the srs2∆ mutant strengthens our hypothesis that the Sgs1-Rad51 
interaction stimulates Rad51 filament formation. Based on the ability of Srs2 to 
disassemble Rad51 filaments [14], suppression of srs2∆ sgs1∆ synthetic lethality by 
RAD51 deletion [90] could be interpreted in two ways: either Sgs1 acts like Srs2 by 
disassembling presynaptic Rad51 filaments, or Sgs1 in complex with Top3/Rmi1 is 
needed to dissolve the accumulating recombination intermediates that overwhelm the 
cell because Rad51 filaments are no longer disrupted by Srs2. Our findings suggest the 
second explanation to be true; if the Sgs1-Rad51 interaction indeed promoted the 
disassembly of presynaptic Rad51 filaments, then the disruption of the Sgs1-Rad51 
interaction by the sgs1-FD mutation would not have suppressed the DNA-damage 
sensitivity of the srs2∆ mutant (Figure 3B).  
Thus, taken together, the genetic interactions of the sgs1-FD allele are distinct from 
those of the sgs1∆ and helicase-defective sgs1-hd alleles (Figure 6B) and consistent 
with a model (Figure 6A) whereby Sgs1 is not only responsible for the resection of DSB 
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ends and the formation of ssDNA overhangs but, through binding Rad51, promotes HR 
by stimulating formation of the Rad51 presynaptic filament. As DNA ends are resected, 
RPA binding to the newly formed ssDNA overhangs limits the initiation of the Rad51 
filament. Rad52 is essential to overcome this limitation and form a productive Rad51 
presynaptic filament on RPA-coated ssDNA. In addition to binding Rad51 C-terminal of 
the helicase core, Sgs1 binds RPA N-terminal of the helicase core [38]. However, the 
biological significance of this interaction has remained unclear. We propose that the 
acidic regions in the N-terminus of Sgs1 to which RPA binds serve as a DNA mimic, 
and that via this DNA mimic Sgs1 can compete with the ssDNA overhang for RPA 
binding, thereby freeing up ssDNA locally for Rad51 and stimulating filament initiation 
(Figure 6A). Such a role for Sgs1 is reminiscent of the function of E. coli RecBCD not 
only in resection but also in assembling the RecA filament [91]. Moreover, the ability of 
BRCA2 to load Rad51 onto ssDNA in vitro was recently shown to be aided by 
interaction with a protein, DSS1, that appears to act as a DNA mimic and targets RPA 
on ssDNA [92].    
We also observed a stimulatory effect of the Sgs1-Rad51 interaction on the 
formation of the direct-repeat mediated, large deletions characteristic of pol32∆ cells. 
Unlike in DSB resection, however, Sgs1 had the opposite effect of Exo1: the Sgs1-
Rad51 interaction promoted the deletions, and Exo1 suppressed them, both to 
approximately the same extent (4-fold). The large deletions in pol32∆ cells most likely 
form during inefficient replisome progression, which makes the nascent DNA strands 
prone to dissociation, followed by misannealing at a repeated downstream sequence, 
thus deleting the sequence between the repeats. We propose a model (Figure 6A) 
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whereby Exo1 prevents large deletions through its ability to degrade the nascent 
lagging DNA strand at stalled forks [93] and the Sgs1-Rad51 interaction, in contrast, 
promotes annealing of dissociated nascent strands with downstream repeated 
sequences on both, the leading and the lagging strand. 
Finally, our study also provided new insight into the repair of DSBs in cells where 
long-range resection by Sgs1/Dna2 and Exo1 is disrupted. It is thought that for HR, the 
ends need to be resected extensively by Sgs1/Dna2 or Exo1 before the Rad51 filament 
can form and initiate a homology search. Hence, sgs1∆ exo1∆ mutants should not be 
able to rely on HR as a major pathway for DNA lesion repair. It was therefore surprising 
that sgs1∆ exo1∆ cells depend on RAD52 for their survival. That the fitness of these 
cells was more dependent on Rad59 than Rad51 suggests that the minimally resected 
DSB ends in sgs1∆ exo1∆ cells are mainly repaired by Rad59/Rad52-dependent HR. 
This is consistent with a preference of Rad59 for the repair of short substrates, including 
by Rad51-independent BIR [25, 26, 94]. Interestingly, we also found that Rad59 
suppressed genome rearrangements in sgs1∆ exo1∆ mutants whereas Rad51 
increased them, suggesting that both Rad51 and Rad59 can act on minimally resected 
ends, but with Rad59 leading to proper repair, whereas Rad51 is mutagenic. That the 
genetic interactions between SGS1, RAD51, and RAD59 were the same in the 
presence or absence of EXO1 – that is, Rad59 suppressed GCRs in the absence of 
Sgs1 whereas Rad51 generated them – further indicates that sgs1∆ and sgs1∆ exo1∆ 
cells simply differ in the abundance of the lesions, but the lesions are of the same type 
and accessed in the same manner by Rad59 and Rad51 whether Exo1 is present or 
not. 
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In addition to Rad51, Sgs1 interacts with numerous other DNA repair factors, including 
Top2, Top3, RPA, Mre11, Rad16, and Mlh1, and the checkpoint kinase Rad53. 
However, determining the significance of these interactions for Sgs1 function has 
remained challenging due to the lack of point mutations that disrupt individual 
interactions. Identifying the binding sites on Sgs1 for these other interacting partners will 
allow to further dissect the well-characterized, but pleiotropic, effect of an SGS1 deletion 
on DNA break repair and provide a more precise understanding of the specific roles of 
Sgs1 in promoting genome integrity.  
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FIGURES AND TABLES 
 
 
Figure 4.1. Rad51 binds to Sgs1 downstream of the winged-helix domain. (A) 
Domain structure of Sgs1. The helicase core of Sgs1 consists of the ATPase domain, 
which is formed by two RecA-like lobes, and the RecQ-C terminal (RQC) domain, which 
consists of a zinc-binding (Zinc-BD) and a winged-helix (WH) domain. The helicase- 
and RNaseD C-terminal (HRDC) domain are separated from the helicase core by a 
proline/glycine-rich loop. The 645-residue unstructured N-terminal tail is omitted. (B) 
Pulldown of Rad51-V5-3XVSV with GST-tagged Sgs1 fragments and sgs1-FD and 
sgs1-FA mutants. (C) Unlike an SGS1 deletion, the sgs1-FD allele does not cause 
hypersensitivity to MMS or HU in haploid cells. Homozygosity for the sgs1-FD mutation 
causes mild sensitivity to HU and MMS in diploid cells.          
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Figure 4.2. Effect of the sgs1-FD mutation on fitness, DNA-damage sensitivity and 
genome stability of sae2∆, mre11∆ and yku70∆ mutants. (A) sgs1-FD causes a 
severe growth defect in the sae2∆ mutant, but not the mre11∆ mutant. Deletion of 
MRE11 suppresses the growth defect of sgs1-FD sae2∆. (B) sgs1-FD increases the 
HU/MMS sensitivity of the sae2∆ mutant, but not the mre11∆ mutant. (C) Unlike 
mre11∆, yku70∆ does not the suppress growth defect and HU/MMS hypersensitivity of 
the sgs1-FD sae2∆ mutant. (D) sgs1-FD causes synergistic GCR rate increases in 
sae2∆ and exo1∆ mutants but has no effect on GCR accumulation in the mre11∆ 
mutant. Median GCR rate is shown with 95% confidence intervals (see also Table 1).  
 
 
 
D 
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Figure 4.3. Effect of the sgs1-FD mutation on fitness and DNA-damage sensitivity 
of exo1∆, srs2∆, rrm3∆ and top3∆ mutants. (A) sgs1-FD sensitizes the exo1∆ mutant 
to MMS and, to a lesser extent, HU. (B) sgs1-FD suppresses HU/MMS sensitivity of the 
srs2∆ mutant and increases HU/MMS sensitivity of the rrm3∆ mutant. (C) sgs1-FD 
suppresses top3∆ slow growth nearly as effectively as a deletion of SGS1 or helicase-
dead sgs1-HD. (D) Unlike deletion of SGS1, sgs1-FD does not cause a GCR rate 
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increase in the rrm3∆ mutant. sgs1-FD does not affect GCR formation in the srs2∆ 
mutant (see also Table 1). (E) Improved growth of sgs1-FD top3∆ in the presence of HU 
and MMS correlates with partial suppression of the top3∆ fitness defect by sgs1-FD. 
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Figure 4.4. Effect of sgs1-FD on DNA-damage sensitivity and large deletion 
formation in the absence of Pol32. (A) Suppression of hydroxyurea sensitivity of the 
pol32∆ mutant by sgs1-FD. In contrast, SGS1 deletion or helicase-defective sgs1-HD 
increase DNA-damage sensitivity of pol32∆ cells.  (B) Accumulation of large deletions (> 
3 bp) in CAN1, characteristic of cells lacking the Pol32 subunit of polymerase δ, is 
suppressed by sgs1-FD or by deletion of SGS1 but stimulated by deletion of EXO1. (C) 
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Whereas exo1∆ and sgs1-FD suppress HU sensitivity of the pol32∆ mutant, the 
combination of both exo1∆ and sgs1-FD mutations increases DNA damage sensitivity of 
the pol32∆ mutant. (D) Deletion of RAD51 in the pol32∆ mutant causes severe 
hypersensitivity to HU and MMS.    
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Figure 4.5. Effect of RAD52, RAD51 and RAD59 deletions on viability and genome 
stability of the sgs1∆ exo1∆ mutant. (A) As shown by tetrad dissections, deletion of 
RAD52 in the sgs1∆ exo1∆ mutant is lethal, and deletion of RAD59 causes a severe 
growth defect. In contrast, deletion of RAD51 causes only a mild growth defect. Triple 
mutant spores are indicated by a white circle. (B) Deletion of RAD51 suppresses gross-
chromosomal rearrangements (GCRs) in the sgs1∆ mutant whereas deletion of RAD59 
stimulates GCR formation in the sgs1∆ mutant. (C) Deletion of EXO1 increases GCR 
formation in the sgs1∆ mutant ~700-fold, but does not affect the genetic interactions of 
sgs1∆ with rad51∆ and rad59∆.     
  176 
 
Figure 4.6. Model for a stimulatory role of the Sgs1-Rad51 interaction in 
homology-dependent repair of spontaneous DNA lesions. (A) Replication stress, 
exogenous DNA damage, or disruption of factors with roles in replisome progression 
(e.g., rrm3∆, pol32∆) can impair replication forks and give rise to mutations (left) and 
DSBs (right). Right panel: Unprocessed DNA breaks can be bound by Ku and MRX. 
The nuclease activity of MRX/Sae2 trims the ends, which are then extensively resected 
by Exo1 and Sgs1/Dna2. Bound Ku and MRX inhibit long-range resection by Exo1 and 
Sgs1/Dna2, respectively. As the sgs1-FD mutant does not benefit from YKU70 deletion, 
suggesting it does not have a significant resection defect, we propose that the Sgs1-
Rad51 interaction could instead stimulate HR by linking Sgs1’s role in long-range 
resection to Rad51 filament formation. Specifically, the acidic regions (AR) in the 
unstructured N-terminal tail of Sgs1, through their capacity to bind RPA, could act as a 
DNA mimic, allowing Sgs1 to compete with ssDNA for RPA binding, thereby facilitating 
deposition of Sgs1-bound Rad51 onto ssDNA during resection. Note: Ku, MRX, Exo1 
and Sgs1/Dna2 can act on the same DSB end; two ends are shown to separate their 
activities for clarity only. Left panel: In the absence of Pol32, cells are known to 
accumulate large deletions of sequences flanked by direct short repeats. We propose a 
model whereby Sgs1, through its interaction with Rad51, stimulates the formation of 
these deletions (Figure 4B) by mediating misannealing of the nascent strands with 
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downstream repeated sequences, whereas the 5’-3’ exonuclease Exo1 reduces 
deletion formation (Figure 4B) by degrading nascent DNA on the lagging strand from its 
accessible 5’ end. (B) Summary of differential genetic interactions of the sgs1-FD allele 
and the SGS1 deletion with mutations in DNA recombination and replication factors 
(n.a., not available; n.d., not determined).  
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Table 4.1. Effect of the sgs1-FD mutation on the rate of accumulation of gross-
chromosomal rearrangements (GCRs).   
Relevant 
genotype 
GCR rateI 
(Canr 5-FOAr x 10-10) 
95% CIII 
(Canr 5-FOAr x 10-10) 
wildtype 1.1 < 1 – 6.2 
sgs1 71 53-104 
sgs1-FA <9 <7-9 
sgs1-FD <7 <6-8 
exo1 14 7-28 
sgs1 exo1 40500 31000-49900 
sgs1-FD exo1 83 49-124 
sae2 12 <7-18  
sgs1-FD sae2 306 (124-424) 
mre11 2200 n.d. 
mre11 sgs1-FD 2030 1170-2480 
top3 27 17-96 
top3 sgs1-FD 12 9-36 
rad24 23 9-37 
sgs1 rad24 136 117-216 
sgs1-FD rad24 26 10-69 
pol32 20 15-26 
sgs1 pol32 25 <24-105 
sgs1-FD pol32 <8 <7-19 
rrm3 14 5-28 
sgs1 rrm3 656 311-1290 
sgs1-FD rrm3 <6 <5-8 
srs2  0.6 <2-11 
sgs1-FD srs2 8 <7-11 
i Gross-chromosomal rearrangement (GCR) rates for mre11 and top3 mutants are from 
(48); for sgs1 rrm3 from Schmidt and Kolodner (30); for sgs1 exo1 and exo1 from 
Doerfler, 2014 (69); and for srs2 from Schmidt et al. 2010 (61). 
ii95% confidence intervals (CI) were calculated according to Nair et al. 1940 (64).    
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Table 4.2. Differential effects of RAD51 and RAD59 deletions on gross-
chromosomal rearrangement (GCR) formation in sgs1 and sgs1 exo1 
mutants 
Genotype GCR Ratei 
(Canr 5-FOAr x 10-10) 
95% CIii 
(Canr 5-FOAr x 10-10) 
wildtype 1.1 < 1 – 6.2 
sgs1 71 53-104 
exo1 14 7-28 
rad51 < 8 < 7-15 
rad59 24 13-50 
rad52 138 16-267 
sgs1 exo1 40500 31000-49900 
sgs1 rad51 14  12-24 
sgs1 rad59 126 107-300 
sgs1 rad52 308 140-452 
sgs1 rad51 exo1   13100  8520-21900 
sgs1 rad59 exo1   94900 67400-185000 
iGross-chromosomal rearrangement (GCR) rate for sgs1 rad59 is from DOERFLER 
et al. 2011 (31). 
ii95% confidence intervals (CI) were calculated according to NAIR et al. 1940 (64). 
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Table S4.1. Saccharomyces cerevisiae strains used in this study 
 
Strain IDi Genotype 
KSHY802 MATa, ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2Bgl, hom3-10, ade2Δ1, ade8, hxt13::URA3 
KHSY978 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, srs2::G418 
KHSY1256  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, rrm3::G418 
KHSY1338 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, sgs1::TRP1 
KHSY2295  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, rad59::G418, 
sgs1::TRP1 
KHSY2333 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, pol32::loxP-
G418-loxP 
KHSY2338 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, exo1::loxP-
G418-loxP 
KHSY2385 MATα, ura3∆0, leu2∆0, his3∆1, lys2∆0, RAD51.V5.3xVSV.KANMX6 
KHSY2402 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, exo1::loxP-
G418-loxP, sgs1::TRP1 
KHSY2437 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, pol32::loxP-
G418-loxP, sgs1::TRP1 
KHSY4458 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, exo1::loxP-
G418-loxP, pol32::loxP-G418-loxP 
KHSY4484  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3 exo1::loxP-
G418-loxP, rad59::G418 
KHSY4716  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, top3::G418 
KHSY4800 ura3-52/ura3-52, trp1Δ63/trp1Δ63, hisΔ200/hisΔ200, EXO1/exo1::HIS3, RAD52/rad52::URA 
KHSY4805 MATα, ura3-52, trp1Δ63, hisΔ200, exo1::HIS3, rad52::URA 
KHSY4810 ura3-52/ura3-52, trp1Δ63/trp1Δ63, hisΔ200/hisΔ200, EXO1/exo1::HIS3, RAD52/rad52::URA, 
SGS1/sgs1::TRP1 
KHSY5049 MATa, ura3-52, trp1Δ63, hisΔ200, rad59::HIS3 
KHSY5051 MATα, ura3-52, trp1Δ63, hisΔ200, exo1::HIS3, rad59::HIS3 
KHSY5052 ura3-52/ura3-52, trp1Δ63/trp1Δ63, hisΔ200/hisΔ200, EXO1/exo1::HIS3, RAD59/rad59::HIS3 
KHSY5055  MATa, ura3-52, trp1Δ63, hisΔ200, rad51::HIS3 
KHSY5056 ura3-52/ura3-52, trp1Δ63/trp1Δ63, hisΔ200/hisΔ200, EXO1/exo1::HIS3, RAD51/rad51::HIS3 
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Table S4.1. Saccharomyces cerevisiae strains used in this study (continued). 
KHSY5057 MATα, ura3-52, trp1Δ63, hisΔ200, exo1::HIS3, rad51::HIS3 
KHSY5059 ura3-52/ura3-52, trp1Δ63/trp1Δ63, hisΔ200/hisΔ200, EXO1/exo1::HIS3, RAD51/rad51::HIS3, 
SGS1/sgs1::TRP1 
KHSY5060 ura3-52/ura3-52, trp1Δ63/trp1Δ63, hisΔ200/hisΔ200, EXO1/exo1::HIS3, RAD59/rad59::HIS3, 
SGS1/sgs1::TRP1 
KHSY5067  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, rad59::HIS3 
KHSY5068  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, rad51::HIS3 
KHSY5095  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, rad51::HIS3, 
sgs1::TRP1 
KHSY5098  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, exo1::loxP-
G418-loxP, rad59::HIS3, sgs1::TRP1 
KHSY5099  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, exo1::loxP-
G418-loxP, rad51::HIS3 
KHSY5099  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, exo1::loxP-
G418-loxP, rad51::HIS3 
KHSY5102  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, exo1::loxP-
G418-loxP, rad51::HIS3, sgs1::TRP1 
KHSY5109 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, sgs1-
F1192D.TRP1 
KHSY5132 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, exo1::loxP-
G418-loxP, sgs1-F1192D.TRP1 
KHSY5222 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, rrm3::G418, 
sgs1-F1192D.TRP1 
KHSY5225  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, sgs1-
F1192D.TRP1, srs2::G418 
KHSY5229  ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, hom3-10/ 
hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, sgs1::TRP1/sgs1-F1192D.TRP1 
KHSY5233 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, pol32::loxP-
G418-loxP, sgs1-F1192D.TRP1 
KHSY5253 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, hom3-10/ 
hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, sgs1::TRP1/sgs1::TRP1 
KHSY5255  ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, hom3-10/  
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Table S4.1. Saccharomyces cerevisiae strains used in this study (continued). 
 hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, SGS1/sgs1-F1192D.TRP1 
KHSY5257  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, sae2::TRP1 
KHSY5262  ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, hom3-10/ 
hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3 
KHSY5265 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, hom3-10/ 
hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, SGS1/sgs1::TRP1 
KHSY5274 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, mre11::HIS3 , 
sgs1-F1192D.TRP1 
KHSY5289  ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, hom3-10/ 
hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3, sgs1-F1192D.TRP1/sgs1-
F1192D.TRP1 
KHSY5304 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, sae2::TRP1, 
sgs1-F1192D.TRP1 
KHSY5312 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, sgs1-
F1192D.TRP1, top3::G418 
KHSY5315 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, exo1::loxP-
G418-loxP, pol32::loxP-G418-loxP, sgs1-F1192D.TRP1 
KHSY5320 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, sgs1-K706A, 
F1192D.TRP1 
KHSY5321  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, sgs1-
K706A.TRP1 
KHSY5335  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, pol32::loxP-
G418-loxP, rad51::HIS3 
KHSY5354  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, mre11::HIS3 
KHSY5356  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, sgs1::TRP1, 
top3::G418 
KHSY5363 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, pol32::loxP-
G418-loxP, sgs1-K706A, F1192D.TRP1 
KHSY5365 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, pol32::loxP-
G418-loxP, sgs1-K706A.TRP1  
KHSY5373 MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, mre11::HIS3 , 
sae2::TRP1 
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Table S4.1. Saccharomyces cerevisiae strains used in this study (continued). 
KHSY5377  MATa, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3, mre11:HIS3: , 
sae2::TRP1, sgs1-F1192D.TRP1  
RDKY2614 MATα, ura3-52, trp1Δ63, hisΔ200, exo1::HIS3 
RDKY2666 MATa, ura3-52, trp1Δ63, hisΔ200 
RDKY2710 MATa, ura3-52, trp1Δ63, hisΔ200, rad52::URA 
RDKY5290  MATa, ura3-52, trp1Δ63, hisΔ200, sgs1::TRP1 
i RDKY strains are a gift from Richard Kolodner (University of California, San Diego). 
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Table S4.2. Rates of accumulating spontaneous mutations at CAN1, hom3-10, and 
lys2-Bgl loci            
i 95% confidence intervals (CI) were calculated according to NAIR et al. 1940 (64).                               
Genotype Mutation rate 
  Canr  
(x 10-7) 
 
95% CIi 
 Hom+  
(x 10-9) 
 
95% CI 
Lys+  
(x 10-9) 
 
95% CI 
wildtype 1.5 0.9-2 2.2 1.8-2.8 4.7 2.3-6.3 
sgs1 2.7 1.8-4 1.7 1.1-2.4 11 7.6-12 
sgs1-FD 1.4 1.2-1.6 4.1 3.3-5.3 6.0 4.6-11.9 
pol32 2.1 1.1-3.4 8.7 5.1-12.1 6.9 4.5-8.9 
pol32 sgs1 1.5 0.9-2.4 10.0  8.0-16.0 10.0 6.0-14.0 
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CHAPTER FIVE: IMPLICATIONS AND FUTURE DIRECTIONS 
 
Proper repair of DNA lesions is essential for cell survival and prevention of 
disease. Defects in a variety of proteins involved in DNA repair have been shown to 
directly impact humans as illustrated by the increased predisposition to develop cancer. 
While only a small portion of cancers are hereditary, accounting only for ~10% of all 
cancers, the ability of the cell to respond to DNA damage plays a major role in all 
tumorigenesis and late-stage tumors that have become chemoresistant [1-4].  
Hereditary defects in DNA repair proteins can lead to severe syndromes where patients 
have a higher propensity to develop cancer at an early age. Such is seen in defects in 
RecQ-helicases (Bloom’s syndrome, Werner’s syndrome, Rothmund-Thompson 
syndrome), mismatch repair (Lynch syndrome), and nucleotide excision repair 
(xeroderma pigmentosum) [5].  Increased prevalence of cancer is not exclusively linked 
to defects that result in syndromes, defects in some homologous recombination factors 
increase the risk of development of breast and ovarian cancer (BRCA1, BRCA2, 
BARD1, ATM, CDH1, CHEK2, PALB2, PTEN, STK11, and TP53) [1]. 
Understanding the role of components of the DNA damage response in maintaining 
genomic integrity is essential to understanding cancer risk, development, and in the 
advancement of drugs to treat cancer. We have, in these studies, used yeast as a 
model to study the role SGS1 and EXO1 in maintaining genomic stability. We have 
characterized their genetic interactions with other repair pathways and checkpoints, and 
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identified the domains of Exo1 required for these genetic interactions. We have also 
described the importance of a physical interaction site of Sgs1 with the homologous 
recombination factor Rad51 [6, 7]. Understanding SGS1 and EXO1 function is 
informative as both have human homologs, BLM and EXO1, respectively that have 
been shown to have similar functions [8, 9]. 
   
Chromosomal translocations in cells lacking Sgs1 are dependent on Rad52 
paralog, Rad59.   
In chapter two of this dissertation we have identified, through a candidate screen, 
checkpoint and DNA metabolic factors that suppress the formation of gross 
chromosomal rearrangements. We assessed the candidate's ability to promote or 
suppress a chromosomal translocation event between CAN1, LYP1, and ALP1 (C/L/A) 
that is observed in the absence of the Sgs1 helicase and the DNA damage checkpoint 
sensor, Mec3. It was previously found that the translocations between C/L/A in the 
sgs1∆ mec3∆ depend on the presence of the homologous recombination factor Rad52 
[10]. We additionally found that these translocations that use short regions of homology 
rely on the Rad52 paralog Rad59 and checkpoint components Mec1 and Dun1. Rad51, 
the homologous recombination component that searches for homology in this study has 
been identified to be dispensable for translocations in the absence of Sgs1, the only 
RecQ helicase in S. cerevisiae.  A defect in BLM in humans is associated with the 
genomic instability that is also observed in yeast lacking the BLM homolog Sgs1 [10].  
Although the rate of GCRs did not differ between sgs1∆ mec3∆ rad51∆ and sgs1∆ 
mec3∆ rad59∆, this has distinguished the role of Rad59 in the formation of the types of 
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GCRs as opposed to the rate of accumulation.  The absence of Rad59 preventing the 
formation C/L/A translocations but not change the accumulation of GCRs leaves other 
repair mechanisms that must generate other forms of GCRs. The other types of repair 
in the absence of Rad59 leave the open questions, what pathways contribute the 
genome instability rate and what kind of GCR is formed to understand better what other 
mechanisms contribute to genome instability. 
  In chapter four we investigated further the role of Rad51 and Rad59 in the 
suppression of genome rearrangements.  We found that Exo1 is a strong suppressor of 
genome rearrangements in cells lacking Sgs1 and that both of these proteins are 
required for long-range resection of DNA double-strand break ends.  Through a 
candidate screen of DNA metabolic factors, we found that Rad52 is essential in 
resection deficient sgs1∆ exo1∆ mutants.  The synthetic lethality of the sgs1∆ exo1∆ 
rad52Δ mutant indicates that homology-mediated repair is necessary for cells that are 
lacking Sgs1 and Exo1 resection. When we assessed the role of two sub-pathways of 
Rad52 mediated repair we found that Rad59 rather than Rad51 was required for the 
fitness of cells defective in the resection.  We found that this role of Rad59 in preventing 
mutagenic Rad51 mediated HR repair is also important in cells that just lack Sgs1, 
indicating a larger role than previously thought for Rad59 in the prevention of genome 
rearrangements.  Determining what type of repair Rad59 engages in to prevent 
illegitimate recombination by Rad51 still needs to be resolved.  Assessing the 
rearrangement type by mapping the breakpoint that is assessed in the GCR assay 
would help determine how repair by Rad51 or Rad59 prevent these rearrangements 
from occurring and will help elucidate the mechanism by which Rad59 prevents 
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genomic instability.  Mutant alleles of RAD59 have been identified that reduce Rad52 
association with double-strand breaks (rad59-K166A), have an effect on homologous 
recombination (rad59-K174Aand rad59-F180A), and affect homologous recombination 
without diminishing Rad52 association to DNA breaks (rad59-Y92A) [11]. To help 
identify the role of Rad59 in preventing aberrant recombination the mutant alleles of 
RAD59 in the sgs1∆ mutants could combined and assessed for types of genome 
rearrangements. 
 
Characterization of the Exo1 C-terminus in the prevention of genome 
instability   
 Sgs1 and Exo1 are known to redundantly resect DNA double-strand breaks to 
generate 3′-overhangs used for the homology search in homology-driven repair [12, 13]. 
We have shown that the loss of both Sgs1 and Exo1 substantially increase the 
accumulation of GCRs.  Exo1 contains an N-terminal and enzymatic domain, and the C-
terminus (predicted to unstructured) has been characterized to harbor physical 
interaction sites with mismatch repair proteins Msh2 and Mhl1. There are four 
phosphorylation sites implicated in the inhibition of its enzymatic function [14-16]. The 
role of the C-terminus of Exo1 in the formation of GCRs had not yet been determined. 
To better characterize the genetic interaction of SGS1 and EXO1, we investigated what 
domains of Exo1 are required for the suppression of GCRs.  We created systematic 
truncations from the C-terminus of Exo1 to determine what was necessary to maintain 
genome stability and challenged these cells with DNA damaging agents and measured 
the accumulation of GCRs. We show that the loss of phosphorylation sites and domains 
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required for the physical interaction of mismatch repair proteins of Exo1 is dispensable 
for its function in the suppression of GCRs in the absence of Sgs1 and only its 
enzymatic function is essential. The loss of Exo1 function occurs from the loss of 260 to 
280 amino acids of the C-terminus, where three of the known phosphorylation sites are 
lost, and the fourth remains intact in both truncations. The loss of the phosphorylation 
sites that were found to modulate Exo1 function did not affect the formation of GCRs. 
These phosphorylation sites were found to be important in the context of uncapped 
telomeres where regulation single strand DNA produced by Exo1 is important for 
modulating the checkpoint response [16].  The inhibition of Exo1 nuclease function is 
not required in suppressing spontaneous mutations or GCRs.  The enzymatic domain of 
the exo1∆C280 allele is still intact, although this truncation still impacts the enzymatic 
function of Exo1 [7]; this could be due to the loss of another post-translational 
modification that occurs in this region or protein interaction site not yet identified.  The 
structure prediction program IUPRED has shown this domain may not be structured, but 
a single amino acid changes the prediction drastically to a more structured prediction 
[7]. While testing this change would not explain the significance of this region it could be 
used to determine if the structure of that region is enough to challenge its enzymatic 
function. Additionally, upon analysis of the amino acid sequence, there is a motif that 
resembles a nuclear localization signal, which could be verified by mutating the motif 
and determining the effect on Exo1 subcellular localization.  Purified wildtype Exo1 and 
exo1 truncation mutants could be analyzed by mass spectrometry for additional physical 
interactions with unknown factors that may play a role in regulating Exo1 function. For 
example, in humans, RPA may play a role in displacing Exo1 as a form of regulation, 
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but a physical interaction with RPA has not been identified in yeast or humans [17]. 
Also, PCNA was found to interact at a PCNA interaction motif (PIP box) located at the 
end of the C-terminus of human Exo1 and is thought to contribute to Exo1's resection 
processivity [18]. 
In chapter three we identify a role for the Exo1 phosphorylation sites in the 
cellular response to replication stress.  Phosphorylation of Exo1 was found to play a role 
in inhibiting its enzymatic function at uncapped telomeres where it has been shown to 
be the principle exonuclease responsible for generating ssDNA at these sites [16, 19].  
Here, we find a new role for the previously described phosphorylation sites at stalled 
replication forks where Exo1 is also known to generate ssDNA preventing fork reversal 
in Rad53 checkpoint-deficient cells to promote error-free repair by template switching 
[20]. We show by using Exo1 mutants that mimic constitutive phosphorylation and a 
mutant that is not able to be phosphorylated, that this post-translational modification 
does not necessarily inhibit Exo1 activity but may be in an active state, which is 
detrimental at stalled forks. It has not yet been determined if just a single 
phosphorylation site out of the four identified is required rather than in combination; 
testing this could reveal the cause for the difference in Exo1 regulation at replication 
intermediates versus uncapped telomeres. The possibility of additional post-
translational modifications of Exo1 and these exo1 mutants, both in the presence and 
absence of HU, could be assessed by mass-spectrometry.  
Moreover, measuring the amount of single-strand DNA in the phospho-mutants 
of Exo1 in a pol32∆ mutant challenged with HU using electron-micrographs would help 
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determine if there is more Exo1 mediated resection, whereas 2D gel analysis could 
reveal the accumulation of replication-dependent recombination intermediates.    
A new separation of function allele of Sgs1 reveals a role in stimulating HR 
repair 
In chapter four we have described a new function of Sgs1 dependent on the 
physical interaction with HR repair factor Rad51.  We previously determined that the 
loss of the C-terminal 260 amino acids of Sgs1 causes defects similar to that of the 
complete loss of Sgs1 with regard to sensitivity to DNA damaging agents and the 
accumulation of genome rearrangements [21]. It was also shown that Rad51 physically 
interacts with Sgs1 in that region although the significance of this physical interaction 
had not been determined [22].  We hypothesized that loss of the physical interaction of 
Sgs1 and Rad51 might be contributing to the defects seen in the sgs1 truncation 
mutant, as this truncation did not impinge on the enzymatic domain.  We identified a 
single amino acid change (F1192D) that disrupts the physical interaction of Sgs1 and 
Rad51 (sgs1-FD allele).  Unexpectedly we found that the sgs1-FD mutant did not exhibit 
any of the defects seen in the sgs1∆C260 truncation mutant. However, when combined 
with the loss of DNA repair factors known to have a genetic interaction with SGS1 we 
observed phenotypes unique to recombination defects. We found a separation of 
function allele where we propose the physical interaction of Sgs1 and Rad51 promotes 
homology-mediated repair, possibly by helping mediate the exchange of RPA and 
Rad51 at DNA breaks. Assessing association of Rad51 with an HO-induced DSB in 
wildtype cells and in the sgs1-FD mutant by chromatin-immunoprecipitation could test 
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whether Sgs1 promotes HR by helping Rad51 load on the ssDNA. The difference in 
RPA affinity for single-strand DNA in the presence of the Sgs1/Rad51 complex could 
also be assessed to determine Sgs1 does help remove RPA and help promote Rad51 
filament formation. 
Together, these findings add to the functions of Sgs1 and Exo1 in protecting the 
genome. 
 
 REFERENCES 
[1] N. Romero-Laorden, E. Castro, Inherited mutations in DNA repair genes and cancer 
risk, Current problems in cancer, 41 (2017) 251-264. 
[2] P.A. Jeggo, L.H. Pearl, A.M. Carr, DNA repair, genome stability and cancer: a 
historical perspective, Nature reviews. Cancer, 16 (2016) 35-42. 
[3] V.G. Gorgoulis, L.V. Vassiliou, P. Karakaidos, P. Zacharatos, A. Kotsinas, T. 
Liloglou, M. Venere, R.A. Ditullio, Jr., N.G. Kastrinakis, B. Levy, D. Kletsas, A. Yoneta, 
M. Herlyn, C. Kittas, T.D. Halazonetis, Activation of the DNA damage checkpoint and 
genomic instability in human precancerous lesions, Nature, 434 (2005) 907-913. 
[4] J. Bartkova, Z. Horejsi, K. Koed, A. Kramer, F. Tort, K. Zieger, P. Guldberg, M. 
Sehested, J.M. Nesland, C. Lukas, T. Orntoft, J. Lukas, J. Bartek, DNA damage 
response as a candidate anti-cancer barrier in early human tumorigenesis, Nature, 434 
(2005) 864-870. 
[5] J. German, M.M. Sanz, S. Ciocci, T.Z. Ye, N.A. Ellis, Syndrome-causing mutations of 
the BLM gene in persons in the Bloom's Syndrome Registry, Human mutation, 28 
(2007) 743-753. 
 206 
[6] L. Doerfler, K.H. Schmidt, Exo1 phosphorylation status controls the hydroxyurea 
sensitivity of cells lacking the Pol32 subunit of DNA polymerases delta and zeta, DNA 
Repair (Amst), 24 (2014) 26-36. 
[7] L. Doerfler, L. Harris, E. Viebranz, K.H. Schmidt, Differential genetic interactions 
between Sgs1, DNA-damage checkpoint components and DNA repair factors in the 
maintenance of chromosome stability, Genome integrity, 2 (2011) 8. 
[8] K. Yamagata, J. Kato, A. Shimamoto, M. Goto, Y. Furuichi, H. Ikeda, Bloom's and 
Werner's syndrome genes suppress hyperrecombination in yeast sgs1 mutant: 
implication for genomic instability in human diseases, Proceedings of the National 
Academy of Sciences of the United States of America, 95 (1998) 8733-8738. 
[9] D.X. Tishkoff, N.S. Amin, C.S. Viars, K.C. Arden, R.D. Kolodner, Identification of a 
human gene encoding a homologue of Saccharomyces cerevisiae EXO1, an 
exonuclease implicated in mismatch repair and recombination, Cancer research, 58 
(1998) 5027-5031. 
[10] K.H. Schmidt, J. Wu, R.D. Kolodner, Control of translocations between highly 
diverged genes by Sgs1, the Saccharomyces cerevisiae homolog of the Bloom's 
syndrome protein, Molecular and cellular biology, 26 (2006) 5406-5420. 
[11] L.C. Liddell, G.M. Manthey, S.N. Owens, B.X. Fu, A.M. Bailis, Alleles of the 
homologous recombination gene, RAD59, identify multiple responses to disrupted DNA 
replication in Saccharomyces cerevisiae, BMC Microbiol, 13 (2013) 229. 
[12] E.P. Mimitou, L.S. Symington, Sae2, Exo1 and Sgs1 collaborate in DNA double-
strand break processing, Nature, 455 (2008) 770-774. 
 207 
[13] Z. Zhu, W.H. Chung, E.Y. Shim, S.E. Lee, G. Ira, Sgs1 helicase and two nucleases 
Dna2 and Exo1 resect DNA double-strand break ends, Cell, 134 (2008) 981-994. 
[14] P.T. Tran, J.A. Simon, R.M. Liskay, Interactions of Exo1p with components of 
MutLalpha in Saccharomyces cerevisiae, Proceedings of the National Academy of 
Sciences of the United States of America, 98 (2001) 9760-9765. 
[15] D.X. Tishkoff, A.L. Boerger, P. Bertrand, N. Filosi, G.M. Gaida, M.F. Kane, R.D. 
Kolodner, Identification and characterization of Saccharomyces cerevisiae EXO1, a 
gene encoding an exonuclease that interacts with MSH2, Proceedings of the National 
Academy of Sciences of the United States of America, 94 (1997) 7487-7492. 
[16] I. Morin, H.P. Ngo, A. Greenall, M.K. Zubko, N. Morrice, D. Lydall, Checkpoint-
dependent phosphorylation of Exo1 modulates the DNA damage response, The EMBO 
journal, 27 (2008) 2400-2410. 
[17] L.R. Myler, I.F. Gallardo, Y. Zhou, F. Gong, S.H. Yang, M.S. Wold, K.M. Miller, T.T. 
Paull, I.J. Finkelstein, Single-molecule imaging reveals the mechanism of Exo1 
regulation by single-stranded DNA binding proteins, Proceedings of the National 
Academy of Sciences of the United States of America, 113 (2016) E1170-1179. 
[18] X. Chen, S.C. Paudyal, R.I. Chin, Z. You, PCNA promotes processive DNA end 
resection by Exo1, Nucleic acids research, (2013). 
[19] X. Jia, T. Weinert, D. Lydall, Mec1 and Rad53 inhibit formation of single-stranded 
DNA at telomeres of Saccharomyces cerevisiae cdc13-1 mutants, Genetics, 166 (2004) 
753-764. 
 208 
[20] C. Cotta-Ramusino, D. Fachinetti, C. Lucca, Y. Doksani, M. Lopes, J. Sogo, M. 
Foiani, Exo1 processes stalled replication forks and counteracts fork reversal in 
checkpoint-defective cells, Mol Cell, 17 (2005) 153-159. 
[21] H. Mirzaei, S. Syed, J. Kennedy, K.H. Schmidt, Sgs1 truncations induce genome 
rearrangements but suppress detrimental effects of BLM overexpression in 
Saccharomyces cerevisiae, Journal of molecular biology, 405 (2011) 877-891. 
[22] L. Wu, S.L. Davies, N.C. Levitt, I.D. Hickson, Potential role for the BLM helicase in 
recombinational repair via a conserved interaction with RAD51, The Journal of 
biological chemistry, 276 (2001) 19375-19381. 
 
 
 
 
 
 209 
 
 
 
Appendix A: 
Phosphoproteomics Reveals Distinct Modes of Mec1/ATR Signaling during DNA 
Replication  
Note to the reader: This chapter has been previously published with permission from the 
publisher as Francisco Meirelles Bastos de Oliveira, Dongsung Kim, Jose ́ Renato 
Cussiol, Jishnu Das, Min Cheol Jeong, Lillian Doerfler, Kristina Hildegard Schmidt, 
Haiyuan Yu, and Marcus Bustamante Smolka.   (2015) ”Phosphoproteomics Reveals 
Distinct Modes of Mec1/ATR Signaling during DNA Replication” Molecular Cell.  57:6, 
1142-32. Permissions are found in appendix B. Genetic analysis was performed by 
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ABSTRACT 
The Mec1/Tel1 kinases (human ATR/ATM) play numerous roles in the DNA 
replication stress response. Despite the multi-functionality of these kinases, studies of 
their in vivo action have mostly relied on a few well-established substrates. Here we 
employed a combined genetic-phosphoproteomic approach to monitor Mec1/Tel1 
signaling in a systematic, unbiased, and quantitative manner. Unexpectedly, we find 
that Mec1 is highly active during normal DNA replication, at levels comparable or higher 
than Mec1’s activation state induced by replication stress. This ‘‘replication-correlated’’ 
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mode of Mec1 action requires the 9-1-1 clamp and the Dna2 lagging-strand factor and 
is distinguishable from Mec1’s action in activating the downstream kinase Rad53. We 
propose that Mec1/ATR performs key functions during ongoing DNA synthesis that are 
distinct from their canonical checkpoint role during replication stress. 
 
INTRODUCTION 
During DNA replication, cells are prone to accumulate genomic instabilities. 
Progression of the replication machinery is often impeded by barriers such as DNA 
adducts, DNA-RNA hybrids, and protein-DNA complexes (Lambert and Carr, 2013). 
Replication forks often stall upon encountering these hard-to-replicate regions, leading 
to exposure of single-stranded DNA (ssDNA), which, in turn, is a major signal for the 
activation of the evolution- arily conserved PI3K-like sensor kinase ATR (yeast Mec1) 
(Mac- Dougall et al., 2007). Once activated, ATR and Mec1 initiate a signaling response 
that induces key effects such as cell-cycle arrest, inhibition of origin firing, and 
stabilization of stalled replica- tion forks (Branzei and Foiani, 2010; Santocanale and 
Diffley, 1998). The importance of ATR is highlighted by the fact that deletion or 
mutations that affect its activity are associated with embryonic lethality, chromosomal 
fragmentation, and increasing sensitivity to genotoxic drugs (Brown and Baltimore, 
2000; Wright et al., 1998). In budding yeast, strains with mec1 mutations were shown to 
accumulate gross chromosomal rearrangements (GCRs) (Myung et al., 2001) and be 
exquisitely sensitive to genotoxic drugs that induce replication stress (Weinert et al., 
1994). Like ATR, the PI3K-like sensor kinase ATM (yeast Tel1) is also important during 
DNA damage responses. Cells lacking ATM show sensitivity to DNA-damaging agents 
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and elevated levels of mitotic recombination (Meyn, 1993), but differently from ATR, 
which is a sensor for ssDNA accumulation, ATM responds mainly to DNA double-strand 
breaks (DSBs) (Shiloh and Ziv, 2013). In yeast, tel1Δ mutants are viable and show no 
significant sensitivity to DNA-damaging agents. However, mec1Δ tel1Δ double mutants 
are more sensitive to replication stress and display a more severe growth defect than 
the single deletion mutants, revealing functionally redundant roles for these kinases 
(Morrow et al., 1995).  
Over the last decade, others and we have identified many candidate substrates 
of Mec1/Tel1 and ATR/ATM using large- scale mass spectrometry (MS)-based 
approaches (Chen et al., 2010; Matsuoka et al., 2007; Smolka et al., 2007). However, 
our understanding of how these kinases promote a systemic cellular response that 
safeguards genomic integrity and allows cells to better cope with the effects of 
replication stress is still limited. A major limitation toward a more comprehensive charac- 
terization of Mec1/Tel1 and ATR/ATM action is posed by the difficulty of reproducibly 
and quantitatively monitoring the many substrates identified by MS. Consequently, the 
use of anti- body-based approaches to monitor well-established substrates remains the 
method of choice. Substrates commonly monitored using western blotting techniques 
include the histone variant H2AX (yeast H2A) and the downstream checkpoint kinases 
CHK1 and CHK2 (yeast Rad53). Despite the biological relevance of these substrates, 
the use of their phosphorylation as readouts for the checkpoint response has introduced 
a marked bias in studies aiming at characterizing Mec1/Tel1 action. To address this 
problem, here we employed a combined genetic-proteomic approach (which we refer to 
as quantitative mass-spectrometry analysis of phospho-substrates [QMAPS]) for 
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identifying and monitoring multiple in vivo kinase substrates in a systematic, unbiased, 
and quantitative manner. Using QMAPS, we show that Mec1 is robustly activated during 
unperturbed DNA replication, in a manner that correlates with the extent of DNA 
replication and that is distinct from a canonical checkpoint. Collectively, our results 
demonstrate the importance of unbiased and quantitative analysis of kinase substrates 
to comprehensively characterize the in vivo action of multi-functional kinases.  
 
RESULTS 
 
 
Unbiased Delineation of Mec1 and Tel1 Action Using a Genetic-Proteomic 
Approach   
Our current understanding of Mec1 and Tel1 action is biased toward the use of a 
few established substrates as reporters of the in vivo activity of these kinases. In 
particular, the activation state of the major downstream kinase Rad53 has been 
extensively used as a key indicator of Mec1 and Tel1 activation status. To circumvent 
this bias and be able to comprehensively characterize the action of Mec1 and Tel1, we 
used quantitative MS analysis of kinase mutant strains to identify and monitor as many 
candidate substrates of these kinases as possible. First, we performed a proteomic 
screen to globally define the set of Mec1 and Tel1 candidate targets. Building on our 
previously published work (Smolka et al., 2007), we used quantitative MS to compare 
the phosphoproteome of wild-type (WT) and mec1∆ tel1∆ cells treated with methyl 
methanesulfonate (MMS) or hydroxyurea (HU) to induce replication stress. To facilitate 
the classification of Mec1/Tel1-dependent phosphorylation sites into direct or indirect 
Mec1/Tel1 phosphorylation events, we also quantified the relative abundance of the 
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phosphopeptides in cells lacking Rad53, the major kinase downstream of Mec1/ Tel1. 
We were able to identify and quantify more than 6,000 phosphopeptides over distinct 
biological replicates (Figure 1A; Table S1). Of interest, the abundance of 232 of the 
identified phosphopeptides was significantly reduced in cells lacking Mec1 and Tel1, 
and we refer to them as Mec1/Tel1-dependent events. Among the 232 Mec1/Tel1-
dependent targets, 115 were found to be dependent on Rad53, and thus considered as 
indirect Mec1/Tel1-dependent events (Figure 1B). In our strategy, direct targets of 
Mec1/Tel1 should be present in the group of phosphopeptides carrying a Mec1/Tel1-
dependent and Rad53-independent phospho-site. As shown in Figure 1C (Table S1), 
analysis of the amino acid in the +1 position of Mec1/Tel1- dependent and Rad53-
independent phospho-sites revealed a strong enrichment of the S/T-Q motif, consistent 
with previous work indicating this preferential motif for Mec1 and Tel1 (Kim et al., 1999; 
Smolka et al., 2007). Of the 117 Mec1/Tel1-depen- dent and Rad53-independent 
phosphorylation events, 97 are in the preferred S/T-Q motif, and we considered them as 
directly targeted by Mec1 or Tel1. On the other hand, Rad53 showed a bias toward the 
S/T-bulky amino acid (c) motif (Figure 1B; Table S1). For more than 60% of the proteins 
found to have a Mec1/Tel1-dependent phosphorylation, we were able to also detect at 
least one Mec1/Tel1-independent phosphorylation event, supporting that most of the 
observed changes are not due to changes in protein abundance (Figure S1; Table S1).  
To sort out the relative contribution of Mec1 or Tel1 in the response, we performed 
similar analyses as described above, but comparing WT cells to cells lacking either 
Mec1 or Tel1 (Figure 1D). Of the Mec1 and Tel1 direct phospho-events identified 
above, 67% were found to heavily depend mostly on Mec1 (Fig- ure 1E; Table S1). Only 
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four phospho-sites were found to heavily depend exclusively on Tel1, consistent with 
the fact that cells lacking Tel1 don’t exhibit significant sensitivity to replication stress-
inducing agents (Morrow et al., 1995). Importantly, about 29% of Mec1/Tel1-dependent 
sites were found to remain robustly phosphorylated in cells lacking either Mec1 or Tel1 
and represent a set of common candidate substrates of these kinases (Figures 1D–1F; 
Table S1). These results establish a large set of Mec1 and Tel1 targets and define their 
relative level of dependency for each of these kinases. This defined set of 
phosphorylation sites targeted by Mec1 and/or Tel1 forms the basis of our unbiased 
strategy to characterize the action of these kinases in different growth conditions and 
genetic backgrounds. The output of this analysis of substrates is a quantitative map, 
herein named QMAPS, revealing the relative levels of phosphorylation of identified 
phosphopeptides in two different conditions being tested (see Figure 2A).  
 
QMAPS Reveals Robust Activation of Mec1 during Normal DNA 
Replication   
It is currently accepted that activation of Mec1 is strongly induced by replication 
stress. This notion is mainly based on the fact that HU-induced replication fork stalling 
leads to a robust activation of Rad53 (Tercero et al., 2003). To test if our unbiased 
QMAPS approach could reveal new insights into the action of Mec1 or Tel1, we 
compared the phosphorylation level of Mec1/Tel1 candidate substrates in cells 
undergoing normal S-phase with cells treated with HU. In both cases, cells were 
arrested in G1 with α-factor and then released from the arrest in media containing HU or 
not for 45 min. As shown in Figure 2A and Table S2, nearly all phosphopeptides 
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carrying a Rad53- dependent phosphorylation site were induced by HU. Unexpectedly, 
only a minor fraction of Mec1 and/or Tel1 candidate substrates was induced by HU 
treatment. This fraction included a phosphorylation site in Rad53 (serine 24) and a 
phosphorylation in the Mrc1 protein (serine 189), the adaptor known to transduce 
signals from Mec1 to Rad53 in response to HU. Most phosphorylation events in Mec1 
and/or Tel1 targets were either only slightly induced by HU or did not change at all when 
comparing cells going through normal replication with cells experiencing HU-induced 
replication stress. Remarkably, a Mec1 autophosphorylation site (serine 38) and 
phosphorylation of Rfa1 and Rfa2 (serines 178 and 122, respectively), which are highly 
dependent on Mec1, were in fact inhibited by HU. Targeted analysis of purified Mec1 
complexes further confirmed that the Mec1 auto- phosphorylation site and 
phosphorylation of Rfa1 are indeed induced during normal S-phase and accumulate as 
more DNA is replicated, following a similar trend observed for the acetylation of H3K56, 
which is a well-established replication mark (Fig- ure 2B) (Masumoto et al., 2005). To 
test if Mec1 activation in normal S-phase is dependent on DNA replication, we used 
QMAPS to compare the phosphorylation levels of its targets in WT cells as well as in 
cells lacking the S-phase cyclins Clb5 and Clb6, which display delayed replication 
initiation due to delayed CDK activation but undergo normal budding dynamics as they 
progress through S-phase (Figures 2C and 2D) (Donaldson et al., 1998). As shown in 
Figure 2D, several Mec1 candidate substrates are highly induced during S-phase in WT 
cells but are not induced in clb5∆ clb6∆ cells at the 35 min time point, when only limited 
DNA replication had occurred in the mutant (Figures 2C and 2D; Table S2). Taken 
together, these results show that Mec1 action in normal S-phase depends, at least 
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partially, on DNA replication. While the MS analysis could detect many Mec1/Tel1-
dependent phosphopeptides in G1 in clb5∆ clb6∆ cells (Figure 2D), we attributed this 
basal phosphorylation level to the potential accumulation of these phospho-events in 
the extended and deregulated S-phase from the previous cell cycle. Very few Rad53-
dependent phosphopeptides were detected in the absence of drug-induced replication 
stress (data not shown). Even in cells lacking three phosphatases known to act on 
Rad53, namely Ptc2, Ptc3, and Pph3 (Heideker et al., 2007), we were not able to detect 
robust Rad53 action during a normal S-phase as we still identified a very limited set of 
targets (Figure S2). Nonetheless, we were able to observe an increase in the level of 
phosphorylation of the detected Rad53 targets in ptc2∆ ptc3∆ pph3∆ triple mutant cells 
compared to WT cells, suggesting that phosphatases play a role in counteracting Rad53 
activation during normal DNA replication.  
Collectively, the QMAPS results shown in Figure 2 reveal that Mec1 is robustly 
activated during normal DNA replication and that this mode of Mec1 signaling is partially 
uncoupled from Rad53 activation. On the other hand, HU-induced replication stress 
leads to an increase in the phosphorylation of most Rad53 targets but to minor changes 
in the phosphorylation of a large fraction of Mec1 targets, or even inhibition of some of 
them. We therefore propose that Mec1 can operate in two distinct modes of signaling 
during DNA replication, one correlated with ongoing DNA synthesis (‘‘replication-
correlated’’) and another correlated with the extent of replication stress that involves 
strong Rad53 activation (canonical checkpoint response).  
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The 9-1-1 Clamp and the Lagging-Strand Factor Dna2 Are Important 
for ‘‘Replication-Correlated’’ Mec1 Activation   
Recent work revealed that activation of the Mec1 kinase in response to 
replication stress or DNA damage requires the action of factors such as Ddc1, Dna2, 
and Dpb11, all of which possess an unstructured region that can tether Mec1 for 
activation (Kumar and Burgers, 2013; Navadgi-Patil and Burgers, 2009; Puddu et al., 
2008). To test if the replication-correlated mode of Mec1 action also requires these 
factors for activation, we used QMAPS to compare phosphorylation of substrates in WT 
and mutants of Mec1-activating factors. As shown in Figure 3A and Table S3, mutation 
of two residues (W128A and Y130A) in Dna2 previously shown to be required for the 
ability of Dna2 to activate Mec1 has mild effects on the ability of Mec1 to target some of 
its specific targets, such as Rfa1, Spt7, and Dad1. Deletion of DDC1 had almost no 
effect in most targets (Figure 3A; Table S3), suggesting that Dna2 has a more 
prominent role in activating Mec1 during normal DNA replication. Importantly, deletion of 
DDC1 also prevents the recruitment of Dpb11 and its ability to activate Mec1 (Navadgi-
Patil and Burgers, 2009). Finally, combination of the dna2 WY-AA mutation (herein 
referred as dna2-AA) with DDC1 deletion had a significant impact on the 
phosphorylation levels of targets that highly depend on Mec1, suggesting that Dna2 and 
Ddc1 function redundantly to activate Mec1 during normal DNA repli- cation (Figure 3A; 
Table S3). This is consistent with the fact that these proteins are known to localize and 
function on the lagging strand of the replication fork. These results suggest that Mec1 
may be activated mostly at the lagging strand of a moving replication fork during normal 
DNA replication.  
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Tel1 Phosphorylates a Specific Group of Mec1 Targets to Prevent 
GCR and Support Robust DNA Replication in the Absence of Mec1    
Analysis of GCRs revealed that activation of Mec1 via Dna2 or Ddc1 during 
replication becomes particularly important in the absence of Tel1, as shown by the 
dramatic increase in GCR in tel1∆ ddc1∆ dna2-AA cells (Figure 3B). This result 
highlights the key role of Tel1 in compensating for the loss of Mec1 during normal DNA 
replication. Consistent with this data, while ddc1∆ dna2-AA cells exhibit a major loss of 
phosphorylation of most Mec1-specific phosphorylation, we could still observe robust 
phosphorylation of targets common to Mec1 and Tel1 during an unchallenged S-phase 
(Figure 3A). We interpret this result as Tel1 acting in the absence of Mec1 activation 
during a normal S-phase. Similar to Mec1’s ‘‘replication-correlated’’ mode, the action of 
Tel1 during normal S-phase (and in the absence of Mec1 activation) does not result in 
higher phosphorylation of Rad53 targets (Figure S3). Of importance, while ddc1∆ dna2-
AA cells can still replicate DNA and progress through S-phase at WT rates (data not 
shown), ddc1∆ dna2-AA cells lacking TEL1 display severe replication defects (Kumar 
and Burgers, 2013). These results suggest that phosphorylation events in one, or 
several, common Mec1 and Tel1 targets play an important role in promoting robust DNA 
replication and prevent- ing the accumulation of GCRs. As shown in Table S3, most of 
these targets are proteins involved in transcription, RNA processing, and chromatin 
regulation, and several of them are either essential or required for efficient S-phase 
progression. These results reveal that Tel1 also plays a role during replication-
correlated signaling, in a manner that is uncoupled from Rad53 activation. But 
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differently from Mec1, Tel1 does not rely on Ddc1 and Dna2 for activation during 
replication, so it remains unclear how Tel1 engages and becomes active at sites of 
ongoing DNA replication. Taken together, this analysis uncovers a subset of Mec1 
targets (common to Tel1) whose phosphorylations are correlated with the ability of cells 
to suppress GCRs and maintain robust DNA replication.  
 
Dna2 and Ddc1 Are Not Essential for Activation of the Canonical Mec1-
Rad53 Signaling Response Following Replication Stress    
To determine the extent in which Dna2 and Ddc1 are necessary for activation of 
the canonical Mec1-Rad53 response during replication stress, we performed QMAPS 
analysis comparing WT cells versus ddc1∆ dna2-AA cells treated with MMS, which 
leads to robust Rad53 activation. As shown in Figure 4A (Table S4), ddc1∆ dna2-AA 
cells exhibit strong defects in Mec1 activation during MMS treatment, but unexpectedly, 
activation of Rad53 under this condition does not seem to be greatly affected. On the 
other hand, similar QMAPS analysis comparing WT and mec1∆ cells revealed a strong 
impact in the phosphorylation of Rad53 targets in the absence of Mec1. These results 
show that ddc1∆ dna2-AA cells do not phenocopy mec1∆ cells regarding Rad53 
activation and suggest the existence of additional factors that may activate Mec1 to 
specifically activate Rad53, consistent with a recent paper (Bandhu et al., 2014). In 
support of the idea of additional Mec1 activator(s), ddc1∆dna2-AA cells are not as 
sensitive to MMS or HU as mec1∆ cells (Figure 4B). Also, while mec1∆ and rad53∆ 
cells are well known to require deletion of the ribonucleotide reductase inhibitor SML1 
for viability (Zhao et al., 1998), we found that ddc1∆ dna2-AA cells do not require SML1 
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deletion for viability (Figure 4C). Of note, even tel1∆ ddc1∆ dna2-AA cells do not require 
SML1 deletion for viability, despite these cells showing the dramatic increase in GCR 
rates that is characteristic of mec1∆ tel1∆ cells. We could exclude the possibility of a 
Ddc1- independent role for Dpb11 in the activation of Mec1 under MMS in ddc1∆ dna2-
AA cells as removal of the C-terminal region of Dpb11, which is required for its ability to 
activate Mec1 (Navadgi-Patil and Burgers, 2008), did not cause loss of viability or major 
growth defect (Figure 4D). As shown in the working model in Figure 4E, we propose two 
distinct modes of Mec1 action during DNA replication, one correlated with DNA 
replication and another correlated with the extent of replication stress as part of a 
canonical checkpoint signaling. In our model, the replication-correlated mode of Mec1 
action functions redundantly with Tel1 to ensure robust DNA replication and prevent 
GCR. On the other hand, the canonical checkpoint mode leads to the well-established 
effects of inhibition of DNA replication and increased production of dNTPs.  
 
DISCUSSION  
The ATR and ATM kinases, and their yeast orthologs, regulate hundreds of 
substrates, but our ability to fully capture their multi-functional action in vivo has been 
hampered by the common use of one or a few classical substrates as readouts of their 
activity. Here we used a quantitative MS approach to monitor in vivo Mec1/Tel1 kinase 
action in a systematic, unbiased, and quantitative manner. Our analysis revealed 
surprising insights into how Mec1 functions during DNA replication and provided 
evidence of a non-canonical mode of Mec1 action, which we propose is distinct from 
Mec1’s established role in the checkpoint response (see model in Figure 4E). 
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By quantitatively monitoring the phospho-status of dozens of Mec1 candidate 
substrates, we found that Mec1 is highly active during normal DNA replication. In fact, 
genetic data support the idea that Mec1 functions during normal DNA replication. For 
example, cells lacking MEC1 and TEL1 exhibit high rates of GCR in an assay 
performed in the absence of any exogenously-induced DNA damage (Myung et al., 
2001). But the prevailing hypothesis has been that the ability of Mec1 to suppress 
spontaneous GCR accumulation is attributed to a residual action of Mec1 in response to 
spontaneous DNA damage generated during DNA replication. Distinct from the notion of 
residual Mec1 activation during normal replication, our work supports a model in which 
Mec1 is highly engaged onto sites of ongoing DNA synthesis to become activated in a 
‘‘replication-correlated’’ manner. Also, distinct from the established role of Mec1 in 
checkpoint signaling, our results reveal that the action of Mec1 during normal DNA 
replication is partially uncoupled from the action of the downstream kinase Rad53. Our 
results are consistent with the idea that Mec1 is either continuously activated during 
ongoing DNA synthesis or is activated at many sites in the genome that pose moderate 
level of difficulty for replication forks to pass. At these sites, forks would only 
dynamically pause, allowing sufficient ssDNA exposure for Mec1 recruitment and 
activation but not for robust Rad53 activation, which requires further recruitment and/or 
phosphorylation of mediator proteins to mount a full checkpoint response. Nonetheless, 
it is important to mention that Rad53 also needs to be activated during normal DNA 
replication. Cells lacking Rad53 are not viable, unless the RNR inhibitor SML1 is also 
deleted (Zhao et al., 1998). But contrary to Mec1’s action, our quantitative analysis 
reveals that the activity of Rad53 in normal DNA replication is significantly lower than 
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drug-induced Rad53 activity (Figure 2A). We speculate that during normal DNA 
replication, Rad53 becomes preferentially activated at specific genomic sites that pose 
major challenges for replication, such as hard-to-replicate transcriptional barriers. 
Interestingly, our results suggest that phosphatases such as Pph3, Ptc2, and Ptc3 may 
also function during normal S-phase to prevent excess Rad53 activation, consistent with 
a recent report showing a constitutive Mec1-Pph3 interaction (Hustedt et al., 2015).  
The identification of a replication-correlated mode of Mec1 action leads to a paradox, as 
Rad53 has established roles in inhibiting DNA synthesis as part of a canonical 
checkpoint response to replication stress (Santocanale and Diffley, 1998). We 
hypothesize that Mec1 positively regulates DNA replication when functioning uncoupled 
from Rad53 activation in the replication-correlated mode (Figure 4E). Consistent with 
this hypothesis, the Bell lab has shown that Mec1 phosphorylates the MCM complex to 
prime it for activation (Randell et al., 2010). We further speculate that the replication-
correlated mode of Mec1 signaling plays a major role in facilitating the movement of 
replication forks by preemptively opening chromatin and/or removing RNA and 
transcriptional machineries from DNA.  
Consistent with this notion, we found that Mec1 targets several proteins involved 
in transcription, RNA processing, and chromatin remodeling during unchallenged DNA 
replication. Also, we showed that during normal DNA replication Tel1 partially 
compensates for the lack of Mec1 by targeting substrates involved in transcription and 
chromatin regulation. The fact that cells lacking both Mec1 and Tel1 are extremely slow 
growing further strengthens the idea that the set of Mec1 substrates that can also be 
phosphorylated by Tel1 comprise a critical set of proteins involved in promoting robust 
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DNA replication. Previous reports have functionally connected Mec1 to chromatin and 
transcription regulation (Rodriguez and Tsukiyama, 2013; Seeber et al., 2013). Our 
work suggests that regulation of these processes by Mec1 is actually part of the normal 
replication program that positively controls ongoing DNA synthesis. The delineation of 
which substrates are common to Mec1 and Tel1 should provide the framework of 
targets that will help better understand the mechanisms by which Mec1 and Tel1 
positively impact DNA synthesis. Finally, the observation that replication- correlated 
mode of Mec1 and Tel1 action does not efficiently relay signaling to Rad53 activation is 
consistent with these ideas, as it is well known that Rad53 activation leads to outputs 
that would antagonize the potential role of Mec1 as a positive regulator of DNA 
replication.  
 
EXPERIMENTAL PROCEDURES  
 
Cell Culture  
Yeast strains used in this study are listed in Table S5. For stable isotope labeling 
of amino acids in cell culture (SILAC), auxotrophic yeast strains for lysine and arginine 
were grown in -Arg -Lys synthetic dropout media supplemented with either normal L-
arginine and L-lysine (light culture) or L-lysine 13C6, 15N2 and L-arginine 13C6, 15N4 
(heavy culture) as describe in Ohouo et al. (2013). 
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ACCESSION NUMBERS  
The MS proteomics data have been deposited to the Peptide Atlas database 
(http://www.peptideatlas.org/) with the data set identifier PASS00651 and PASS00652. 
 
Plasmid  
DNA2 sequence was amplified from genomic DNA and cloned into pFA6a 
plasmid (pMBS 538) followed by site-directed mutagenesis reactions for W128A and 
Y130A mutations. The plasmid generated contains a 50bp upstream region of DNA2 
(from positions -50bp to -1bp of start codon), the DNA2-AA ORF and a 214bp 
downstream region of DNA2 (from positions +1bp to +214bp of stop codon) cloned with 
PacI and AscI. Plasmid pMBS 538 also contains a 500bp downstream region of DNA2 
(from positions +215bp to +715bp of stop codon) (cloned with PmeI and EcoRI) for 
subsequent integration into the endogenous DNA2 locus. DNA2-AA was integrated into 
the endogenous DNA2 locus in a diploid strain preserving the DNA2 promoter and 3’ 
UTR sequences. After sporulation, haploid strains containing DNA2-AA mutant were 
isolated by tetrad dissection and genotyped based on PCR and analysis of auxotrophic 
markers. Plasmid pMBS 538 is available upon request.  
 
Cell Synchronization  
For synchronization, yeast cells were arrested in G1 with α-factor and released in 
α-factor-free media for allowing cells to progress into S-phase. Efficiency of cell cycle 
arrest and release was monitored by FACS analysis.  
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FACS analysis  
Cells sample were collected at appropriate time points, fixed in 70% ethanol and 
stored at -20°C. Yeast cells were harvested by centrifugation, ethanol was removed, 
cell pellet was resuspended in 50mM sodium citrate followed by  
treatement with 200μg/ml of RNase A (Qiagen) for 1h at 37°C and 500μg/ml of 
proteinase K (Invitrogen) for 1h at 42°C. Finally, cells were incubated in the presence 
of Sytox Green (Molecular Probes) for 2h at 4°C. FACS profiles were analyzed using a 
BD Accuri C6 - Flow cytometer and CFlow® software.  
 
Gross Chromosomal Rearrangements (GCR) assay  
Rates of accumulating GCRs were determined by fluctuation analysis by taking 
the median rate of at least 15 cultures from at least two isolates (Lea and Coulson, 
1949; Schmidt et al., 2006) and 95% confidence intervals were calculated according to 
(Nair, 1940). Cells with GCRs were identified by their resistance to canavanine and 5-
fluoro-orotic acid (Canr 5-FOAr), which is indicative of simultaneous inactivation of the 
CAN1 and URA3 genes on the modified chromosome V. Selective media for the GCR 
assay was prepared as previously described (Schmidt et al., 2006).  
 
Protein Extraction and Sample Preparation  
"Light" and "heavy"-labeled cultures were combined, harvested by centrifugation 
in TE buffer pH 8.0 containing protease inhibitors and stored frozen at -80°C until cell 
lysis. Approximately 0.4 g of yeast cell pellet was lysed by bead beating at 4°C in 4 mL 
of lysis buffer containing 50 mM Tris-HCl, pH 7.5, 0.2% Tergitol, 150 mM NaCl, 5 mM 
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EDTA, complete EDTA-free protease inhibitor cocktail (Roche), 5 mM sodium fluoride 
and 10 mM β-glycerophosphate. Protein lysates were denatured in 1% SDS, reduced 
with DTT, alkylated with iodoacetamide and then precipitated with three volumes of a 
solution containing 50% acetone and 50% ethanol. Proteins were solubilized in a 
solution of 2 M urea, 50 mM Tris-HCl, pH 8.0, and 150 mM NaCl, and then TPCK-
treated trypsin was added. Digestion was performed overnight at 37°C, and then 
trifluoroacetic acid and formic acid were added to a final concentration of 0.2%. 
Peptides were desalted with Sep-Pak C18 column (Waters). C18 column was 
conditioned with 5 column volumes of 80% acetonitrile and 0.1% acetic acid and 
washed with 5 column volumes of 0.1% trifluoroacetic acid. After samples were loaded, 
column was washed with 5 column volumes of 0.1% acetic acid followed by elution with 
4 column volumes of 80% acetonitrile and 0.1% acetic acid. Elution was dried in a 
SpeedVac evaporator and resuspended in 1% acetic acid.  
 
Phosphopeptide Enrichment  
Phosphopeptide enrichment was performed as described in (Ohouo et al., 2013). 
After protein extraction and trypsin digestion, desalted peptides were resuspended in 
1% acetic acid and loaded in a tip column containing 30μl of immobilized metal affinity 
chromatography (IMAC) resin prepared as previously described (Albuquerque et al., 
2008). After loading, the IMAC resin was washed with 1 column volume of 25% 
acetonitrile, 100 mM NaCl, and 0.1% acetic acid solution followed by 2 column volumes 
of 1% acetic acid, 1 column volume of deionized water and finally, eluted with 3 column 
volumes of 12% ammonia and 10% acetonitrile solution.  
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HILIC Fractionation  
After phosphopeptide enrichment, samples were dried in a SpeedVac, 
reconstituted in 80% acetonitrile and 1% formic acid and fractionated by hydrophilic 
interaction liquid chromatography (HILIC) with TSK gel Amide-80 column (2 mm x 150 
mm, 5 μm; Tosoh Bioscience). One-minute fractions were collected between 10 and 22 
min of the gradient. Three solvents were used for the gradient: buffer D (90% 
acetonitrile); buffer E (80% acetonitrile and 0.005% trifluoroacetic acid) and buffer F 
(0.025% trifluoroacetic acid). The gradient used consists of a 100% buffer D at time = 0 
min; 98 % of buffer E and 2 % of buffer F at time = 5 min; 82 % of buffer E and 18 % of 
buffer F at time = 15 min; and 5 % of buffer E and 95 % of buffer F from time = 25 to 27 
min in a flow of 150 μl/min.  
 
MS Analysis  
Phosphopeptides were subjected to LC-MS/MS analysis using a Q-Exactive 
Orbitrap or an Orbitrap XL mass spectrometer.  
 
 
Mass Spectrometry Analysis and Data Acquisition  
HILIC fractions were dried in a SpeedVac, reconstituted in 0.1% trifluoroacetic 
acid and subjected to LC-MS/MS analysis using a 20-cm-long 125-μm inner- diameter 
column packed in-house with 3 μm C18 reversed-phase particles (Magic C18 AQ 
beads, Bruker). Separated peptides were electrosprayed into a Q- Exactive Orbitrap 
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mass spectrometer (Thermo Fisher Scientific). Xcalibur 2.2 software (Thermo Fischer 
Scientific) was used for the data acquisition and the Q Exactive was operated in the 
data-dependent mode. Survey scans were acquired in the Orbitrap mass analyzer over 
the range of 380 to 2000 m/z with a mass resolution of 70.000 (at m/z 200). MS/MS 
spectra was performed selecting up to the 10 most abundant isotopes with a charge 
state ≥ than 2 within an isolation window of 2.0 m/z. Selected isotopes were fragmented 
by Higher-energy Collisional Dissociation (HCD) with normalized collision energies of 27 
and the tandem mass spectra was acquired in the Orbitrap mass analyzer with a mass 
resolution of 17.500 (at m/z 200). Repeat sequencing of peptides was kept to a 
minimum by dynamic exclusion of the sequenced peptides for 30 seconds. Some 
analyses were performed in an Orbitrap XL mass spectrometer (Thermo Fisher 
Scientific) as previously described (Ohouo et al. 2013).  
 
Peptide Identification and Quantitation  
Raw MS/MS spectra were searched in a SORCERER (Sage N Research, Inc.) 
system using SEQUEST software and a composite yeast protein database, consisting 
of both the normal yeast protein sequences and their reversed protein sequences as a 
decoy to estimate the false discovery rate (FDR) in the search  
results. To increase the confidence of phosphopeptide identification, we performed a 
parallel search on Proteome Discoverer 1.4 software (Thermo Fisher Scientific) running 
SEQUEST and Percolator. Only phosphopeptides identified with high confidence in both 
SORCERER and Proteome discoverer/percolator searches were considered, which 
resulted in the complete elimination of any hits from the decoy database (FDR < 
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0.02%). Searching parameters included a semi-tryptic requirement, a mass accuracy of 
15 ppm for the precursor ions, differential modification of 8.0142 daltons for lysine, 
10.00827 daltons for arginine, 79.966331 daltons for phosphorylation of serine, 
threonine and tyrosine and a static mass modification of 57.021465 daltons for alkylated 
cysteine residues. XPRESS software, part of the Trans-Proteomic Pipeline (Seattle 
Proteome Center), was used to quantify all the identified peptides. The phosphorylation 
localization probabilities were determined using PhosphoRS within Proteome 
Discoverer (version 1.4.1.14, Thermo Fisher Scientific). All checkpoint-dependent 
phosphopeptides were manually inspected for phospho site assignment and 
quantitation. The mass spectrometry data have been deposited to the Peptide Atlas.  
 
Criteria for establishing kinase-dependency  
As we were interested in defining phospho-events that are highly-dependent on 
MEC1 and TEL1, we began by arbitrarily assigning a high cutoff value (> or = to 6-fold 
WT/mec1∆tel1∆) to establish Mec1/Tel1-dependent events. This helped eliminate 
phospho events whose regulation is partially affected by the lack of MEC1 and TEL1 
and that are more likely to reflect indirect events. In addition, by establishing a high 
cutoff for defining MEC1/TEL1-dependent events, we were able to employ a low cutoff 
for defining Rad53-dependent events (which are already highly pre-filtered by the high 
cutoff in MEC1/TEL1). Furthermore, as the high cutoff was previously used to 
stringently assign Mec1/Tel1-dependent events, we were also able to apply a rather 
lower cutoff of > or = to 2.5 fold to  
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establish which phosphopeptides were highly dependent on either Mec1 or Tel1. Briefly, 
the following criteria was used for assigning Mec1/Tel1-dependent phosphopeptides: (1) 
At least 6-fold increase in phosphopeptide abundance in WT relative to mec1∆tel1∆ 
cells. (2) For Mec1 or Tel1 we established a threshold of 2.5-fold increase in WT relative 
to mec1∆ or tel1∆ cells. (3) For Rad53- dependent phosphopeptides, we established a 
threshold of 2-fold increase in abundance in WT relative to rad53∆ cells. (4) Moreover, 
to be considered a Mec1/Tel1-dependent substrate, each phosphopeptide must be 
Mec1/Tel1- dependent but not Rad53-dependent and to be considered a Rad53-
dependent substrate, each phosphopeptide has to be Mec1/Tel1-dependent and 
Rad53- dependent substrate. (4) Finally, we considered only phosphopeptides identified 
in at least 2 biological replicates.  
 
Fold change calculation and QMAPS generation  
Fold change calculation and QMAPS generation were done using custom- 
designed web tool. The web tool allowed upload of data files generated by the 
SORCERER software. Using this data, it calculated the normalized protein/peptide 
abundances and appropriate abundance ratios. These fold changes were used to 
generate QMAPS using Matlab (Mathworks). To generate the QMAPS, results of the 
phosphoproteome analysis were filtered using a list of kinase checkpoint-dependent 
phosphopeptides identified in this study. For each QMAPS, we considered 
phosphopeptides that were identified at least 3 times in 2 biological replicates. 
Phosphopeptides plotted on the QMAPS were manually inspected for phospho site 
assignment and quantitation.  
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Immunoprecipitation (IP) followed by IMAC  
For immunoprecipitation (IP), cell cultures were collected at 25, 30, 35 and 45 
minutes after release from alpha factor-arrested into S-phase. Cells collected at 25, 30 
and 35 minutes were cultured in “light” media while cells collected at 45 minutes were 
cultured in “heavy” media. Cell pellet was lysed by bead beating at 4°C in lysis buffer 
containing 50 mM Tris-HCl, pH 7.5, 0.2% Tergitol, 150 mM NaCl, 5 mM EDTA, 1 mM 
PMSF, Complete, EDTA-free Protease Inhibitor Cocktail (Roche), 5 mM sodium fluoride 
and 10 mM β-glycerophosphate. After adjusting protein concentrations to about 5 
mg/ml, lysates were incubated with either EZviewTM Red Anti-FLAG M2 agarose 
(Sigma) or acetyl lysine antibody agarose (Immunechem) for 2–3 h at 4°C. After three 
washes in lysis buffer, bound proteins were eluted with three resin volumes of elution 
buffer containing 100 mM Tris-HCl, pH 8.0, 1% SDS. Eluted proteins from “light” or 
“heavy” medium were combined accordingly, reduced, alkylated and precipitated with 
three volumes of a solution containing 50% acetone and 50% ethanol. Proteins were 
solubilized in a solution of 2 M urea and 12 mM Tris-HCl, pH 8.0 and then trypsinized 
O.N. at 37°C with 1μg of Trypsin Gold (Promega). For acetylation analysis of histone 
H3, samples were desalted with a Sep-Pak C18 column (Waters), dried in a SpeedVac 
evaporator and resuspended in 0.1% trifluoroacetic acid. For phosphorylation analysis 
of Mec1 and Rfa1, samples were loaded in a tip column containing 15μl of immobilized 
metal affinity chromatography (IMAC) resin. After loading, the IMAC resin was washed 
with 1 column volume of 25% acetonitrile, 100mM NaCl, and 0.1% acetic acid solution 
followed by 1 column volume of deionized water and finally, eluted with 3 column 
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volumes of 12% ammonia and 10% acetonitrile solution. Samples were dried in a 
SpeedVac, and resuspended in 0.1% trifluoroacetic acid. Samples were subjected to 
LC-MS/MS quantitation analysis.  
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FIGURES AND TABLES 
 
Figure A.1. Proteome-Wide Identification of Mec1/Tel1-Dependent 
Phosphorylation Events Using Quantitative MS (A) Identification of Mec1/Tel1-
dependent phosphopeptides (cells treated with 0.2M HU or 0.04% MMS). Orange dots 
correspond to 238 Mec1/Tel1-dependent phosphopeptides. See text for details.  (B ) 
Mec1/Tel1- and Rad53-dependent phosphorylation events (light orange shade) are 
biased toward the S/T-c (red) and S/T-X-c (purple) motifs.  (C) Mec1 /Tel1 -dependent 
and Rad53-independent phosphorylation events (light orange shade) are biased toward 
the S/T-Q motif (blue). (D and E) The phosphoproteome of WT cells was compared to 
the phosphoproteome of mec1∆ or tel1∆ cells (all cells treated with 0.04% MMS) and 
phos- phopeptides carrying phosphorylation in the S/T-Q motif were categorized 
according to the observed change in abundance. Dotted red lines represent the 
established cutoff of 3-fold increase in WT relative to mec1∆ or tel1∆ cells.  (F ) 
Examples of phosphopeptides of each of the indicated groups. Data are represented as 
fold change in phosphopeptide abundance; log2 ± SEM (n R 2). See also Table S1.  
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Figure A.2. Quantitative Analysis of Mec1/Tel1-Dependent Phosphorylation during 
Normal DNA Replication (A) QMAPS showing the relative abundance of 
phosphopeptides categorized according to results from Figure 1. Phosphopeptides 
carrying Mec1 autophosphorylation or Mec1-dependent Rad53 phosphorylation are 
indicated in gray. a-factor arrested cells were released from arrest in normal SILAC 
media or SILAC media containing 0.1 M HU for 45 min. Abscissa indicates fold change 
in phosphopeptide abundance (linear scale) between S-phase cells treated with 0.1 M 
HU and untreated. (B) Protein extracts were prepared from WT cells at indicated times 
after release from a-factor-arrest into fresh media. Mec1 (and Mec1-associated Rfa1) 
was pulled down, and phosphopeptides containing Mec1 autophosphorylation at S38 
and Rfa1 phosphorylation at S178 were monitored by quantitative MS analysis. FACS 
analysis and H3K56 acetylation were used as positive controls for DNA replication 
progression while acetylation of H3K19 was used as a constitutive control. Data are 
represented as mean ± SEM (n R 2). (C) FACS analysis and budding index of WT and 
clb5∆ clb6∆ mutant cells following a-factor arrest and release in drug-free SILAC 
media.  (D) QMAPS  showing the relative abundance of phosphopeptides carrying 
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Mec1/Tel1-dependent S/T-Q motifs. Indicated cells were released from α-factor arrest in 
drug-free SILAC media for 35 min. For all the QMAPS in Figure 2, each dot 
corresponds to a different phosphopeptide identified at least three times in two 
independent biological replicates. See also Table S2.  
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Figure A.3. Importance of Dna2 and Ddc1 for Replication-Correlated Mode of 
Mec1 Activation  (A) QMAPS showing the relative abundance of phosphopeptides 
carrying Mec1/Tel1-dependent S/T Q motifs. WT, dna2-AA, ddc1∆, and dna2-AA ddc1∆ 
cells were released from α-factor arrest in SILAC media for 45 min. See also Table S3.  
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(B) Effects of the dna2-AA mutation on accumulation of gross-chromosomal 
rearrangements in Ddc1 and Tel1 defective mutants. All strains are sml1∆. Error bars 
indicate 95% confidence intervals (CI).  
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Figure A.4. Dna2 and Ddc1 Are Not Essential for Mec1 Activation during 
Replication Stress (A) QMAPS analysis comparing WT and indicated mutant cells. 
Cells were arrested with a-factor and released from arrest in SILAC media containing 
0.04% MMS for 45 min. See also Table S4.  (B ) 5 -fold serial dilutions of indicated cells 
with sml1∆ background were plated on YPD plates containing indicated drugs and 
incubated at 30 C for 48 hr.  (C) Meiotic tetrads from a DNA2/dna-AA DDC1/ddc1∆ 
TEL1/tel1∆ SML1/sml1∆ diploid strain were dissected on YPD plates and incubated at 
30 C for 72 hr. (D) 4-fold serial dilutions of indicated cells were plated on YPD plates 
and incubated at 30 C for 36 hr. (E) Model depicting distinct modes of Mec1 action 
during DNA replication. See text in the discussion. Blue arrows correspond to newly 
synthesized DNA strands.  
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 Figure A.S1, Related to Figure 1.  
(A) Diagram comparing abundance changes between Mec1/Tel1-dependent and 
Mec1/Tel1-independent phosphopeptides. From 142 proteins found to have a 
Mec1/Tel1-dependent phosphorylation we found 92 representative Mec1/Tel1-
independent phosphopeptides. Red and blue bars correspond to Mec1/Tel1-dependent 
phosphopeptides containing S/T-Q or S/T-ψ motifs, respectively. Black bars correspond 
to Mec1/Tel1-independent phosphopeptides. Dotted line represents the 6-fold threshold 
to establish Mec1/Tel1-dependent events. For detailed information see Supplemental 
Table S1. Dotted rectangles highlight Rad9 and Rtt107 phosphopeptides. (B) 
Representative examples for Rad9 and Rtt107 showing the abundance changes of 
theirs Mec1/Tel1-dependent and independent phosphopeptides.  
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Figure A.S2, Related to Figure 2: QMAPS comparing wild-type vs pph3∆ptc2∆ptc3∆ 
mutant cells. Cells were released from α-factor arrest in SILAC media for 45 minutes. 
Abscissa shows relative fold change in phosphopeptide abundance (linear scale). Each 
dot corresponds to a different phosphopeptide identified at least 2 times out of 3 
independent biological replicates.  
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Figure A.S3, Related to Figure 3: QMAPS comparing wild-type vs dna2-AA ddc1∆ 
mutant cells. Cells were released from α-factor arrest in SILAC media for 45 minutes. 
Abscissa shows relative fold change in phosphopeptide abundance (linear scale). Each 
dot corresponds to a different phosphopeptide identified at least 2 times out of 3 
independent biological replicates.  
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Table A.S1. All Quantified Phosphopeptides Related to Figure 1 Separate Excel 
file 
http://dx.doi.org/10.1016/j.molcel.2015.01.043.  
  
Table A.S2. QMAPS Related to Figure 2 Separate Excel file  
http://dx.doi.org/10.1016/j.molcel.2015.01.043.  
 
Table A.S3. QMAPS Related to Figure 3 Separate Excel file 
http://dx.doi.org/10.1016/j.molcel.2015.01.043.  
  
Table A.S4. QMAPS Related to Figure 4 Separate Excel file  
http://dx.doi.org/10.1016/j.molcel.2015.01.043.  
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Table A.S5: Yeast strains used in this study  
 
Strain ID Genotype 
KHSY4729 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2∆Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, ddc1::HIS3, sml1::TRP1  
KHSY4732 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2∆Bgl, hom3-10, ade2Δ1, ade8,  
hxt13::URA3, dna2-WY-AA::kanMX6 , sml1::TRP1  
KHSY5024  MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2∆Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, ddc1::HIS3, sml1::TRP1, tel1::natMX  
KHSY5025  MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2∆Bgl, hom3-10, ade2Δ1, ade8,  
hxt13::URA3, ddc1::HIS3, dna2-WY-AA::kanMX6, sml1::TRP1  
KHSY5027 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2∆Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, sml1::TRP1, tel1::NatMX  
KHSY5028 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2∆Bgl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3, ddc1::HIS3, dna2-WY-AA::kanMX6, sml1::TRP1, tel1::natMX  
KHSY5035 MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1, lys2B∆gl, hom3-10, ade2Δ1, ade8, 
hxt13::URA3,dna2-WY-AA::kanMX6, sml1::TRP1,tel1::natMX  
KHSY4726 MATa, ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2∆Bgl, hom3-10, ade2Δ1, ade8,  
hxt13::URA3 sml1::TRP1  
MBS164 MATa, ura3-52, leu2∆1, trp1-63, his3-200, lys2∆Bgl, hom3-10, ade2∆1, ade8, arg4∆, 
sml1::TRP1 bar1::HIS3  
MBS188 MATa, ura3-52, leu2∆1, trp1-63, his3-200, lys2∆Bgl, hom3-10, ade2∆1, ade8, arg4∆, 
sml1::TRP1, bar1::HIS3, rad53::URA3  
MBS189 MATa, ura3-52, leu2∆1, trp1-63, his3-200, lys2∆Bgl, hom3-10, ade2∆1, ade8, arg4∆, 
sml1::TRP1, bar1::HIS3, mec1::URA3  
MBS1964 MATa, ura3-52, leu2∆1, trp1∆63, his3∆200, lys2∆Bgl, hom3-10, ade2∆1, ade8, arg4∆, 
sml1::TRIP1, bar1::HIS3, ddc1::kanMX6  
MBS2035 MATa, ura3-52, leu2∆1, trp1-63, his3-200, lys2∆Bgl, hom3-10, ade2∆1, ade8, arg4∆, 
sml1::TRP1, bar1::HIS3, tel1::URA3  
MBS2042 ura3-52, leu2∆1, trp1∆63, his3∆200, lys2∆Bgl, hom3-10, ade2∆1, ade8, arg4∆, 
sml1::TRIP1, bar1::HIS3, mec1::URA3, tel1::kanMX6  
MBS2220 MATa, ura3-52, leu2∆1, trp1∆63, his3∆200, lys2∆Bgl, hom3-10, ade2∆1, ade8, arg4∆, 
sml1::TRIP1, DNA2 WY-AA::kanMX6, ddc1::HIS3, bar1::URA3  
MBS2223 MATa, ura3-52, leu2∆1, trp1∆63, his3∆200, lys2∆Bgl, hom3-10, ade2∆1, ade8, arg4∆, 
sml1::TRIP1, DNA2 WY-AA::kanMX6, bar1::URA3  
MBS2411 MATa, ura3-52, leu2∆1, trp1-63, his3-200, lys2∆Bgl, hom3-10, ade2∆1, ade8, arg4∆, 
sml1::TRP1, bar1::HIS3, pph3::kanMX6, ptc2::URA3, ptc3::natMX  
MBS2653 ura3-52, trp1-63, his3-200, lys2-Bgl, hom3-10, ade2∆1, ade8,YEL069C::URA3, DNA2 
WY-AA::kanMX6, ddc1::HIS3, DPB11(aa1-600)::TRP1  
MBS2564 MATa, ura3-52, leu2∆1, trp1-63, his3-200, lys2∆Bgl, hom3-10, ade2∆1, ade8, arg4∆, 
sml1::TRP1, bar1::HIS3, clb5::URA3, clb6::kanMX6  
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